We're proud to be recognised among the top 3 in the 2026 Access to Medicine Index. By 2030, we aim to reach 400 million people from underserved communities with our medicines and Health Equity programmes.
Read more about our results: learn.az/6018By8VU4
@AtMIndex
#healthequity #atmindex10 #accesstomedicine
AstraZeneca
AstraZeneca plc () (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. More on Wikipedia
-
AstraZeneca
@AstraZeneca
-
AstraZeneca
@AstraZeneca
For #investors and #media only.
Our 9M and Q3 2026 results are now available, highlighting continued strong commercial performance, with Total Revenue up 7%.
Learn more: learn.az/6015BHokeN
#azn #financialresults $AZNPost not available here, view on X
AstraZeneca
@AstraZeneca
Core EPS increased 14% in 9M 2026.
Learn more: learn.az/6015BHokeN
#azn #financialresults $AZN
AstraZeneca
@AstraZeneca
Our pipeline has delivered 12 key positive Phase III programme readouts year-to-date and 47 approvals in major markets since our Q4 2025 results.
Learn more: learn.az/6015BHokeN
#azn #financialresults $AZN -
AstraZeneca
@AstraZeneca
For #investors:
We’ll be sharing our 9M and Q3 2026 performance update at 07:00 GMT on 30 October 2026.
An accompanying webcast for investors and analysts will take place at 14:30 GMT. Register to attend virtually here: learn.az/6016BHkNas
$AZN -
AstraZeneca
@AstraZeneca
🧬Today marks the opening of our new global R&D centre in Cambridge, Massachusetts, US.
Bringing together exceptional talent and cutting-edge technologies to help accelerate scientific discovery and advance the next generation of medicines. Learn more: learn.az/6016BGLoRQ
$AZN #whatsciencecando -
AstraZeneca
@AstraZeneca
At #climateweeknyc, we shared how partnership is critical for healthier people, health systems and the planet.
Highlights included: our $100m Young Health Programme commitment, a new tool that models the environmental impact of care pathways and the European Network on Climate and Health Education reaching 6,000 medical students.
Thanks to colleagues, partners and young leaders who made this progress possible. -
AstraZeneca
@AstraZeneca
We’re investing more than $100m in our Young Health Programme 2010 to 2030, in partnership with @UNICEF and 60 NGO partners.
By 2030, the programme aims to reach 10m more young people in underserved communities and train 800,000 youth advocates. Learn more: learn.az/6016BGdXUg
#younghealthprogramme -
AstraZeneca
@AstraZeneca
Patient care delivery accounts for around 40% of emissions from the healthcare sector.
Today we're launching CARESA, a free tool that helps health systems estimate the environmental footprint of care pathways and explore opportunities for more sustainable care🌍
🔗learn.az/6013BGjHml -
AstraZeneca
@AstraZeneca
Named #5 in TIME’s World’s Best Companies and ranked #1 in our industry 🌍
Behind this recognition: 96,000+ colleagues, partners and suppliers working together for people, society and the planet.
learn.az/6013BGKaxt
#whatsciencecando #time #worldsbestcompanies -
AstraZeneca
@AstraZeneca
The barriers are real. The gaps in diagnosis, treatment and support aren't just statistics — they're lived experiences that demand action.
Changing what it means to live with a rare disease isn't something any one of us can do alone. It's something we pioneer together with patients, caregivers, researchers, advocates and communities united by a shared belief: that rare should never mean forgotten.
#raredisease
Swipe to learn why it matters. 👉 -
AstraZeneca
@AstraZeneca
32 young leaders from 24 countries. One shared goal: better health.
Meet our 2026 Young Health Programme Impact Fellows and Scholars taking action on health equity, health systems resilience and climate and nature.
With @OneYoungWorld and @YouthAssembly.
#younghealthprogramme -
AstraZeneca
@AstraZeneca
For #investors and #media only.
Our H1 2026 results are now available, highlighting strong growth momentum, with Total Revenue up 6% and continued pipeline delivery.
Learn more: learn.az/6012BEvvGp
#azn #financialresults $AZNPost not available here, view on X
AstraZeneca
@AstraZeneca
In H1 2026, Core EPS increased 11% reflecting strong commercial execution and confidence in our long-term outlook.
Learn more: learn.az/6012BEvvGp
#azn #financialresults $AZN
AstraZeneca
@AstraZeneca
Since our FY 2025 results, our pipeline has delivered 6 key positive Phase III programmes and 8 first approvals in major markets.
Learn more: learn.az/6012BEvvGp
#azn #financialresults $AZN -
AstraZeneca
@AstraZeneca
Named among @TIME World's Most Sustainable Companies for the third consecutive year.
Sustainability is embedded in our strategy and how we operate — helping us build a more resilient, efficient business as we deliver life-changing medicines and support a healthier future for people and the planet.
Learn more: learn.az/6013BDj2gd
#whatsciencecando -
AstraZeneca
@AstraZeneca
We focus on advancing research and understanding of generalised myasthenia gravis (MG), guided by those affected and aiming to improve care and outcomes.
#mgawarenessmonth #myastheniagravis #rarediseases -
AstraZeneca
@AstraZeneca
Today we rang the opening bell at @NYSE to mark our recent share listing and harmonised trading across New York, London and Stockholm. This moment reflects the science, innovation and teamwork helping us turn bold ideas into life-changing medicines.
#azn #whatsciencecando -
AstraZeneca
@AstraZeneca
Named one of @FinancialTimes Europe’s Climate Leaders for the 6th consecutive year.
Our $1bn Ambition Zero Carbon programme has delivered:
↘️88% cut in Scope 1 & 2 emissions
🔋81% EV fleet
💡80%+ supplier spend with SBT partners.
Read more: www.ft.com/content/1d4be2a3-e986-40e1-96a4-2ef732ed143a?s…
#whatsciencecando -
AstraZeneca
@AstraZeneca
This Eosinophilic Diseases Awareness Month, we're calling for earlier diagnosis, better care and continued progress for people living with eosinophilic diseases such as eosinophilic esophagitis (EoE).
#eam2026 #worldeoeday -
AstraZeneca
@AstraZeneca
For investor audiences and business/financial media only 📈
We delivered strong growth in Q1 2026 with Total Revenue above $15 billion, demonstrating our consistent commercial execution as we transform patient care.
Learn more: www.astrazeneca.com/media-centre/press-releases/2026/q1-2…
#azn #financialresults -
AstraZeneca
@AstraZeneca
Receiving a rare disease diagnosis often takes five years and involves multiple doctors, specialists, and misdiagnoses.
Improving the diagnostic process can help shorten this journey for the rare disease community. #raredisease -
AstraZeneca
@AstraZeneca
We highlight the neuromyelitis optica spectrum disorder (NMOSD) community and share insights to support understanding and collaboration in healthcare.
#nmoawarenessmonth #nmosd #raredisease -
AstraZeneca
@AstraZeneca
Rare Disease Day (28 Feb) is a global call to act for more than 400 million people living with rare conditions and their caregivers.
Learn how we listen to and partner with the rare disease community to speed up access to diagnosis and equitable care: learn.az/6017hmwt9 -
AstraZeneca
@AstraZeneca
More than 10,000 rare diseases affect over 400 million people worldwide. Fewer than 10% of these conditions have an approved treatment. Developing and delivering innovative therapies is essential to reach more people in need. #raredisease
-
AstraZeneca
@AstraZeneca
#news for #investors and #media📈
2025 was another year of strong growth with excellent pipeline delivery across all therapy areas and major regions.
Watch our CEO Pascal Soriot share our FY 2025 results and learn more: learn.az/6013h3PrH
#azn #financialresults -
AstraZeneca
@AstraZeneca
Newborn screenings and genetic testing play a critical role in accelerating diagnosis and reducing healthcare costs, yet access remains limited. Expanding availability of these diagnostic tools can support earlier diagnosis of rare diseases. #raredisease
-
AstraZeneca
@AstraZeneca
#news
Exciting news—we are now trading our ordinary shares on the New York Stock Exchange (NYSE) for the first time, aligning trading across the NYSE, London Stock Exchange (LSE), and Nasdaq Stockholm (STO) under a harmonised global listing structure.
#azn -
AstraZeneca
@AstraZeneca
While the definition of a rare disease varies across countries, the number of people affected remains significant. Improving equitable access to healthcare for those living with rare diseases is essential. #raredisease
-
AstraZeneca
@AstraZeneca
Exciting news: AstraZeneca has been named Pharma Company of the Year at the 2025 SCRIP Awards. This recognition reflects our commitment to helping transform the future of healthcare and delivering potentially life-changing medicines to patients.
AstraZeneca
@AstraZeneca
We also won the 🔬 Innovation Award for the ENaBL in vivo CAR-T therapy platform with EsoBiotec.
AstraZeneca
@AstraZeneca
These awards highlight the power of innovation and collaboration. Huge thanks to our teams and partners for making this possible. #scripawards
-
AstraZeneca
@AstraZeneca
#ash25 may be over, but the collaboration to develop new treatments for patients with blood cancers continues. Our haematology leaders share their perspectives on how scientific innovation and bold ambition are shaping future approaches to blood cancer care. #haematology
-
AstraZeneca
@AstraZeneca
#news We announced plans to invest $2 billion to expand our manufacturing footprint in Maryland, part of the $50 billion US commitment made in July. Supporting 2,600 jobs, strengthening US medicines supply chain, and accelerating access to transformative therapies. #azn
-
AstraZeneca
@AstraZeneca
#news for #investors and #media📈
Our 9M & Q3 results are now available and show strong momentum, with Total Revenue up 11% and excellent pipeline delivery: learn.az/601973eAt
#azn #financialresults -
AstraZeneca
@AstraZeneca
We highlight the hypophosphatasia (HPP) community and share insights into the daily challenges of this rare metabolic condition.
Listening to and learning from this patient community supports progress in HPP care.
#worldhppday #hypophosphatasia #raredisease -
AstraZeneca
@AstraZeneca
#esmo25 highlighted why we do what we do — driving innovation, impact and hope for patients.
Thank you to the global oncology community for advancing progress and pushing boundaries. -
AstraZeneca
@AstraZeneca
On #globalpnhawarenessday, we’re joining the #raredisease community around the world to bring attention to paroxysmal nocturnal hemoglobinuria (#pnh).
By deepening awareness and understanding of this rare disease, we’re committed to improving outcomes for those living with PNH. -
AstraZeneca
@AstraZeneca
We’re proud to announce a historic agreement with @POTUS to lower the cost of prescription medicines for American patients while preserving the America’s cutting-edge biopharmaceutical innovation. Learn more: learn.az/6014AQPWK #azn #news
-
AstraZeneca
@AstraZeneca
#news Today we announced we will invest US$4.5 billion in a new manufacturing facility in Virginia— which includes a proposed $500m increase to enhance manufacturing capabilities to bring a broader range of medicines, including cancer, to patients in the US and worldwide.
#azn -
AstraZeneca
@AstraZeneca
We’re pushing the boundaries of science to redefine outcomes, reduce economic burden and prioritize prevention in respiratory and other immune-mediated diseases. Our goal is that every patient gets the care they need and deserve. Read more: learn.az/6015Aj14z
-
AstraZeneca
@AstraZeneca
On #ahusday, we recognise those living with atypical haemolytic uraemic syndrome. We are inspired by the strength and resilience of the #ahus community and remain dedicated to improving care for those affected by this severe and devastating disease. #ahus24sept
-
AstraZeneca
@AstraZeneca
Meet the 2025 #younghealthprogramme changemakers! From Impact Fellows to Scholars, these young leaders are advancing health equity around the world.
Partnering with @OneYoungWorld & @AFSyouthassembly to support the next generation. -
AstraZeneca
@AstraZeneca
#news for #investors and #media📈
Our H1 results are now available and show strong momentum, with Total Revenue up 11% and remarkable pipeline delivery.
learn.az/6010fRVfk
#azn #financialresults -
AstraZeneca
@AstraZeneca
#news for #investors and #media
We’re investing $50 billion in medicines manufacturing and R&D in the US by 2030, including the largest single manufacturing investment we’ve ever made—a new state-of-the-art drug substance manufacturing centre in Virginia.
#azn -
AstraZeneca
@AstraZeneca
Explore our Sustainability Impact Publication which highlights how we're taking action on climate and nature, health equity and health systems resilience. Through collaboration, we can build a healthier future for people, society & planet: learn.az/6014N4J9E
-
AstraZeneca
@AstraZeneca
#news for #investors and #media📈
We continued our strong growth momentum into 2025 with Total Revenue increasing by 10%, driven by double-digit growth across Oncology/ Haematology and BioPharmaceuticals.
#azn #financialresults -
AstraZeneca
@AstraZeneca
🌍 Calling all youth leaders in global health equity! Join our Young Health Programme Impact Fellowship for a fully funded @OneYoungWorld scholarship, financial grant, and development opportunities.
Apply now: learn.az/6018FZLFp
#oyw25 #younghealthprogramme -
AstraZeneca
@AstraZeneca
Are you a young leader advocating for greater health equity? Now’s the time to apply to the Young Health Programme Impact Fellowship in partnership with @OneYoungWorld: learn.az/6011LU8TU
#younghealthprogramme
#oyw25 -
AstraZeneca
@AstraZeneca
This week we hit a major milestone in our Ambition Zero Carbon journey! We partnered with @FutureBiogas to launch the UK’s first unsubsidised biomethane plant. We're proud to be the first UK pharma company using biomethane at scale to power medicine discovery and production.
AstraZeneca
@AstraZeneca
This clean heat solution cuts CO2 emissions and drives sustainable farming practices. It’s all part of our commitment to sustainability and a healthier future.
AstraZeneca
@AstraZeneca
We celebrated this milestone with Dr Miatta Fahnbulleh (@Miatsf), MP, Minister for Energy Consumers, where we discussed the critical role of projects like this in progressing a cleaner, more sustainable energy network for the UK.
Learn more: 👉 learn.az/6019LbbNT -
AstraZeneca
@AstraZeneca
2024 was another year of double-digit growth with continued scientific progress across all Therapy Areas. Our total annual dividend increased by 7% to $3.10 per share and will further increase in 2025.
Watch CEO Pascal Soriot share our Full Year and Q4 2024 results. #aznThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We’re setting new standards in sustainable science, becoming the first organisation to achieve the new
@My_Green_Lab 2.0 Certification. We have over 78 lab spaces certified and 65 achieved the highest certification level – Green.
#whatsciencecando #greenlabs #racetozero -
AstraZeneca
@AstraZeneca
From lab to patient, we’re focused on sustainable science and leveraging digital advances such as electronic product information (ePI), unlocking benefits for people, society and the planet. Learn more: learn.az/6010Q1ZU0
-
AstraZeneca
@AstraZeneca
COPD is responsible for 425 deaths every hour. You can help change this statistic. Early detection and diagnosis paired with timely access to comprehensive care can reduce the burden.
This #worldcopdday, take a stand against COPD: learn.az/6016s6eBC
#speakupforcopd -
AstraZeneca
@AstraZeneca
Congratulations to Pam Cheng, our EVP of Global Operations & IT and Chief Sustainability Officer, who has been named by #time100climate as one of the top global leaders driving climate action. learn.az/6016sMh8m
-
AstraZeneca
@AstraZeneca
We’re supporting the launch of a new Patient Charter, calling for improvements in the quality of care for those living with systemic lupus erythematous. Learn more on how the lupus community is uniting to drive change: learn.az/6019S4p5z
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Our #younghealthprogramme Impact Fellows attended @OneYoungWorld, and developed their global network of young leaders. Learn more here:
learn.az/6017ST3R5
#oyw24 -
AstraZeneca
@AstraZeneca
The landscape of lupus care is changing rapidly, yet challenges to care persist. Profs. Ian Bruce and Julia Weinmann-Menke discuss how the current state of lupus care can be transformed to make achieving lasting remission a priority learn.az/6013Sp5T3
-
AstraZeneca
@AstraZeneca
We’re driving sustainable science, ensuring that our clinical trials
represent the diversity of the communities we serve.
Discover more: learn.az/6010SJWmm
#whatsciencecando -
AstraZeneca
@AstraZeneca
Digital biomarkers can help scientists better understand #rarediseases and develop medicines to address unmet treatment needs. Learn more about this powerful research tool: learn.az/6018UOJma
#whatsciencecando -
AstraZeneca
@AstraZeneca
As part of our commitment to sustainable science and innovation, we’re accelerating progress towards net zero by decarbonising our clinical trials. 🌍
Learn more: learn.az/6018WHoPA
#whatsciencecando -
AstraZeneca
@AstraZeneca
🌟 Big news! We've been honoured with the Corporate Social Responsibility Programme of the Year at the Pharma Industry UK Awards 2024 and a Bronze for Best Community Involvement at the Corporate Engagement Awards 2024.
Proud moment for our team!
#younghealthprogramme -
AstraZeneca
@AstraZeneca
We’re following the science to better understand the complex pathways behind immune-driven diseases, such as cutaneous lupus erythematosus (CLE).
Through more targeted and proactive approaches, we aim to transform outcomes for patients.
Learn more: learn.az/6014oPThQ -
AstraZeneca
@AstraZeneca
The human and economic impact of chronic respiratory diseases like asthma and COPD continues to grow. Leading experts outline why earlier, more proactive intervention is needed to improve outcomes for patients, society, and the planet. Learn more: learn.az/6011WC7eU.
-
AstraZeneca
@AstraZeneca
New research in Nature Genetics introduces MILTON, a cutting-edge machine-learning research tool that accelerates drug targets and biomarkers discovery, with potential to redefine the landscape of preventative health care: learn.az/6017WsgZD
-
AstraZeneca
@AstraZeneca
Momentum is building to tackle chronic obstructive pulmonary disease (COPD). Together with our partners, we have launched The Global State of COPD Report, offering insights for policymakers to reduce the growing COPD burden. Learn more: learn.az/6011WMKtV #speakupforcopd.
-
AstraZeneca
@AstraZeneca
We’re harnessing the power of sustainable science to transform the future of healthcare. From R&D to manufacturing and the delivery of care, we're embedding sustainability into everything we do – from the lab to the patient: learn.az/6015WDGoX
#whatsciencecando -
AstraZeneca
@AstraZeneca
From Cambridge to Gaithersburg, we’re pioneering sustainable science to achieve our 2026 Ambition Zero Carbon targets.
Discover how our R&D centers are leading the way in sustainability and innovation: learn.az/6017lEznP
#whatsciencecando -
AstraZeneca
@AstraZeneca
Announcing our 2024 Young Health Programme Impact Fellows, inspiring young leaders working to build a healthier future for young people, society, and the planet 🌎
Learn more: learn.az/6014Y0EOA
#younghealthprogramme #oyw24 #internationalyouthday -
AstraZeneca
@AstraZeneca
Our Young Health Programme is working to develop young people as health change-makers to catalyse a healthier, more sustainable future.
Learn more: learn.az/6017iup1N
#worldyouthskillsday #younghealthprogramme -
AstraZeneca
@AstraZeneca
We have collaborated with @Americares on the Cambodia Breast Cancer Initiative, through which over 100,000 women were given information and 10,000 were screened.
Find out more here: learn.az/60149Xcqa
#globalhealth #healthcareforall #patienthealth -
AstraZeneca
@AstraZeneca
We're thrilled to announce that for the second year in a row we've maintained our Gold rating for Ecovadis. Rated in the top 3% of companies assessed, this reflects our commitment to driving sustainability from lab to patient.
Discover more: learn.az/6012goAAg -
AstraZeneca
@AstraZeneca
Up to approximately 40% of people with transthyretin amyloidosis (ATTR) have a record of a diagnosed cardiac condition up to five years before their ATTR diagnosis. Learn more about one patient’s journey to an accurate ATTR diagnosis.
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Together with @IGCSociety & @IGCANetwork, we’re sharing inspiring stories from women around the world impacted by #uterinecancer.
Access the video here learn.az/6016gdXbG
#uterinecancerawarenessmonth #endometrialcancer #wombcancer -
AstraZeneca
@AstraZeneca
Discover why some of our next-gen leaders are passionate about delivering sustainable healthcare solutions for people, society and the planet.
Access the full series on YouTube here: learn.az/6019gbhyV
#whatsciencecandoThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
When it comes to immune-mediated diseases, Maria Belvisi feels it is imperative that we find ways to "intervene earlier and stop progressive tissue damage" as we focus on uncovering new approaches and advancing remission.
Discover more: learn.az/60135zqRH
#eular2024 -
AstraZeneca
@AstraZeneca
Pushing the boundaries in haematology requires scientific innovation and community collaboration. Together, we can transform the haematologic cancer care experience.
#eha2024 -
AstraZeneca
@AstraZeneca
For many lupus patients, unpredictable disease flares, delayed diagnoses, and limited care options remain a challenge.
Care paradigms must change, learn more about the progress being made from our POLITICO article: learn.az/60155gYl1 #eular2024 -
AstraZeneca
@AstraZeneca
Using molecular imaging, we are creating detailed molecular maps of tissue samples that enhance our understanding of disease biology.
Discover more about how we use this technology to accelerate drug discovery, including our latest research: learn.az/60135jzhv -
AstraZeneca
@AstraZeneca
We've expanded our partnership with @DirectRelief as a global medicine donation partner. They provide lifesaving medicines to doctors and nurses in humanitarian and crisis settings.
#humanitarianaid #patienthealth #globalrelief -
AstraZeneca
@AstraZeneca
Dyslipidaemia is a major risk factor for cardiovascular disease. Many patients don’t meet their LDL-C targets, highlighting the need for next generation treatment strategies.
Learn more: learn.az/60175K9SF
#whatsciencecando -
AstraZeneca
@AstraZeneca
We know that supporting a healthy environment is critical to people and planet. On #worldenvironmentday we reaffirm our commitment to protecting and restoring nature to build a healthier future. We are #generationrestoration
Discover more: learn.az/6013e7I4J -
AstraZeneca
@AstraZeneca
Congratulations to our Lead2030 Challenge winners, working to solve climate and health challenges facing young people today.
@ajaymittal033 and Eliezer Lappots-Abreu will each receive a US $50,000 grant, a scholarship to the @OneYoungWorld Summit, and a year of mentorship.🌎 -
AstraZeneca
@AstraZeneca
We’re collaborating with our peers on a new Roadmap to Nature Positive for the pharmaceutical sector, to accelerate joint action in support of nature and the health of our planet.
Find our more: learn.az/6016eeAqe -
AstraZeneca
@AstraZeneca
Blood cancers are complex and diverse. We recognise the unique journey of each individual living with blood cancer. Together, we're reshaping the future of haematologic cancer care.
#worldbloodcancerday -
AstraZeneca
@AstraZeneca
At #wha77, we launched the next chapter of our Healthy Heart Africa programme. We’re expanding our work with global and local partners to address more #ncds.
-
AstraZeneca
@AstraZeneca
European health systems could save billions in the next decade through early, targeted screening and diagnosis of chronic kidney disease and immediate access to treatment and care.
Learn the difference a change can make: learn.az/6019dhm3J #era2024 -
AstraZeneca
@AstraZeneca
We’re exploring novel diagnostic approaches using machine learning to help identify people with undiagnosed proteinuria.
Visit learn.az/6013dhdMh to find out more. #era24 -
AstraZeneca
@AstraZeneca
We’re working with @qureight to leverage AI to quantify radiological features in idiopathic pulmonary fibrosis. Learn more about our work in AI: learn.az/6017da47f #ats2024
-
AstraZeneca
@AstraZeneca
Today we revealed a bold ambition to deliver $80bn in total revenue by 2030 ($45bn in 2023). We are set to launch 20 new medicines by 2030 as we bring patients next generation therapies. We will also halve emissions across our value chain by 2030.
#azn #whatsciencecando -
AstraZeneca
@AstraZeneca
Cardiovascular diseases such as heart failure often coexist with renal disorders such as chronic kidney disease. These diseases share common risk drivers including hypertension and dyslipidaemia. Learn about managing care for these interconnected diseases: learn.az/6014jW9O2
-
AstraZeneca
@AstraZeneca
COPD is a complex disease that can impact both the lungs and heart – termed cardiopulmonary risk. Through scientific innovation and partnership with the medical community, we’re advancing a more proactive approach to address the varied risks elevated by COPD. Learn more. #ats2024
-
AstraZeneca
@AstraZeneca
From asthma to chronic rhinosinusitis, eosinophils drive chronic inflammation. Join us in uncovering their impact and transforming patient care. Discover more: learn.az/6017dkja3
#worldeosday #eosawareThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Respiratory diseases like asthma and COPD are complex, with patients still having unmet needs. As leaders in respiratory care, we seek more than symptom control.
Join us at #ats2024 as we follow the science to transform care today and for the future. learn.az/6012dRys8 -
AstraZeneca
@AstraZeneca
Our Young Health Programme is working to deliver better health choices for brighter life chances. Empowering young people to
avoid risk factors can help prevent diseases that can occur later in life. Learn more: learn.az/6015dXQk1
#worldhypertensionday #younghealthprogramme -
AstraZeneca
@AstraZeneca
When we make the change #forkidneyhealth, we’re creating a better life for chronic kidney disease patients and their caregivers, a healthier economy and environment, and a less strained healthcare system. Take kidney change into your own hands.
-
AstraZeneca
@AstraZeneca
Learn how we’re building a healthier future in ‘Our Sustainability Impact’. From climate change and biodiversity loss, to health equity, health system resilience and ethics in AI, our new publication outlines how we’re addressing urgent health challenges: learn.az/6017dE6hJ
-
AstraZeneca
@AstraZeneca
If not detected early enough, transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) can lead to heart failure with preserved ejection fraction.
Learn more about one patient’s journey to an accurate ATTR-CM diagnosis.This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Understanding the potential causes of heart failure (HF) and its subtypes, HF with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF), can pave the way to timely diagnosis and early intervention. Learn more: learn.az/6017jWdc5 #heartfailure2024
-
AstraZeneca
@AstraZeneca
Switching to sustainable transport solutions is critical for the health of people and planet. That’s why we’re aiming to transition our fleet to battery electric vehicles where technically feasible by the end of 2025. 🚗🔌
Learn more: learn.az/6017jarnW
#evs #ev100 -
AstraZeneca
@AstraZeneca
We’re calling for higher standards of care in lupus to advance remission as an achievable goal.
Learn more about our commitment to transforming lupus care and making remission a reality for more patients: learn.az/6014jqsXa
#worldlupusday #makelupusvisible -
AstraZeneca
@AstraZeneca
Detecting cardiovascular, renal and metabolic (CVRM) diseases earlier allows for prompter intervention, which can slow progression.
Learn more about ways we’re working to innovate and transform CVRM care: learn.az/6019jr0Qb -
AstraZeneca
@AstraZeneca
Are you a passionate young leader working at the nexus of health and climate change?
Apply now for the @YouthAssembly: learn.az/6015jqSdz🌍
#younghealthprogramme #ya29 #changemakers -
AstraZeneca
@AstraZeneca
Earlier diagnosis and treatment of chronic kidney disease can reduce patient and caregiver absenteeism, increase the ability to work and promote long-term productivity. Learn more about the economic impact: learn.az/6013jYDgL #forkidneyhealth
-
AstraZeneca
@AstraZeneca
On #worldovariancancerday, we stand with @OvCancerDay in calling for action to ensure ovarian cancer is recognised as a global health priority. Add your voice to their petition:
learn.az/6012jYDwM #wocd2024
AstraZeneca was not involved in the development of this petition. -
AstraZeneca
@AstraZeneca
Congratulations to Pam Cheng, our EVP of Global Operations & IT and Chief Sustainability Officer, who was named to the #time100health list of people who most influenced global health this year for her leadership addressing the climate-health nexus learn.az/6018jdKq2
-
AstraZeneca
@AstraZeneca
Chronic kidney disease (CKD) represents a growing global challenge, which has a significant impact on economies around the world. #forkidneyhealth
AstraZeneca
@AstraZeneca
In 2022, 647 million unpaid full-time caregivers worldwide refrained from job-seeking due to their caregiving responsibilities — this is equivalent to 8% of the world’s population. Learn how we can mitigate the economic impact of CKD: globalkidneyalliance.org/make-the-change/?linkId=418154127
-
AstraZeneca
@AstraZeneca
COPD is responsible for millions of deaths a year. We’re investigating the multiple pathways and mechanisms involved in COPD, seeking to improve the care pathways available to patients. Learn about our work to advance COPD management.
#whatsciencecando -
AstraZeneca
@AstraZeneca
Early intervention and management can slow progression of chronic kidney disease (CKD) and ease the burden on caregivers’ psychological, physical, and economic wellbeing. Make a change for CKD caregivers by visiting: learn.az/6019bCrJv #forkidneyhealth
-
AstraZeneca
@AstraZeneca
Real-world evidence continues to highlight the ongoing impact of COVID-19 for immunocompromised patients. Reinforcing that they carry a disproportionately large share of the disease impact compared to the general population. Learn more: learn.az/6018bCFTQ #eccmid2024
-
AstraZeneca
@AstraZeneca
As vulnerable populations may be more susceptible to viral or bacterial infections than those who are healthy individuals, there is a need to innovate scientifically, while evolving regulatory pathways. We explore this and more in @statnews: learn.az/6011baNOb #eccmid2024
-
AstraZeneca
@AstraZeneca
Vaccines are one of the most important advancements in the history of modern medicine. We are committed to advancing vaccine research and innovation and preventing infectious disease. #worldimmunisationweek
-
AstraZeneca
@AstraZeneca
Diagnosing chronic kidney disease (CKD) earlier can help reduce the need for dialysis. This would lower the environmental impact of CKD by reducing the need for fresh water and electricity, lessening carbon emissions and healthcare waste.
Learn more: learn.az/6012bciYM -
AstraZeneca
@AstraZeneca
We’re committed to reducing our impact on the planet. This includes reducing the environmental burden of plastics. Wherever possible, we look to incorporate a circular approach into our processes and product designs – from lab to patient: learn.az/6018bwRIe
#earthday -
AstraZeneca
@AstraZeneca
Diagnosing and treating chronic kidney disease in its early stages could reduce costs and preserve health systems’ resources, allowing investment to be redirected to other areas of need. Make the change for kidney health by visiting: learn.az/6019wbbbN
-
AstraZeneca
@AstraZeneca
AstraZeneca recognised with two @Reuters awards 🎉
We’re delighted to win both the ‘Driving Health Equity’ and ‘Sustainability’ categories at #repharma2024 this week for our Young Health Programme and Electronic Product Information.
Thank you, Reuters, for the recognition.This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
New modelling evidence presented at #wcn24 predicts the percentage of the population with chronic kidney disease by 2032 as up to 16.5% across 8 countries. Let’s change this outcome.
Get involved to make a change #forkidneyhealth by visiting learn.az/6017b6PWR -
AstraZeneca
@AstraZeneca
Chronic kidney disease (CKD) is life-changing and can become very serious if left untreated. Earlier detection and treatment of CKD can improve patients’ health-related quality of life. Learn the difference a change can make learn.az/6016wXpq0 #forkidneyhealth
-
AstraZeneca
@AstraZeneca
Good health is at the heart of a sustainable future.
We’re transforming healthcare to secure a future where all people have access to affordable, sustainable and innovative care: learn.az/6017wD5LV
🩺
#myhealthmyright -
AstraZeneca
@AstraZeneca
We have the power to make the change for kidney health and improve the lives of patients, caregivers, healthcare systems, the economy and the environment.
Take kidney change into your own hands by visiting: learn.az/6010ZAcMq
#forkidneyhealth -
AstraZeneca reposted
The Health Policy Partnership
@HealthPolicyPtp
On 16 April, 15:00–16:00 CEST, hear from experts on how electronic product information can provide accessible, environmentally sustainable medicine information.
Sign up for our free webinar: us02web.zoom.us/webinar/register/WN_cjsYyJEuQouJgPwXeHMvEg
#policymakers #regulators #digitalhealth -
AstraZeneca
@AstraZeneca
We’ve announced a pioneering clean heat partnership with China Resources Gas and Everbright Environment to decarbonise the manufacture medicines at our Wuxi site in China.
Discover more: learn.az/6016ZV9Gi -
AstraZeneca
@AstraZeneca
We are calling on policymakers to elevate chronic kidney disease as an urgent global health priority to help create positive change. Make the change #forkidneyhealth: learn.az/6017ZPhxc
-
AstraZeneca
@AstraZeneca
We continue to develop evidence to empower nephrologists, cardiologists, and primary healthcare providers to achieve guideline directed medical care to optimise cardiorenal protection for hyperkalaemia patients. Learn more: learn.az/6011kCKYc
-
AstraZeneca
@AstraZeneca
We’re investing in nature and #waterstewardship to drive positive impact.
To scale action, we partnered with @BioPhorum on a new publication to support the shift to water stewardship for the biopharma industry: learn.az/6013kCzmT
#worldwaterday -
AstraZeneca
@AstraZeneca
Momentum is building to transform lupus care, with EULAR recommendations prioritising earlier intervention with optimised therapy.
Let’s forge a brighter future for those living with lupus and make remission a reality:
learn.az/6015kUbBD
#lupus2024 -
AstraZeneca
@AstraZeneca
People with COPD face increased risk of lung and heart events. This cardiopulmonary risk is elevated after a COPD exacerbation and can last for up to a year. Profs. Chris Gale and Frederik Trinkmann explore how proactive COPD care could address this: learn.az/6013kkOAc
-
AstraZeneca
@AstraZeneca
It’s time to make the change for kidney health. By partnering with @globalkidney, we aim to elevate CKD as an urgent global health priority to drive change.
AstraZeneca
@AstraZeneca
You have the power to make the change. Find out what happens when you do by visiting: learn.az/6019kk8b5 #forkidneyhealth
-
AstraZeneca
@AstraZeneca
Earlier detection of CKD can improve patient outcomes, limiting the impact on health systems, caregivers, economies and the environment. We must create a future where the nearly 850 million people worldwide affected by CKD can live better, healthier lives. learn.az/6017kHmCP
-
AstraZeneca
@AstraZeneca
Intended for investors:
We have entered into a definitive agreement to acquire @AmolytPharma, further expanding our late-stage rare disease pipeline. Learn more about the financial considerations here: learn.az/6019kTK63 -
AstraZeneca
@AstraZeneca
We’re taking joint, scalable action to accelerate the delivery of net zero healthcare alongside public and private members of @TheSMI Health Systems Task Force.
Our work is highlighted in the latest @TheSMI Impact Report: learn.az/6019krUCb.This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Chronic kidney disease (CKD) is a widely underdiagnosed condition, yet it affects more than 10% of the world’s population. We must elevate CKD as an urgent global health priority. Let’s act now. #worldkidneyday #forkidneyhealth
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
COPD mechanisms increase the risk of both lung and heart events, which can include severe COPD exacerbations and cardiac events.
Learn more about how proactive care can address these cardiopulmonary risks from Profs. Chris Gale and Frederik Trinkmann: learn.az/6016k3JNM -
AstraZeneca
@AstraZeneca
We've joined the @HFPolicyNetwork to support the 2024 Summit, bringing together policy, advocacy and clinical experts to discuss advancements in research and therapy to help improve heart failure care. Learn more about the event.
Heart Failure Policy Network
@HFPolicyNetwork
The #hfpolicysummit24 is the only dedicated policy forum bringing together experts to discuss improving the outcomes of people diagnosed with #heartfailure.
In April, join the conversation on how we position heart failure as a global health priority.
www.hfpolicynetwork.org/project/heart-failure-policy-summ… -
AstraZeneca
@AstraZeneca
We’re celebrating the impact that women have in our organisation and the teams around them.
Discover how our colleagues champion diversity and inspire inclusion every day.
#inspireinclusion #iwd2024This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Rare is many. Rare is strong. Rare is proud.
Today, we stand together in support of the broader community. Join us in amplifying the needs of people living with rare diseases.
#rarediseaseday -
AstraZeneca
@AstraZeneca
Our inclusion in the @FTSEWomenLeader and @equileap’s Gender Equality report reinforces our mission to create inclusive and equitable environments where people can thrive and unlock the power of what science can do.
#gerr2024 #ftsewomenThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Calling all young changemakers.
Apply for a fully funded place at @OneYoungWorld Summit Montréal 2024 and be part of the Young Health Programme (YHP) Fellowship. Learn more here: learn.az/6016VfgGi
#younghealthprogramme #oyw24 -
AstraZeneca
@AstraZeneca
People living with #rarediseases face unique challenges, which are further exacerbated by health inequities that prevent quality access to care.
Learn about the bold steps we’re taking to help make a difference in the lives of people with rare diseases: learn.az/6010nhTFm -
AstraZeneca
@AstraZeneca
Our recent publication in Nature Communications shows how we are harnessing the power of AI and data science to augment our approach to drug discovery.
Find out more: learn.az/6019n0GiT
#whatsciencecando -
AstraZeneca
@AstraZeneca
Calling all changemakers. Find out if you can apply for the Lead2030 Challenge, supported by our Young Health Programme Fellowship to receive a grant & the opportunity to attend the @OneYoungWorld Summit in Montréal: learn.az/6010Vfe2I #younghealthprogramme #oyw24 #lead2030
-
AstraZeneca
@AstraZeneca
Recent research provides valuable insights into the role of eosinophilic inflammation in diseases like eosinophilic granulomatosis with polyangiitis (EGPA), offering a window into how patients can achieve remission and elevate care. Learn more: learn.az/6011nmzwW
#aaaai24 -
AstraZeneca
@AstraZeneca
Working in rare disease requires researchers to think differently about clinical trials, and we remain committed to leading the way through our deep understanding and connections with patients and their experiences.
Learn more: learn.az/6011n5qI3 #whatsciencecando -
AstraZeneca
@AstraZeneca
Discover how we’re contributing to a more sustainable future for people, society and the planet in our 2023 Sustainability Report.
We’re making progress on our bold targets by embedding sustainability into everything we do – from the lab to the patient: learn.az/6019nT7Lf -
AstraZeneca
@AstraZeneca
Detecting lung cancer in its early stages is one of the most effective ways to improve survival outcomes and reduce health care costs. Learn how we are prioritising this with our oncology advancements: learn.az/6041nRejR
-
AstraZeneca
@AstraZeneca
#investors #media: We have officially completed our acquisition of @icosavax, helping us build on our expertise in RSV and #vaccinedevelopment. Learn more about our approach to developing next-generation combination VLP vaccines: learn.az/6016nP2gE
-
AstraZeneca
@AstraZeneca
We’re looking for passionate youth advocates to join our Young Health Programme (YHP) Impact Fellowship with @OneYoungWorld to be part of a global health community: learn.az/6010VfVLn
#younghealthprogramme
#oyw24 -
AstraZeneca
@AstraZeneca
Accessible spirometry tests could improve the diagnosis and monitoring of chronic respiratory diseases.
We’re exploring the potential of home spirometry supported by @ArtiQHealth artificial intelligence: learn.az/6016nMVZE
#digitalhealth #healthtech -
AstraZeneca
@AstraZeneca
Health and environmental leaders identified ways to improve health system resilience in the face of climate change at a roundtable we convened with @Seed_Global & @Devex. Find out how we can adapt to climate change challenges: learn.az/6018VfjJQ
#itstartswithhealth #wef24 -
AstraZeneca
@AstraZeneca
Proposal submissions for our CoSolve Challenges close 6th March. We are looking for novel solutions to challenges in health and life sciences research. Apply now: learn.az/6016VpGFe #cosolve
-
AstraZeneca
@AstraZeneca
Our comprehensive resource hub for infectious respiratory viruses includes a symptom comparator for RSV, influenza and COVID-19. Plus essential data for busy healthcare professionals. Learn more at learn.az/6013VbeLJ.
This post is intended for healthcare professionals only -
AstraZeneca
@AstraZeneca
We’re partnering across the healthcare ecosystem to increase access to early intervention for cardiorenal diseases to both improve patient outcomes and reduce the environmental footprint of care. This is sustainable science: learn.az/6017pWD0J #whatsciencecando
-
AstraZeneca
@AstraZeneca
Our collaboration with Dr Walter Moss aims to advance computational approaches in RNA-based target discovery, - identified through CoSolve 2023, our Open Innovation programme, to open doors for advancing scientific research and innovation. Discover more: learn.az/6011VpEZT
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
2023 was another year of double-digit growth and scientific progress. In 2024, we are excited to celebrate our 25th anniversary, and continue to deliver for people, society and the planet. #azn #whatsciencecando
-
AstraZeneca
@AstraZeneca
Join us live tomorrow at the @LSEplc's Market Open Ceremony as we announce our FY and Q4 2023 Results and mark 25 years of pioneering science.
Set up a reminder to watch here: learn.az/6014V3soA -
AstraZeneca
@AstraZeneca
Congratulations to Professor Sir Mene Pangalos, who received the prestigious @BIA_UK Lifetime Achievement Award last night, celebrating his career and recognising the incredible impact scientists have on patients and society. learn.az/6012T0fG8
-
AstraZeneca
@AstraZeneca
At #wef24 we co-hosted a roundtable with @Seed_Global & @Devex on strengthening health system financing in the face of the climate crisis. Experts highlighted an urgent need to:
- Enhance frontline care
- Act early to detect and treat disease
- Strengthen health system financing -
AstraZeneca
@AstraZeneca
We’ve just launched an industry-first renewable power agreement in China through collaboration across the health sector.
We can do more when we work together.
Learn more: learn.az/6013r8Fq9
@LonzaGroup, @Novartis, @novonordisk, @Roche, @envisioncn, @TheSMI -
AstraZeneca
@AstraZeneca
Health is the bedrock of society. By transforming how healthcare is delivered, people, societies, economies and the planet can all thrive. #itstartswithhealth #wef24
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
At #wef24, we’ll focus on how medical and scientific innovation can build a healthier future. Our Chairman Michel Demaré shared his thoughts with @wef on how we can work together to transform healthcare delivery and strengthen health systems. learn.az/6014RSR2M
-
AstraZeneca
@AstraZeneca
We are looking for novel solutions to challenges in health and life sciences research with our CoSolve challenges. Submit a proposal by 6th March. Apply here: learn.az/6011RookL #cosolve
-
AstraZeneca
@AstraZeneca
We are focused on equipping cardiorenal healthcare professionals with new scientific insights to drive proactive management of hyperkalaemia (HK) to transform care for patients. Learn more: learn.az/6012ut1NY
-
AstraZeneca
@AstraZeneca
When hyperkalemia (HK) is diagnosed, lifesaving RAASi therapy is often reduced or discontinued, which can have serious consequences. Learn how we are helping to empower physicians with important insights to advance guideline-directed care: learn.az/6010ut1Qn
-
AstraZeneca
@AstraZeneca
Congratulations to Penny James, COO in R&D BioPharmaceuticals, for her appointment to the Board of Directors of non-profit @My_Green_Lab.
Through our collaboration, we’re embedding sustainable science across our value chain – from the lab to patient: learn.az/6014RpKu6 -
AstraZeneca
@AstraZeneca
Patients with chronic kidney disease (CKD) and heart failure (HF) typically have similar risk factors including diabetes, obesity, and hypertension. They are also likely to share similar related complications such as hyperkalaemia, or elevated potassium levels in the blood.
AstraZeneca
@AstraZeneca
Our research is helping to empower cardiorenal healthcare professionals to optimise guideline-directed medical therapies for hyperkalaemia to achieve more effective cardiorenal protection and improve patient outcomes. Learn more: learn.az/6012ut1ws
-
AstraZeneca
@AstraZeneca
Through clinical innovation, we are leveraging digital health solutions to reduce the environmental footprint of clinical trials. Learn more about our sustainable science efforts to create a healthy future for society and the planet: learn.az/6012ROHPe #whatsciencecando
-
AstraZeneca
@AstraZeneca
#investors #media:
Our agreement to acquire @Icosavax aims to unlock new possibilities in #vaccinedevelopment by pioneering the next generation of VLPs to address high unmet need in infectious diseases. Additional important information can be found here: learn.az/6019RO8tH -
AstraZeneca
@AstraZeneca
The climate crisis is a health crisis. We’re more committed than ever to collaborating with partners to transition to net zero, resilient and equitable health systems - for the health of people, society and the planet.
#cop28uae #whatsciencecando -
AstraZeneca
@AstraZeneca
Blood cancer patients can be insufficiently protected against COVID-19, which can result in an increased risk of infection and serious health outcomes. Learn more: learn.az/6010RH2fn #ash23
-
AstraZeneca
@AstraZeneca
Through our #younghealthprogramme Impact Fellowship, our young leaders are equipping others with the knowledge and resources they need to make informed decisions about their health.
Discover more here: learn.az/6010RKmfn
#cop28uae -
AstraZeneca
@AstraZeneca
Cardiorenal patients with hyperkalaemia experience an increased risk of hospitalisations. We aim to help reduce mortality rates and hospitalisations by providing important insights to advance guideline directed hyperkalaemia management. Learn more: learn.az/6017ut1rP
-
AstraZeneca
@AstraZeneca
Prioritising perspectives of those with lived experiences like Tim and Tony is critical to better understand the challenges faced and what we can do to break down barriers along the care pathway and close the care gap in prostate cancer.
-
AstraZeneca
@AstraZeneca
We are focused on expanding understanding around hyperkalaemia management to help equip physicians with the latest evidence to achieve guideline directed medical RAASi therapy for patients with heart failure and chronic kidney disease. Learn more: learn.az/6012u7zhj
-
AstraZeneca
@AstraZeneca
More than 500,000 genomes are linked to over 15 years of health data. This new global health resource has the potential to advance drug discovery and development of new medicines. It shows what collaboration can achieve. #500kgenomes #whatsciencecando
UK Biobank
@uk_biobank
🧬 We’re excited to announce that we have sequenced the whole genomes of 500,000 UK Biobank volunteers! 🧬
The dataset is the world’s largest of its kind and we’re proud to make it available to approved researchers around the world 🌍
www.ukbiobank.ac.uk/learn-more-about-uk-biobank/news/worl…
#500kgenomes -
AstraZeneca
@AstraZeneca
Immunocompromised (IC) patients and those who care for them continue to carry a significant and disproportionate burden as COVID-19 persists. Learn more: learn.az/6017R6Gx3
-
AstraZeneca
@AstraZeneca
Healthcare contributes around 5% of global emissions. Through @TheSMI Health Systems Task Force, we’re collaborating to scale renewable power in China and India and decarbonise the healthcare supply chain. #cop28uae
-
AstraZeneca
@AstraZeneca
Today we’re announcing a partnership with @The_MRC and @TheMilnerInst, @Cambridge_Uni to establish an innovative new functional genomics lab supporting drug discovery efforts in chronic diseases.
#drugdiscovery #crispr #functionalgenomicsThis media couldn't be displayed. See it on the original post.
AstraZeneca
@AstraZeneca
Thanks to CRISPR technologies, functional genomics is helping us to understand the underlying biology of diseases and revealing promising new drug targets. Discover more: learn.az/6012R61nw #functionalgenomics
-
AstraZeneca
@AstraZeneca
Coordinated care is important to optimally manage hyperkalaemia (HK). Learn more about how we are working to ensure that cardiorenal patients receive guideline-directed treatment and patient-centric disease management. Learn more: learn.az/6017ut16z
-
AstraZeneca
@AstraZeneca
Pancreatic cancer is an ongoing global health burden, with more than 495,000 patients diagnosed worldwide in 2020.
Symptoms are often non-specific so knowing the signs and symptoms is important for early diagnosis and better patient outcomes.
#pancreaticcancerawarenessmonth -
AstraZeneca
@AstraZeneca
Chronic kidney disease (CKD) is one of the world’s biggest health challenges, requiring greater commitment from policymakers across the world. We collaborated with @devex at the 78th U.N. General Assembly to highlight the importance of improving kidney health across the globe.
-
AstraZeneca
@AstraZeneca
We’re putting health at the heart of climate action. Both by driving deep decarbonisation across our business, and by collaborating with partners across the healthcare sector and beyond.
#cop28uae #whatsciencecando -
AstraZeneca
@AstraZeneca
One in three patients with chronic kidney disease and heart failure will have their RAASi therapy discontinued following a hyperkalaemia diagnosis. Learn more about the consequences and why RAASi therapy should be continued: learn.az/6016ut6TM
AstraZeneca
@AstraZeneca
Learn how the evolving science demonstrates that maintaining guideline recommended RAASi therapy can enable patients with hyperkalaemia to achieve more effective cardiorenal protection: learn.az/6016ut6TM
AstraZeneca
@AstraZeneca
We are focused on expanding understanding around HK management to equip physicians with the latest scientific evidence to achieve guideline directed medical therapy for patients and ensure a patient-centric management of hyperkalaemia.
-
AstraZeneca
@AstraZeneca
Our CEO Pascal Soriot, chair of the @TheSMI Health Systems Task Force and @LarsFruergaard, CEO of Novo Nordisk discuss the climate-health crisis, and the transformative action the Task Force is taking to accelerate the delivery of net zero health systems.
-
AstraZeneca
@AstraZeneca
Access to reliable information without language barriers for anyone living with ovarian cancer is critical. Olivia, the digital patient support platform for all those affected by ovarian cancer is now available in German for Swiss residents. learn.az/6016u4Xv4 #occ
-
AstraZeneca
@AstraZeneca
We are reducing the environmental impact of our lab operations by empowering our lab-based colleagues with sustainable research practices: learn.az/6012u4XWr
This is sustainable science.
#whatsciencecando -
AstraZeneca
@AstraZeneca
Our Young Health Programme enables young people to become change-makers in their communities by engaging with their families, peers, community leaders, and policymakers on how to affect change on a greater scale. Discover more here: learn.az/6011uNC3W
-
AstraZeneca
@AstraZeneca
Together with Quell Therapeutics, we have won the Quris Best Partnership Award at SCRIP 2023 for our collaboration to advance T-reg cell therapies, recognising innovative science collaboration towards a shared ambition of cure and remission for chronic immune-mediated conditions.
-
AstraZeneca
@AstraZeneca
Today we announce the launch of Evinova, a health-tech business within AstraZeneca. With strategic collaborations in place with @Parexel and @Fortrea, Evinova offers science based, globally scaled digital products & services to the life sciences sector. learn.az/6019u20nT!
-
AstraZeneca
@AstraZeneca
Flu viruses can impact all ages, and young children are highly effective at spreading the disease, which contributes to the transmission of the virus. While children tend to recover quickly, safety measures like regular hand washing can help protect you and your family.
-
AstraZeneca
@AstraZeneca
Congratulations to our CEO Pascal Soriot, named by #time100climate as one of the 100 most influential leaders driving climate action. Pascal is named as a "Titan" for his sustainability efforts, alongside leaders from governments, business & philanthropy learn.az/6014uLeZI
-
AstraZeneca
@AstraZeneca
Despite affecting 391M people and being the 3rd leading cause of death globally, COPD doesn’t get the attention it deserves on many national health agendas. Let’s act now and make COPD a public health priority. Learn more: learn.az/6018uIRNO
#speakupforcopd #worldcopddayThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Although type-2 diabetes (T2D) is a known risk factor of chronic kidney disease (CKD), T2D patients can often develop CKD without a timely diagnosis.
AstraZeneca
@AstraZeneca
With global prevalence of both T2D and CKD on the rise, there is a need for earlier and proactive detection and treatment of these conditions.
Learn more: learn.az/6019uauIP
#worlddiabetesday -
AstraZeneca
@AstraZeneca
Ahead of COP28, our CEO Pascal Soriot and supply chain apprentice Kate Stevenson reflect on their motivations to prioritise our sustainability efforts and advance collective climate action.
#cop28uae #theclimateandus -
AstraZeneca
@AstraZeneca
Many patients with immune-driven diseases manage symptoms with oral corticosteroids (OCS), increasing the risk of irreversible organ damage long-term. We’re committed to building a better future in Immunology care. Learn more: learn.az/6010utuin. #acr2023
-
AstraZeneca
@AstraZeneca
It’s important to continue the dialogue around the impact of respiratory syncytial virus (RSV) in infants. Awareness plays a vital role in reducing the burden of this leading cause of childhood illness worldwide. learn.az/6011uQkx3
#sharetobersvaware #rsvweek23 -
AstraZeneca
@AstraZeneca
Understanding the complex pathways behind immune-driven diseases can lead to more targeted care plans and improved patient outcomes.
We're challenging the status quo by advancing understanding of remission as a treatment goal at #acr2023.
Learn more: learn.az/6017utuRD -
AstraZeneca
@AstraZeneca
Last month, our #younghealthprogramme (YHP) Impact Fellows attended @OneYoungWorld, and developed their global network of young leaders dedicated to positive social change. Learn more here: learn.az/6019uQBsX
#oyw23This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Intended for investor or business / science media.
The number of people living with cardiometabolic conditions and obesity today is already over one billion.
AstraZeneca
@AstraZeneca
Intended for investor or business / science media.
We are excited that today we announced an agreement with Eccogene to develop next generation therapeutic options for these patients.
Learn more here: learn.az/6012utHz4 -
AstraZeneca
@AstraZeneca
We’re accelerating the development of our next-generation respiratory inhalers using a near-zero Global Warming Potential propellant to help decarbonise respiratory care. This is sustainable science. learn.az/6016uUhHs #whatsciencecando
-
AstraZeneca
@AstraZeneca
Transthyretin amyloidosis (ATTR) cardiomyopathy and polyneuropathy can cause symptoms such as fatigue, exercise intolerance and sensory deficits, which mimic symptoms of other, more common diseases.
Learn more about managing care for ATTR patients: learn.az/6015ul26R -
AstraZeneca
@AstraZeneca
Transthyretin amyloidosis-polyneuropathy (ATTRv-PN) occurs when TTR proteins misfold and build up in the peripheral nervous system. These misfolded proteins cause damage and can lead to motor disability. Learn more about improving outcomes for ATTRv-PN: learn.az/6019ulFtN
-
AstraZeneca
@AstraZeneca
Hyperkalaemia (HK) can be a recurring condition in patients with chronic kidney disease (CKD), and new data are revealing how a HK event is associated with CKD progression. #asn2023
AstraZeneca
@AstraZeneca
A new dual-country real-world evidence study found that risk of progression to kidney failure is over 70% higher in CKD patients who discontinued RAASi therapy after a HK event compared to patients who remained on this lifesaving therapy.
AstraZeneca
@AstraZeneca
Patients with CKD that maintain RAASi after an episode of HK have improved outcomes. Learn more about HK: learn.az/6012ulL00 #asn2023
-
AstraZeneca
@AstraZeneca
New data highlights the high risks associated with chronic kidney disease and illustrates the need for earlier intervention to mitigate cardiorenal complications and optimise kidney-protective treatment. #asn2023
Post not available here, view on X
AstraZeneca
@AstraZeneca
The risks were independent of type 2 diabetes (T2D) status, although those without T2D were less well managed compared to those with T2D. #asn2023
AstraZeneca
@AstraZeneca
Learn how we’re working to understand the interconnections of these conditions to help improve outcomes for patients and mitigate costs driven by cardiorenal complications: learn.az/6017ulL15 #asn2023
-
AstraZeneca
@AstraZeneca
New real-world evidence illustrates that patients with hyperkalaemia (HK) experience significantly higher rates of chronic kidney disease progression compared to patients without HK. #asn2023
AstraZeneca
@AstraZeneca
This data helps to confirm HK is a condition requiring proactive care. Learn more about the connection between HK and CKD: learn.az/6016ulxhQ #asn2023
-
AstraZeneca reposted
AMMF
@CharityAMMF
Data now show numbers of #cca are similar to HCC, the better recognised primary liver cancer. But CCA is less well known, harder to diagnose, has appalling survival rates & rising incidence worldwide, inc younger people. www.ammf.org.uk/rethink-liver-cancer #rethinklivercancer #livertwitter
-
AstraZeneca
@AstraZeneca
Prof. Nicolas Roche discusses the need to protect healthcare for people with #respiratorydiseases alongside efforts to protect the environment. Learn more: learn.az/6015ulWmU
-
AstraZeneca
@AstraZeneca
#lungcancer rates are increasing every year. Find out how you or your loved one can take control of their lung health. learn.az/6017u9HJV #taketheplunge #lcam
-
AstraZeneca
@AstraZeneca
Even at low concentrations, we understand that the risks associated with Pharmaceuticals in the Environment (PIE) should be determined, minimised and managed.
This media couldn't be displayed. See it on the original post.
AstraZeneca
@AstraZeneca
Learn more about our sustainable science focus and industry leading approach to the management of PIE. learn.az/6013uYiP9 #whatsciencecando
-
AstraZeneca
@AstraZeneca
New real-world evidence highlights the disproportionate burden facing IC individuals in COVID-19 even when fully vaccinated against the virus.
Learn more: learn.az/6016u9TC6 -
AstraZeneca
@AstraZeneca
By growing three different types of cells together in the lab our scientists have worked with @emulateinc to create a reliable model of a key part of the human kidney. Find out how this valuable tool is advancing our research into chronic kidney disease: learn.az/6017ugFYV
-
AstraZeneca
@AstraZeneca
Ahead of COP28, our CEO Pascal Soriot has joined fellow CEOs from the @wef Alliance of CEO Climate Leaders to call for action to accelerate and scale efforts to decarbonise. learn.az/6017ugysN #cop28
-
AstraZeneca
@AstraZeneca
We're partnering with @AmyloidosisA to raise awareness about transthyretin amyloidosis (ATTR) and its phenotypes, cardiomyopathy and polyneuropathy.
Learn more about the challenges these patients often face receiving the correct diagnosis. #worldamyloidosisdayThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Find out how we’re unlocking the power of sustainable science to build a healthier future for people, society and planet: learn.az/6017udKTV
#whatsciencecando -
AstraZeneca
@AstraZeneca
In 2020 alone, approximately 417,400 women* were diagnosed with endometrial cancer, a reality Bar and Kyriaki know too well. Stories like these are important to raise awareness of endometrial cancer, ensuring patients and caregivers are heard.
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We continue to share our data to accelerate scientific progress that benefits human health. Data from our recent research, published in Nature, are now available to the scientific community on our open access portal: learn.az/6010uZ0yK
-
AstraZeneca
@AstraZeneca
Discover @iian_info's call to action, advocating for policy strategies to protect immunocompromised people from COVID-19 risks. Learn more: learn.az/6019uk6x9
Disclaimer: We funded the development of the network without influencing the direction of the activities. -
AstraZeneca
@AstraZeneca
We imagine a future where every person is protected from infectious disease, for every season. #idweek2023
-
AstraZeneca
@AstraZeneca
We’re aiming to lead the science in vaccines and immune therapies, pioneering new ways to protect the most vulnerable from infectious diseases. #idweek2023
-
AstraZeneca
@AstraZeneca
Eight early-career scientists from around the world have won the R&D Postdoctoral Challenge.
The winners have been awarded postdoctoral positions at one of our strategic R&D centres to turn their own innovative research ideas into reality: learn.az/6018uTirjThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Our Young Health Programme supports Girls Belong Here 2023, an annual call to action deepening the awareness of issues perpetuating gender inequality.
Discover more here: learn.az/6016uRmxE #dayofthegirl #girlsbelonghere2023 #younghealthprogramme -
AstraZeneca
@AstraZeneca
Transthyretin amyloidosis (ATTR) is a progressive disease with different phenotypes such as cardiomyopathy and neuropathy. Some people experience symptoms of both, known as mixed phenotype.
Learn more about improving ATTR outcomes: learn.az/6015uM7rB #hfsa2023 -
AstraZeneca
@AstraZeneca
Breakthrough research published today in @Nature shows never-before identified connections between rare genetic variants and proteins.
By applying insights from these findings to our ongoing drug discovery efforts, we are turning science into medicine: learn.az/6015uM6ZD -
AstraZeneca
@AstraZeneca
Transthyretin amyloidosis (ATTR) is a potentially fatal condition. If left untreated, it can lead to issues such as heart failure (HF) and peripheral nerve damage.
Learn more about the need for increased awareness of this condition: learn.az/6011uKGRR -
AstraZeneca
@AstraZeneca
Despite progress, breast cancer remains the leading cause of cancer deaths in women.
Many deaths could be prevented if all patients had access to early diagnosis and optimal care. That’s why we're working to make breast cancer a public health priority. #breastcancerawarenessmonth -
AstraZeneca
@AstraZeneca
Pam Cheng our EVP, Global Operations, Global IT and Chief Sustainability Officer has been named by Fierce as one of its Fierce 50 Honorees of 2023 and being recognized for pushing boundaries, defying limitations and shaping the future of healthcare. learn.az/6011uK8gX
-
AstraZeneca
@AstraZeneca
Language shouldn't be a barrier to education and support for anyone living with ovarian cancer; this is why Olivia, the digital patient support platform for all those affected by ovarian cancer, is now also available in the Turkish language. learn.az/6017uHQLT #esgo2023 #occ
-
AstraZeneca
@AstraZeneca
Hyperkalaemia (HK) can be a serious, chronic condition where potassium levels in the blood are higher than normal and it is often associated with heart failure (HF).
AstraZeneca
@AstraZeneca
A HK diagnosis can sometimes prevent patients with HF from achieving guideline recommended RAASi therapy.
But evolving science shows HK can be managed, allowing RAASi therapy to be maintained in patients with both HF and HK.
AstraZeneca
@AstraZeneca
We're working to address the unique needs of cardiorenal patients living with HK by advancing research to help patients optimise treatment options.
Learn more about HK in cardiorenal patients: learn.az/6016uHYxq #worldheartday -
AstraZeneca
@AstraZeneca
We’re ranked number 1 in the STAT rankings report for pharma and biotech. Through bold climate action and innovative partnerships, we’re leading our sector in accelerating the decarbonisation of healthcare.
STAT
@statnews
An exclusive analysis reveals that many biotech and pharma companies are starting to take action to combat global warming as they face pressure from investors and other stakeholders. www.statnews.com/2023/09/28/a-stat-analysis-shows-how-top… via @betsyladyzhets
-
AstraZeneca
@AstraZeneca
The heart and the kidneys are interconnected, meaning chronic kidney disease and similar conditions can cause or worsen cardiovascular conditions such as heart failure (HF).
Learn more about the cardiorenal connection: learn.az/6013uGUuX #worldheartday -
AstraZeneca
@AstraZeneca
The @OneYoungWorld World Summit 2023 will equip our Young Health Programme and employee delegation with the motivation to create even more impact within their communities and workplaces.
Learn more at: learn.az/6015u1sAv
#younghealthprogramme #oyw23 #oneyoungworld -
AstraZeneca
@AstraZeneca
The climate crisis is the most urgent public health threat of our time. At #climateweeknyc and #unga78, we explored the bold action needed to address the climate-health nexus: learn.az/6014u1Urj
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
In our latest paper in Nature Medicine, we discuss how we’re transforming our clinical trials with digital health solutions, helping us deliver the next generation of life-changing medicines for patients. Discover more: learn.az/6018uEU4k
-
AstraZeneca
@AstraZeneca
We support the newly formed Global Patient Alliance for Kidney Health, @globalkidney which aims to bring together global patient advocacy organizations to raise awareness and improve access to early screening and treatment of chronic kidney disease.
This media couldn't be displayed. See it on the original post.
AstraZeneca
@AstraZeneca
Learn more at the Global Patient Alliance for Kidney Health website: learn.az/6019u6UCW
-
AstraZeneca
@AstraZeneca
New research allows us to advance our understanding of the role eosinophilic inflammation plays in a range of inflammatory diseases such as eosinophilic granulomatosis with polyangitis (EGPA) to improve diagnosis and care. Discover more: learn.az/6014u65HI
-
AstraZeneca
@AstraZeneca
Our Young Health Programme (YHP) partnership with @OneYoungWorld are supporting our Impact Fellows to attend the 2023 Summit for a transformative experience to help create a positive change. Meet our YHP Fellows: learn.az/6012PhIck #younghealthprogramme #oyw23 #oneyoungworld
-
AstraZeneca
@AstraZeneca
Today we revealed the seven recipients of our postdoctoral funding with @the_MRC supporting research on cell therapies and oligonucleotides leading universities across the UK.
Find out more: learn.az/6013P4ksh
#celltherapies #oligonucleotidesThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Endometrial cancer is one of the most common cancers that affect hundreds of thousands of women* globally. As cases continue to grow, we must prioritise research to improve outcomes.
@WorldGODay @EngageEsgo #gynaecologiccancerawarenessmonth
*assigned female at birth -
AstraZeneca
@AstraZeneca
Good health is at the heart of a sustainable future. Collaboration at scale is needed to build resilient, equitable and net zero health systems, so that people, society and our planet can thrive. #whatsciencecando learn.az/6019P74JN
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
The link between transthyretin amyloidosis and heart failure highlights intricate connections within cardiovascular, renal and metabolic (CVRM) diseases. Learn how understanding this link is crucial for early detection, management and improved outcomes: learn.az/6018Po8Ds
-
AstraZeneca
@AstraZeneca
A deeper understanding of the critical role of the epithelium is key to advancing our understanding of #severeasthma and elevating patient care. Explore epithelial science at EpiCentral to access tools and resources to enhance clinical practice: learn.az/6015PNUNV
-
AstraZeneca
@AstraZeneca
We are pioneering scientific innovation to better understand the significance of eosinophilic inflammation in a range of inflammatory diseases. We hope to address the unmet needs many patients face with the aspiration to help transform care. learn.az/6011PfKrd #erscongress
-
AstraZeneca
@AstraZeneca
Heat and power are critical to the R&D, and production of medicines.
To enable sustainable manufacturing, we’re partnering with @FutureBiogas to power our UK sites with #cleanheat, and we’re also investing in energy efficiencies. learn.az/6019P4T7f
#whatsciencecandoThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
The 5-year survival rate of endometrial cancer is an encouraging 95% if caught early – but can drop as low as 20% if it spreads. We are raising awareness of the symptoms to help catch endometrial cancer early and improve patient outcomes.
#gynaecologicalcancerawarenessmonth -
AstraZeneca
@AstraZeneca
We recently published new research in Nature Communications that shows how we are developing more precise and efficient gene therapy technology. Discover more: learn.az/6011PFcNb
-
AstraZeneca
@AstraZeneca
Severe asthma has historically been underprioritised, but there is an opportunity to change this. Addressing urgent issues could help improve patients’ quality of life, relieve the strain on health systems and reduce the risk of death. learn.az/6011PFir1
-
AstraZeneca
@AstraZeneca
550 million people are living with chronic respiratory diseases, yet many still don’t receive the most appropriate care for their condition. Learn more from physicians @ProfHurst & @CPorsbjerg about clinical changes that could help improve care: learn.az/6013PLp2R
-
AstraZeneca
@AstraZeneca
Metabolic diseases like diabetes and non-alcoholic steatohepatitis profoundly impact health. They raise the risk of cardiovascular complications like a heart attack or stroke while impairing renal function, which could lead to chronic kidney disease.
AstraZeneca
@AstraZeneca
Our research is uncovering the intricate mechanisms connecting diabetes to metabolic comorbidities. By exploring this link we’re finding new ways to potentially reduce cardiovascular risk and end organ failure in the heart, liver or kidneys: learn.az/6013PoBqt
-
AstraZeneca
@AstraZeneca
The #younghealthprogramme is our global community investment initiative that supports the health and well-being of young people worldwide. Learn more here: learn.az/6015Pa0VV
#internationalcharityday -
AstraZeneca
@AstraZeneca
Disruption to care and quality of life continue to be a daily concern for patients like Miguel, and his family. Learn more here: learn.az/6012PaBTw
-
AstraZeneca
@AstraZeneca
Establishing timely #lungcancer patient referrals will form a critical component in improving the quality of care and reducing overall mortality. Learn more about the barriers and recommendations for improving patient referral pathways outlined in this report.
Lung Ambition Alliance
@LungAmbition
Early diagnosis is paramount when it comes to #lungcancer diagnosis as it allows patients to receive treatment sooner which can result in result in improved patient outcomes. A better patient pathway is needed for this to happen. Read our recommendations: www.lungambitionalliance.com/News/optimising-access-to-ca…
-
AstraZeneca
@AstraZeneca
Hyperkalaemia (HK), or elevated levels of potassium in the blood, can be life-threatening when left untreated. Learn more: learn.az/6014PtGe6
This media couldn't be displayed. See it on the original post.
AstraZeneca
@AstraZeneca
Job’s story inspires us to continue driving efforts to advance research using real world evidence to help those with cardiovascular, renal and metabolic diseases with the management of their conditions while maintaining quality of life. Learn more: learn.az/6014PtGe6
-
AstraZeneca
@AstraZeneca
Even though up to 48% of people* with stages 3-4 chronic kidney disease and heart failure can also have hyperkalaemia (HK), patient awareness of the disease remains low.
AstraZeneca
@AstraZeneca
Learn more about the challenges people with HK face and how broader understanding can help improve management: learn.az/6013Ptymc
-
AstraZeneca
@AstraZeneca
The heart and kidneys are intrinsically connected and conditions like heart failure, hypertension and diabetes impact both. Addressing the cardiorenal connection can enable better prevention, early intervention and integrated care for patients #esccongress learn.az/6012PWZys
-
AstraZeneca
@AstraZeneca
Detecting, diagnosing and treating cardiovascular, renal and metabolic diseases requires joint efforts. Learn how partnering with healthcare professionals, patients and governments, can create more advanced care options: learn.az/6013PoBd5
-
AstraZeneca
@AstraZeneca
Heart failure (HF) affects about 64 million people globally, but there's hope for improved outcomes. We’re advocating for policy reforms and empowering the HF community. Learn more about our efforts: learn.az/6018PWkIC #esccongress
-
AstraZeneca
@AstraZeneca
Heart failure is more than a heart condition. We’re leading the way in understanding its connections to other diseases, such as diabetes and chronic kidney disease. Learn how unraveling these links can help improve patient outcomes: learn.az/6013PoBZT
-
AstraZeneca
@AstraZeneca
Cardiovascular, renal and metabolic (CVRM) conditions affect hundreds of millions of people around the world. We estimate that one in three people with a CVRM disease are living with two or more of these chronic diseases. Find out more: learn.az/6013PoqYF
This media couldn't be displayed. See it on the original post.Post not available here, view on X
AstraZeneca
@AstraZeneca
Through collaboration with healthcare professionals, researchers, and patients, we are advancing knowledge and target the shared underlying factors of CVRM diseases. Together, we can make a meaningful impact on patients’ lives.
AstraZeneca
@AstraZeneca
By understanding the CVRM interconnections and targeting the mechanisms that drive them we’ll be able to detect, diagnose and treat people earlier and more effectively. Learn about our goal to stop disease progression and pave the way to a cure: learn.az/6013PoqYF
-
AstraZeneca
@AstraZeneca
Research suggests treating heart disease alone is likely not enough. Understanding the cardiorenal connection is crucial in protecting and managing both heart and kidney health effectively. #esccongress learn.az/6012PWbAw
-
AstraZeneca
@AstraZeneca
Our global disaster relief partnerships including @DirectRelief, @IMC_UK, @BritishRedCross, @UNICEF and @projecthopeorg, deliver crucial healthcare resources to those who need it most in times of crisis: learn.az/6016PeYJs
#worldhumanitarianday
Photo Credit: Direct Relief -
AstraZeneca
@AstraZeneca
Kateřina Šédová is one of our YHP Lead2030 Challenge winners with @OneYoungWorld. Her work encourages preventive check-ups and facilitates access to youth-friendly health information.
Meet all of our YHP Fellows: learn.az/6019PcsT1
#younghealthprogramme
#oyw23 -
AstraZeneca
@AstraZeneca
Alejandro is a YHP Lead2030 Challenge winner with @OneYoungWorld, working to reduce air pollution to create a healthier future
Meet all of our YHP Fellows: learn.az/6013Pi7Ax
@elderechoalno -
AstraZeneca
@AstraZeneca
Our 2023 Young Health Programme Impact Fellows are inspiring young changemakers who are working to deliver better health choices for brighter life chances: learn.az/6017PiOZT
@OneYoungWorld
#younghealthprogramme
#oyw23 -
AstraZeneca reposted
Climate Group
@ClimateGroup
We are delighted to announce @AstraZeneca as a Stream Partner for #climateweeknyc 2023!
-
AstraZeneca
@AstraZeneca
As health risks and other concerns still exist, it’s clear COVID-19 is far from over for immunocompromised patients like Johanne. Learn more: learn.az/6014Pe2pA
-
AstraZeneca
@AstraZeneca
COPD is not well known by the public, a recent @Ipsos poll suggests. Misperceptions can exacerbate existing stigma, inhibiting people from seeking timely help for symptoms. Let's make COPD the health priority it should be and #speakupforcopd.
Read more: learn.az/6012Pbguw -
AstraZeneca reposted
Global Allergy & Airways Patient Platform
@gaapporg
Chronic obstructive pulmonary disease (#copd) is the third leading cause of death worldwide, yet a recent poll shows it remains poorly understood and under-recognised.
Join us to #speakupforcopd and make it the public health priority it needs to be: www.who.int/news-room/fact-sheets/detail/the-top-10-cause… -
AstraZeneca
@AstraZeneca
Despite its potential severity, understanding of hyperkalaemia (HK) remains low. This condition can also be seen as a barrier for achieving guideline-directed medical care (GDMT) in cardiorenal patients.
AstraZeneca
@AstraZeneca
Through advanced research, we aim to improve outcomes by investigating holistic care management for patients with heart failure, chronic kidney disease and HK. Learn more: learn.az/6018PZ7Du
-
AstraZeneca
@AstraZeneca
Our commitment to #sustainability earned us an EcoVadis Gold Medal for 2023. This rating reflects our focus on the environment, human rights and ethics, as well as our efforts to ensure sustainable practices extend across our value chain. #whatsciencecando
-
AstraZeneca
@AstraZeneca
To accelerate the transition to net-zero healthcare, we sponsored @SustHCoalition & @NewcastleNMAHPs to develop a free tool to help hospitals globally understand the CO2 footprint of in-centre haemodialysis: learn.az/6018PVqEk
-
AstraZeneca
@AstraZeneca
Respiratory syncytial virus (RSV) disease is a serious health threat to infants.
Learn more about our efforts to innovate RSV care for all infants from this serious respiratory illness here: learn.az/6016PrsPw -
AstraZeneca
@AstraZeneca
Our CEO Pascal Soriot convenes the @TheSMI Health Systems Task Force. Today, he signed an open letter together with global healthcare leaders calling on suppliers to commit to minimum climate & sustainability targets: learn.az/6018PrDSG
-
AstraZeneca
@AstraZeneca
Enkhuun Byambadorj is on a mission to combat air pollution in Mongolia. Discover how our Young Health Programme champions young leaders: learn.az/6019POFkv #wysd
-
AstraZeneca
@AstraZeneca
Understanding eosinophilic inflammation is crucial. By following the science, we aspire to uncover new and effective ways of managing a range of inflammatory diseases and ultimately, empower patients to improve their quality of life. learn.az/6015P3JRh #ies2023
-
AstraZeneca
@AstraZeneca
Net-zero healthcare is possible through collaboration. We recently convened health leaders for a discussion about decarbonizing healthcare and solutions that reduce emissions and improve health outcomes. Discover more: learn.az/6017PMUOx
-
AstraZeneca
@AstraZeneca
Bronchiectasis is one of the most common lung diseases worldwide but remains relatively unknown.
Learn more: www.astrazeneca.com/what-science-can-do/topics/disease-un…
#worldbronchiectasisday
AstraZeneca
@AstraZeneca
There are currently no approved treatments for bronchiectasis. We are aiming to change this by targeting Pseudomonas aeruginosa, one of the key bacteria that drives disease progression. #worldbronchiectasisday
Post not available here, view on X
AstraZeneca
@AstraZeneca
We’re working with leading clinicians including @ProfJDChalmers at @dundeeuni to understand the clinical need and experiences of people living with bronchiectasis who often experience reduced quality of life. #worldbronchiectasisday
AstraZeneca
@AstraZeneca
We’re following the science to reveal ways to target the bacteria that drive disease progression. Stopping them from damaging the lungs and making them more vulnerable to attack from the immune system. #worldbronchiectasisday
-
AstraZeneca
@AstraZeneca
We are pioneering clinical innovation with the goal of developing new approaches to how we engage with patients, trial teams and healthcare providers, in the clinic and beyond.
Discover more: www.astrazeneca.com/r-d/clinical-innovation.html #clinicalinnovation #clinicaltrial #digitalhealth -
AstraZeneca
@AstraZeneca
We’re expanding #azforest to plant 200 million trees globally by 2030. Our science-led approach to reforestation is focused on mitigating climate change, helping nature and #biodiversity to flourish and creating sustainable livelihoods across six continents.
-
AstraZeneca
@AstraZeneca
Clinicians provide lifesaving care to thousands of people who experience a gastrointestinal (GI) bleed each year.
Read about the fast, coordinated care required to treat these patients: www.astrazeneca.com/media-centre/articles/2023/care-manag… #isth2023 -
AstraZeneca
@AstraZeneca
As a leading cause of death globally, it’s critical that respiratory disease is brought to the forefront of health policy. The International Respiratory Coalition aims to reduce respiratory deaths by a third globally by 2030 – learn more: international-respiratory-coalition.org/wp-content/upload…
-
AstraZeneca
@AstraZeneca
At #isth2023 this week, our team is collaborating with the haematology research and medical communities to help advance vascular care. Through knowledge sharing and collaboration, we can improve the therapies available for these patients. @ISTH
-
AstraZeneca
@AstraZeneca
Major bleeds, including intracerebral and severe gastrointestinal haemorrhages, can become life-threatening emergencies requiring hospitalisation.
Learn more about the need for clear protocols and fast, coordinated care: www.astrazeneca.com/media-centre/articles/2023/care-manag… #isth2023 -
AstraZeneca
@AstraZeneca
#younghealthprogramme and our partners at @UNICEF catalyse a global youth-led advocacy movement for healthier lifestyles and the prevention of NCDs. Together we aim to reach more than five million young people. Discover more: www.younghealthprogrammeyhp.com/updates/YHP-UNICEF-partne…
-
AstraZeneca
@AstraZeneca
Discover Me South Africa is diversifying our genomic data, and together with health information, aims to better understand disease progression and improve personalised patient care. www.astrazeneca.com/what-science-can-do/topics/technologi…
-
AstraZeneca
@AstraZeneca
Our partners at @OneYoungWorld have released their annual Impact Report, and many of our YHP Young Leaders have received recognition for their impactful health promotion work.
Access the report here.
One Young World
@OneYoungWorld
Our 2022 Impact Report has launched! 🤩
Across 190 countries, our Ambassadors have worked on solutions for climate change, social justice, political reform, health equity, and more, directly impacting 5.77 million people in 2022. Read the full report here:www.oneyoungworld.com/impact -
AstraZeneca
@AstraZeneca
Guidelines recommend RAASi therapy for patients with heart failure and chronic kidney disease. Often, hyperkalaemia (HK) can act as a barrier to optimising this therapy.
AstraZeneca
@AstraZeneca
We’re advancing research in HK using real world evidence to help those with HK optimally manage the condition alongside cardiorenal diseases through guideline-directed medical therapies. #era23
-
AstraZeneca
@AstraZeneca
Chronic kidney disease (CKD), defined by decreased kidney function, is a serious, progressive condition. Late diagnosis can be costly and challenging for patients and the healthcare systems. Our ACT on CKD programme aims to mitigate its impact. #era23
AstraZeneca
@AstraZeneca
ACT on CKD and its associated evidence programme have increased disease awareness and generated urgency to transform care. Our ambition is to help transform kidney health and reduce the proportion of patients developing kidney failure by 20% by 2025.
AstraZeneca
@AstraZeneca
To do this, we’re raising awareness of CKD and its consequences as well as helping drive earlier detection of CKD at stage 3 while building on the benefit of earlier intervention. Learn more about our CKD efforts: www.astrazeneca.com/media-centre/articles/2023/transformi…
-
AstraZeneca
@AstraZeneca
The 30 June deadline for the R&D Postdoctoral Challenge is approaching.
If you are an early career scientist with an innovative research idea, submit your proposal today for the chance to earn a fully funded postdoctoral position with us.
Learn more: openinnovation.astrazeneca.com/rd-postdoctoral-challenge.… -
AstraZeneca
@AstraZeneca
Our CEO, Pascal Soriot, & @VictorDzau of @theNAMedicine co-hosted a roundtable on decarbonizing healthcare in the US. Together with leaders from across the health ecosystem, they discussed scalable action and best practices to accelerate the delivery of net zero health systems.
-
AstraZeneca
@AstraZeneca
While the symptoms caused by respiratory syncytial virus (RSV) are cold-like, this contagious virus can lead to serious respiratory illness in infants and can sometimes lead to hospitalisation for infants globally.
Learn more: www.astrazeneca.com/media-centre/articles/2022/in-the-fig… -
AstraZeneca
@AstraZeneca
357M people worldwide will be affected by NASH by 2030, yet zero treatments exist today. To change this, we need to improve access to diagnosis and find new screening methods to help more people join clinical trials.
Learn about our work in NASH: www.astrazeneca.com/what-science-can-do/topics/clinical-i… #nashday -
AstraZeneca
@AstraZeneca
Improved Care Coordination is vital for all people with cancer and, particularly so, for people with lung cancer who tend to have a high symptom load and can require support across a range of services. Find out how this report can help here www.lungambitionalliance.com/News/improving-the-coordinat… #lungcancer
Lung Ambition Alliance
@LungAmbition
Care Coordination refers to the synchronized delivery of the various aspects of a patient’s care – in and outside of the clinic. Our new report identifies barriers to Care Coordination in #lungcancer and provides recommendations to overcome them. www.lungambitionalliance.com/News/improving-the-coordinat…
-
AstraZeneca
@AstraZeneca
While managing uncontrolled bleeds, emergency clinicians lead a multidisciplinary team and follow hospital protocols to quickly deliver lifesaving care.
Learn more about improving outcomes for life-threatening bleeds in the emergency setting: www.astrazeneca.com/media-centre/articles/2023/care-manag… -
AstraZeneca
@AstraZeneca
Several health authorities agree that immunobridging trials can potentially help bring medicines to patients faster.
Learn more about this research approach here: www.astrazeneca.com/what-science-can-do/topics/covid-19/i… -
AstraZeneca
@AstraZeneca
Lupus is a complex autoimmune disease that has historically had limited care options. We’re working with the community to improve standards of care and advance our understanding of the underlying drivers of lupus. www.astrazeneca.com/our-therapy-areas/respiratory-and-imm… #eular2023
-
AstraZeneca
@AstraZeneca
Patients diagnosed with advanced endometrial cancer have limited care options and poor prognoses compared to those diagnosed at an earlier stage.
It is crucial that new research delivers expanded and improved care options, ultimately enhancing patient outcomes. -
AstraZeneca
@AstraZeneca
Emergency medicine clinicians provide lifesaving care to millions of people each year. While it’s important to manage these urgent conditions quickly, patient safety should always be at the center of the care plans. #emergencymedicineday @EmergencyDay
-
AstraZeneca
@AstraZeneca
As active PSCI members, we’re proud of the sustainability achievements outlined in the 2022 #psciannualreport. Together with our peers, we’re driving responsible supply chain practices, including supplier targets to cut Scope 3 emissions and accelerating the switch to renewables.
-
AstraZeneca
@AstraZeneca
Our Chair Michel Demaré joined a #wha76 formal session on the role the health community plays in climate action, emphasising the link between keeping people healthy and keeping our planet healthy. www.who.int/news-room/events/detail/2023/05/24/default-ca…
-
AstraZeneca
@AstraZeneca
Uncontrolled major bleeds must be managed swiftly in the emergency setting. Learn more about the importance of early, guideline-driven care: www.astrazeneca.com/media-centre/articles/2023/care-manag… #esoc2023
-
AstraZeneca
@AstraZeneca
People with heart failure with preserved ejection fraction (HFpEF) often have other related conditions like obesity, coronary artery disease, hypertension & chronic kidney disease. The complex links between these conditions can further complicate managing HFpEF.
AstraZeneca
@AstraZeneca
These conditions can cause widespread inflammation in small blood vessels, which stops them from relaxing and contracting normally.
AstraZeneca
@AstraZeneca
The more we explore diverse patient cohorts, the better we can understand evolution of inflammation and fibrosis in HF and identify novel disease targets. Learn more about heart failure: www.astrazeneca.com/our-therapy-areas/cardiovascular-rena… #heartfailure2023
-
AstraZeneca
@AstraZeneca
People with COPD may be at an elevated risk of lung exacerbations and cardiovascular events, such as heart attacks. Learn how a transformation in COPD management is urgently needed to reduce this risk: www.statnews.com/sponsor/2023/05/12/cardiopulmonary-risk-… #ats2023
-
AstraZeneca
@AstraZeneca
We’re taking steps to understand water-related risks within our supply chain. Check out these key lessons on how to build a deeper awareness of water risks associated with strategic commodities in this joint case study with WWF ⬇️
Rylan Dobson 💧
@rylan_dobson
🚨 NEW CASE STUDY🚨 Almost every #business has commodities within their #supplychains - Do you know the #waterrisks facing your key commodities? Learn how @AstraZeneca used the @WWFRiskFilter to start answering this question #waterstewardship #a4ws2023 cdn.kettufy.io/prod-fra-1.kettufy.io/documents/riskfilter…
-
AstraZeneca
@AstraZeneca
Heart failure (HF) is becoming more prevalent worldwide. It’s important to understand the spectrum of HF and how to best care for patients living with chronic HF. One way to improve care is by delivering guideline-directed medical therapy in treating HF.
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Inflammation could be one of the critical factors leading to heart failure with preserved ejection fraction (HFpEF). Patients living with HFpEF need effective treatment options. Learn more about inflammation in HF and what science can do: www.astrazeneca.com/our-therapy-areas/cardiovascular-rena… #heartfailure2023
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Eosinophilic inflammation plays a key role across several debilitating diseases such as eosinophilic asthma, yet much about the underlying driver remains to be uncovered. That’s why we’re furthering our research to help address this unmet need. www.eosinflammation.com
-
AstraZeneca
@AstraZeneca
Earlier diagnosis and management of heart failure (HF) can help limit further damage to patients' hearts.
Given the severity of HF, it’s crucial that we use all the tools and insights at our disposal such as guideline directed medial therapy.This media couldn't be displayed. See it on the original post.
AstraZeneca
@AstraZeneca
Following HF guidelines helps provide patient-centric recommendations to help physicians to limit progression of HF and improve outcomes. Learn more: www.astrazeneca.com/our-therapy-areas/cardiovascular-rena… #heartfailure2023
-
AstraZeneca
@AstraZeneca
We worked with Dr. Javed Butler, other experts, and a patient with heart failure (HF) to develop an in-depth look at living with HF. The peer-reviewed journal article amplifies the insights of their lived experiences with HF. Learn more: idp.springer.com/transit?redirect_uri=https%3A%2F%2Flink.… #heartfailure2023
-
AstraZeneca
@AstraZeneca
Our lifelong learning culture aids individual development so we can meet our collective goals. Marc Howells reflects on the importance of supported learning in keeping us innovative and agile, so we can continue to meet patients’ needs. #createthefuture www.astrazeneca.com/media-centre/articles/2023/fostering-…
-
AstraZeneca
@AstraZeneca
Last year, six early career scientists from around the world won the first R&D Postdoctoral Challenge and earned fully funded postdoctoral positions with us.
Learn more and apply: openinnovation.astrazeneca.com/rd-postdoctoral-challenge.… #whatsciencecando -
AstraZeneca reposted
World Heart Federation
@worldheartfed
Thank you @AstraZeneca for supporting the #worldheartsummit 2023!
Join us on 19-21 May as we work together to bring cardiovascular disease to the top of the global health agenda 🌍🌎🌏👉 www.worldheartsummit.org -
AstraZeneca
@AstraZeneca
Working with our partners, Healthy Heart Africa aims to reach 10 million people with elevated blood pressure by 2025, through disease awareness, education on risk factors, training, screening, and treatment services. #worldhypertensionday #healthequity www.astrazeneca.com/sustainability/access-to-healthcare/h…
-
AstraZeneca
@AstraZeneca
Infection remains a major risk for patients with #cll. But we hope the newly published White Paper, developed in partnership with @CLLAN, demonstrates how to help address these challenges. Learn more here: www.clladvocates.net/whitepaper-CLL-immune-challenges/
-
AstraZeneca
@AstraZeneca
Our Young Health Programme partnership with @UNICEF, has won the @BetterSociety Award for its impact in creating a healthier, more sustainable future for young people worldwide. Learn more about the YHP here: www.yhp.astrazeneca.com
Photo: © UNICEF South Africa/2022/Francisco -
AstraZeneca
@AstraZeneca
As global momentum to promote #planetaryhealth grows, Pam Cheng and Juliette White joined @hgpi_2004 and @NU_planethealth to discuss the role of multi-stakeholder collaboration in accelerating the transition to net zero, resilient health systems.
#g7hiroshimasummitThis media couldn't be displayed. See it on the original post. -
AstraZeneca reposted
World Ovarian Cancer Coalition
@WOCCnews
As approach #wocd2023, help us get closer to #nowomanleftbehind by sharing 🔄 this post with the symptoms. of #ovariancancer with your friends and contacts and see your doctor if you have any concerns.
For more information visit: worldovariancancercoalition.org -
AstraZeneca
@AstraZeneca
We are focused on protecting those most at risk from #infectiousdiseases. Together with our partner Sanofi , we reconfirmed our shared commitment to #science and #innovation at #espid2023.
-
AstraZeneca
@AstraZeneca
We can support those affected by #bladdercancer by showing compassion and understanding. Together, let’s help break down the stigma surrounding its signs and symptoms. #bladdercancermonth23
World Bladder Cancer Patient Coalition
@WorldBladderCan
People affected by #bladdercancer often experience stigma related to their disease that might come from their surrounding environment. It is important that they have access to support they need.
Learn more about the impact of stigma and #bladdercancer 👉 worldbladdercancer.org/news_events/stigma-the-invisible-s… -
AstraZeneca
@AstraZeneca
We’re uniting experts in respiratory diseases and infections to help change the outlook for people with bronchiectasis. We are following the science to target the infections that drive disease exacerbation and progression. #ats2023 #bronchiectasis www.astrazeneca.com/what-science-can-do/topics/disease-un…
-
AstraZeneca reposted
World Ovarian Cancer Coalition
@WOCCnews
By 2040 it is predicted that incidence of #ovariancancer will rise by 42% and mortality will go up by nearly 52%. Help us get to #nowomanleftbehind this #wocd2023.
For more information worldovariancancercoalition.org/wp-content/uploads/2023/0…
#worldovariancancerday -
AstraZeneca
@AstraZeneca
People living with lupus often face inaccurate diagnosis, debilitating symptoms, and limited care options. We’re working toward a future where all people living with lupus have access to the quality care they deserve. #worldlupusday @POLITICOEurope www.politico.eu/sponsored-content/advocates-make-the-case…
-
AstraZeneca
@AstraZeneca
We’re advancing research to gain a deeper understanding of the drivers of heart failure (HF) to help to address the unique care needs across the spectrum of left ventricular ejection fraction and beyond. Learn more: www.astrazeneca.com/content/astraz/media-centre/articles/…
-
AstraZeneca
@AstraZeneca
We’re proud to launch #dontoverlook, under the umbrella of OCC. The campaign highlights the importance of rapid diagnosis and better access to specialist care for women with ovarian cancer.
Discover more: parkedpage.astrazeneca.com -
AstraZeneca
@AstraZeneca
The increase in flu activity last influenza season has highlighted the unmet need to vaccinate high-risk groups.
We continue to push the boundaries of science to help provide better immunity for our community. -
AstraZeneca
@AstraZeneca
We’re driving innovation in #cancer cell therapy to help achieve our ambition of putting cures within reach for patients. Our expansion into next-generation T-cell receptor therapy (TCR-T) technology explores the potential of #celltherapy in solid tumours: www.astrazeneca.com/what-science-can-do/topics/next-gener…
-
AstraZeneca
@AstraZeneca
We’re continuing our partnership with STEM education nonprofit @LearningUNDFTD to help inspire the next generation of #stem leaders who will develop solutions for tomorrow’s challenges. #whatsciencecando
Learning Undefeated
@LearningUNDFTD
We are filled with gratitude when teachers & students thank us for the work we do! Proud to have our leaders joined by @AstraZeneca partners for a special moment with a 6th grade science teacher. @MCPS #stemeducation #doinggood #partnership
-
AstraZeneca
@AstraZeneca
We had a strong start to 2023, with Total Revenue excluding COVID-19 medicines increasing 15%.
Ahead of his retirement, we’d also like to say thank you to Leif Johansson for his outstanding contribution as Chair of the Board. -
AstraZeneca
@AstraZeneca
Patients with chronic kidney disease (CKD) often also experience hyperkalaemia (HK). We’re committed to a future in which we can mitigate complications of comorbidities to improve patient quality of life.
-
AstraZeneca
@AstraZeneca
Transthyretin amyloidosis (ATTR) is a progressive disease caused by the buildup of misfolded amyloid fibrils in organs and tissues. We're committed to advancing the science behind ATTR because it interferes with the normal functions of the body. #aan2023 www.astrazeneca.com/media-centre/articles/2022/raising-aw…
-
AstraZeneca
@AstraZeneca
Neuropathy and heart failure could be signs of transthyretin amyloidosis (ATTR). ATTR is a systemic disease that can cause several neurologic and cardiac conditions. We're committed to advancing care for these patients to improve outcomes. #aan2023 www.astrazeneca.com/media-centre/articles/2022/raising-aw…
-
AstraZeneca
@AstraZeneca
The increased risk of adverse effects from frequent oral corticosteroid (OCS) use is often underestimated. Our goal is to ensure that #severeasthma patients are not reliant on OCS and instead, have more access to OCS-sparing options where possible. www.astrazeneca.com/media-centre/articles/2023/ocs-severe…
-
AstraZeneca
@AstraZeneca
Why do some people develop severe illnesses following viral lung infections? We’re working hard to understand these cases and find ways to make changes. Find out more about our research:
This media couldn't be displayed. See it on the original post.
AstraZeneca
@AstraZeneca
There’s more to learn about viral lung infections with our research leaders, Ioannis and AnnaMaria, who are leading our investigations in this area. Follow the science: www.astrazeneca.com/what-science-can-do/topics/disease-un…
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Through Ambition Zero Carbon and AZ Forest we’re taking bold action to #investinourplanet. Listed first among pharmaceutical companies and in the top 50 overall, the recognition on the @FT 'Europe’s Climate Leaders' list reflects our focus on reaching net zero. #earthday
FT Europe
@ftbrussels
Europe’s Climate Leaders 2023: interactive listing www.ft.com/content/9de90563-903d-4604-849c-49ed744feaa3
-
AstraZeneca
@AstraZeneca
Many are turning the page on COVID-19 & returning to pre-pandemic life, but the story is different for immunocompromised (IC) people who aren’t protected by COVID-19 vaccination. It's vital that we prioritise the burden facing the IC community: insights.economistenterprise.com
-
AstraZeneca
@AstraZeneca
Preventative cancer medicines may one day help eliminate cancer as a cause of death. Explore the challenges researchers face when developing medicines to prevent cancer, as well as potential opportunities to accelerate progress. #whatsciencecando www.astrazeneca.com/what-science-can-do/topics/disease-un…
-
AstraZeneca
@AstraZeneca
Among the many impacts of the COVID-19 pandemic is an increased focus on protection against infectious diseases like RSV and influenza. We are focused on protecting those most at risk from infectious diseases. #eccmid2023
-
AstraZeneca
@AstraZeneca
The effects of the COVID-19 pandemic resulted in inter-seasonal respiratory syncytial virus (RSV) and influenza, impacting the predictability of seasonality in these viruses. More needs to be done to understand the impact of RSV, flu and COVID-19 co-circulation on patients.
-
AstraZeneca
@AstraZeneca
Pushing the boundaries of science has never been more urgent. Enter the 2023 R&D Postdoctoral Challenge to pitch your innovative ideas with the potential to secure a fully funded postdoctoral position at AstraZeneca. #postdoc #whatsciencecando openinnovation.astrazeneca.com/rd-postdoctoral-challenge.…
-
AstraZeneca
@AstraZeneca
A new @economistimpact article, explains how the COVID-19 pandemic is far from over for the immunocompromised (IC) community. It's vital that we continue to prioritise the IC community in policy and healthcare system decisions. Discover more: insights.economistenterprise.com
-
AstraZeneca
@AstraZeneca
We’re advancing our oncology portfolio with innovations in cell therapy, immuno-oncology, antibody-drug conjugates and epigenetics, to attack cancer from multiple angles and bring potentially transformative medicines to patients. #aacr23
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We believe young people have the power and potential to shape a healthier future. Through our #younghealthprogramme, we are developing the next generation of youth advocates to help prevent chronic diseases.
Courtney Sunna shares more here: www.younghealthprogrammeyhp.com/updates/advocacy-initiati… -
AstraZeneca
@AstraZeneca
"Decarbonising the economy is an opportunity and a driver of growth”. In this @guardian OpEd, our CEO Pascal Soriot underlines the need to take bold action on climate change now to protect human health: www.theguardian.com/business/2023/apr/10/climate-emergenc…
-
AstraZeneca
@AstraZeneca
We are working towards making #healthforall a reality, so everyone can access sustainable healthcare solutions. Our Young Health Programme takes an equitable approach to building healthier generations, led by and for young people: www.know.az/6013OHNRx #worldhealthday
-
AstraZeneca
@AstraZeneca
Congratulations to Qing-Dong Wang and colleagues at the Chinese Academy of Sciences on publishing in @NatureGenet. They examine fibroblast cells in #heartfailure revealing a key pathway involved in regulating fibrosis. Find out more about Qing-Dong’s work: www.astrazeneca.com/what-science-can-do/topics/next-gener…
-
AstraZeneca
@AstraZeneca
Primary care physicians (PCPs) are often the first line of defense against chronic kidney disease (CKD) for their patients. PCP Dr. Kevin Fernando shares his insights on the importance of testing patients for CKD.
Post not available here, view on X
AstraZeneca
@AstraZeneca
To calculate UACR, you just need to divide albumin concentration in milligrams by creatinine concentration in grams and follow the chart linked here to define any abnormalities.
AstraZeneca
@AstraZeneca
The second test is eGFR which shows the percentage of kidney functions remaining in patients. This test can be included in a patients’ blood and metabolic screenings and the results can help track kidney function over time.
Post not available here, view on X
AstraZeneca
@AstraZeneca
The KDIGO CKD evaluation and management guidelines are a particularly helpful tool to gain a deeper understanding of early identification and intervention of CKD. kdigo.org/guidelines/ckd-evaluation-and-management/
AstraZeneca
@AstraZeneca
Early diagnosis changes lives. It can mean fewer complications, slowed disease progression, and importantly a better quality of life for patients.
-
AstraZeneca
@AstraZeneca
Transthyretin amyloidosis (ATTR) is a potentially fatal condition. If left untreated, it can lead to issues such as heart failure (HF) and peripheral nerve damage. Learn more about the need for increased awareness of this condition. www.astrazeneca.com/content/astraz/media-centre/articles/…
-
AstraZeneca
@AstraZeneca
These simple-looking balls of cells are complex models that mimic kidney function and are helping us to follow the science of kidney diseases. With #organoids like these we’re improving our ability to predict clinical success of candidate drug molecules. www.astrazeneca.com/what-science-can-do/topics/technologi…
-
AstraZeneca
@AstraZeneca
We #embraceequity through our Young Health Programme community programmes and partnerships. Discover how we are working towards a more equitable future for young people: www.know.az/60183hOgq
-
AstraZeneca reposted
IFLScience
@IFLScience
Explore the importance of personalised care with @BanerjeeSusana as she explains the benefits of biomarker testing and when a doctor will decide to use this type of test.
Speaker and sponsor are not affiliated.
#ad #sponsored -
AstraZeneca reposted
IFLScience
@IFLScience
Find out how biomarker testing can help doctors care for cancer patients here: ifls.online/Ovarian-Cancer-Biomarkers
Organised and funded by AstraZeneca
#ad #sponsored -
AstraZeneca reposted
FAO Forestry
@FAOForestry
Forests give us so much🌲🌳
🫧They purify our water
🧽They clean our air
🌎They fight climate change
💊They give us food and life-saving medicines
Healthy forests for healthy people
21 March is #forestday!
#intlforestday -
AstraZeneca
@AstraZeneca
We are celebrating the value our differences bring to our organisation, ultimately helping us to deliver more for patients. Find out more about what #inclusion means to us from our neurodivergent colleagues and allies. www.know.az/601137RPD
#neurodiversitycelebrationweek -
AstraZeneca reposted
IFLScience
@IFLScience
Join us as @BanerjeeSusana sheds light on biomarker testing and discover what these tests can tell us.
Speaker and sponsor are not affiliated.
#ad #sponsored -
AstraZeneca reposted
IFLScience
@IFLScience
Testing for biomarkers can help doctors get a better understanding of a person’s cancer. Find out how here: ifls.online/Ovarian-Cancer-Biomarkers
Organised and funded by AstraZeneca
#ad #sponsored -
AstraZeneca
@AstraZeneca
Do you share our passion for advancing scientific discovery? Our R&D Postdoctoral Challenge could be your opportunity to join us and share your solutions for some of the world’s most complex diseases. www.know.az/60123fD7r #whatsciencecando #postdoc
This media couldn't be displayed. See it on the original post. -
AstraZeneca reposted
IFLScience
@IFLScience
The role of biomarkers in cancer is not commonly known. Follow along as @BanerjeeSusana examines what biomarkers are.
Speaker and sponsor are not affiliated.
#ad #sponsored -
AstraZeneca reposted
IFLScience
@IFLScience
Biomarkers have the potential to improve the way we detect, manage, and monitor ovarian cancer. Learn more here: ifls.online/Ovarian-Cancer-Biomarkers
Organised and funded by AstraZeneca
#ad #sponsored -
AstraZeneca reposted
IFLScience
@IFLScience
IFLScience talked to Susan McCutcheon, (International Medical Head of Oncology at AstraZeneca) about biomarkers and ovarian cancer.
Organised and funded by AstraZeneca
#ad #sponsored
www.youtube.com/watch?v=XyIWM4jh-2A -
AstraZeneca
@AstraZeneca
A new video from @LungAmbition guides patients and caregivers through the first steps of a #lungcancer diagnosis, empowering them to better understand and ask questions about their care along the way. Learn more: www.know.az/60133NI4F
-
AstraZeneca reposted
IFLScience
@IFLScience
Find out how doctors can use biomarkers for ovarian cancer diagnosis and care here: ifls.online/Ovarian-Cancer-Biomarkers
Organised and funded by AstraZeneca
#ad #sponsored -
AstraZeneca
@AstraZeneca
Prevalence of chronic kidney disease (CKD) is rising, yet it is under diagnosed. A new @economistimpact report, initiated and supported by AstraZeneca, on CKD highlights the need for global and local policy changes. Read the full report at Economist Impact:insights.economistenterprise.com/health-society/chronic-k…
-
AstraZeneca
@AstraZeneca
Are you an outstanding final year MD, PhD student or Postdoctoral Researcher? Our R&D Postdoctoral Challenge is now open for applications, and we’re looking for your ideas on how to transform treatment of some of the world’s most complex diseases #postdoc www.know.az/601630Co8
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Precision medicine is now a critical part of our approach to drug discovery, and we believe it has the potential to provide novel treatment for patients with NASH. www.astrazeneca.com/what-science-can-do/topics/next-gener…
-
AstraZeneca
@AstraZeneca
Take one minute to prioritise kidney health. Chronic kidney disease (CKD) affects nearly 850 million people worldwide, but 9 out of 10 people don’t know they have it. Take a quiz to learn about your risk of developing CKD: www.know.az/6014301aO
#worldkidneyday -
AstraZeneca
@AstraZeneca
Penny James’ keynote presentation at the My Green Lab Europe 2023 Summit will showcase best practices on the delivery of our science-based net zero targets. Find out more about our approach in our newly published Sustainability Report: www.astrazeneca.com/content/dam/az/Sustainability/2023/pd…
My Green Lab
@My_Green_Lab
Tomorrow is the day! Our FREE 2023 Europe Summit, From Inspiration to Implementation, is happening online. Be sure to join us to hear from key leaders in European scientific communities, including keynote speaker Penny James of @AstraZeneca. Register here: mygreenlab.regfox.com/building-a-lasting-culture-of-susta…
-
AstraZeneca
@AstraZeneca
We are celebrating the achievements of women in our organisation and in the communities we serve. Find out what we're doing to advance #inclusion and #diversity from Rebekah Martin and YHP Young Leader, Swarnima Bhattacharya. www.know.az/60123Ljs4
-
AstraZeneca
@AstraZeneca
Our latest research sheds new light on the role of the tumour microenvironment in #cancer progression.
Explore the findings and their potential to improve patient responses to treatment. #whatsciencecando www.know.az/60163Ldrj -
AstraZeneca
@AstraZeneca
Chronic kidney disease (CKD) affects up to 850 million people worldwide, but most don’t know they have it. Early detection and treatment is the best defence against CKD progression. Take one minute to check your CKD risk: kidneyquiz.theisn.org
-
AstraZeneca
@AstraZeneca
Shortness of breath, dizziness, and fatigue can be signs of cardiovascular (CV) disease. Knowing the symptoms can help physicians intervene early. Read more about the importance of early detection: www.astrazeneca.com/media-centre/articles/2023/managing-c… #acc2023
-
AstraZeneca
@AstraZeneca
Hypertension, high cholesterol, diabetes and other risks factors can lead to cardiovascular (CV) disease if left untreated. Learn how early clinician detection and intervention can help patients lower their risks here: www.astrazeneca.com/media-centre/articles/2023/managing-c… #acc2023
-
AstraZeneca
@AstraZeneca
Good to see #oneforestsummit bring world leaders together to protect forests. Through AZ Forest, we aim to plant and maintain over 50 million trees, including through a community-led project in Ghana, with partners @CircBioAlliance & @NGP_TechAssist.
-
AstraZeneca
@AstraZeneca
There are still 2 more days to submit your solutions to our latest #cosolve Challenges. We’re looking for innovators from around the world and entries are open until 3rd March. Discover more about the challenges: openinnovation.astrazeneca.com/cosolve/cosolve-challenges…
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
The cardiorenal connection means that chronic kidney disease (CKD) and heart failure (HF) are interconnected. Dr. Alfonso Valle recommends working with patients to prevent both conditions at the same time because as CKD progresses, cardiovascular complications can worsen.
-
AstraZeneca
@AstraZeneca
Our contribution to the @FTSEWomenLeader reinforces our commitment to gender equality and inclusion.
Discover more here: www.know.az/60133vHuT -
AstraZeneca
@AstraZeneca
Millions of severe #asthma patients continue to experience frequent exacerbations, hospitalisation and a reduced quality of life. We remain committed to raising standards in asthma care to enable patients to live fuller lives with greater flexibility. www.know.az/60163sKb8
-
AstraZeneca
@AstraZeneca
The Lead2030 Challenge is looking for health promotion ideas and projects to reduce risk behaviours in young people. Apply now for our Lead2030 Challenge, for your chance to attend the @OneYoungWorld Summit and earn a US $50,000 grant. Find out more: www.know.az/60193sQNZ
-
AstraZeneca
@AstraZeneca
Primary care physicians (PCPs) can act as the first line of defense against chronic kidney disease (CKD) for their patients.
Through routine testing and screening of at-risk patients, PCPs can make a significant impact in slowing the progression of CKD.
AstraZeneca
@AstraZeneca
-
AstraZeneca
@AstraZeneca
Certain risk factors predispose people to prostate cancer.
We must address shifts in prostate cancer and disparities in care to improve patient outcomes across the globe.
#gu23 -
AstraZeneca
@AstraZeneca
Prostate cancer that does not respond to hormone therapy is called castration-resistant and can spread, leading to worse outcomes. Knowing the symptoms can lead to rapid diagnosis and help ensure the best possible outcomes.
#gu23 -
AstraZeneca
@AstraZeneca
We've launched our 2022 Sustainability Report. By harnessing the power of science, setting bold targets and measurable actions, and embedding sustainability into the core of our business, we’re accelerating the delivery of net zero sustainable healthcare. www.know.az/60173SpxH
-
AstraZeneca
@AstraZeneca
Around 10-20% of men with advanced prostate cancer will develop castration-resistant prostate cancer within five years of diagnosis and the majority will unfortunately succumb to this aggressive disease within two to three years. Know your risk factors – talk to your doctor #gu23
-
AstraZeneca
@AstraZeneca
#climatechange is impacting human health and driving a rise in chronic conditions like #respiratory diseases. We partnered with MEP, Stelios Kympouropoulos and Professor Christer Janson to discuss balancing environmental needs with respiratory healthcare.
-
AstraZeneca
@AstraZeneca
#cholangiocarcinoma, or bile duct cancer, often doesn’t have clear symptoms, making it difficult to diagnose. Most cases are diagnosed at an advanced stage when treatment options are limited. We encourage all to learn more about the risk factors. #worldccaday
Global Cholangiocarcinoma Alliance
@CCA_Alliance
Cholangiocarcinoma (CCA) is a rare cancer of the bile duct, however there are some key risk factors that can put people at higher risk. This #worldccaday you can #pledgeforcca to show your support for the community and raise awareness: www.globalccaalliance.com/en/get-involved/the-pledge #livertwitter
-
AstraZeneca
@AstraZeneca
Visit @CCA_Alliance for more information about #cholangiocarcinoma, a rare cancer affecting the bile ducts within or outside the liver that affects approximately 6 in 100,000 people worldwide. #worldccaday know.az/60163ikrO
-
AstraZeneca
@AstraZeneca
Heart failure (HF) is a complex syndrome that is often complicated by multiple interrelated diseases. A greater understanding of the drivers of HF will help address the unique needs of the 64 million people living with the disease. www.astrazeneca.com/content/astraz/media-centre/articles/…
-
AstraZeneca
@AstraZeneca
We are using data analytics and #ai to match existing medicines with new disease indications. This unique approach aims to make drug discovery faster and more efficient. Discover more: www.astrazeneca.com/content/astraz/what-science-can-do/to…
-
AstraZeneca
@AstraZeneca
New data of over 600,000 heart failure (HF) patients is helping reveal the true impact and prevalence of the disease. Up to 2% of the adult population has HF with a staggering 13% annual mortality rate. Learn more about the study: bmjgroup.com/media-hub/
-
AstraZeneca
@AstraZeneca
Are you tackling non-communicable diseases among youth through advocacy and innovation?
Apply now for our YHP Impact Fellowship, for your chance to attend the @OneYoungWorld Summit and earn a US $10,000 grant.
Find out more: www.know.az/60173mqgF -
AstraZeneca
@AstraZeneca
We asked some of our #womeninscience what they hope women and girls can achieve in #stem. Watch to reveal their vision for the future. #february11 #womeninstem www.astrazeneca.com/r-d/our-approach/stem-at-astrazeneca.…
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Nearly 64 million people are living with heart failure (HF) around the world, and the five-year mortality rate after diagnosis is approximately 50%. Early diagnosis and intervention of HF is essential for improving patient outcomes. www.astrazeneca.com/content/astraz/media-centre/articles/…
-
AstraZeneca
@AstraZeneca
2022 was a year of continued strong company performance and execution of our long-term growth strategy. Looking ahead, we’ll deliver 15+ new medicines before the end of the decade. $AZN
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We're moving closer to achieving our ambition of eliminating cancer as a cause of death. Dave Fredrickson shares reasons for hope and how uniting globally and acting locally will affect change in an article for @POLITICO. #closethecaregap #worldcancerday protect-de.mimecast.com/s/dIdyCgpRGySY2p5j9fNi1mf?domain=…
-
AstraZeneca
@AstraZeneca
Our ongoing commitment to gender equality has been recognised in the 2023 @Bloomberg Gender-Equality Index. This is the fifth consecutive year we've been included for our transparency and efforts to ensure an inclusive and diverse workforce. #bloomberggei know.az/3HiPaQp
-
AstraZeneca
@AstraZeneca
Since its launch in 2010, our Young Health Programme has reached more than nine million young people with health information to prevent non-communicable diseases. Discover more about the programme here: know.az/3j8vGWv
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Explore key milestones in the field of precision medicine and find out how they are enhancing our understanding of chronic diseases and transforming pharmaceutical drug discovery.
#whatsciencecando
know.az/3HiPf7L -
AstraZeneca
@AstraZeneca
At @WEF we were recognised for our leadership in sustainability. Science-based targets, public-private collaboration such as our role championing the @TheSMI Health Systems Task Force and transparent reporting are critical. Learn more: know.az/3Hine00
-
AstraZeneca
@AstraZeneca
🌍 Good health is the foundation of strong societies and economies.
That’s why at #wef23 this week, we’re highlighting the importance of working together to prioritise health and build sustainable, resilient and equitable health systems.
#itstartswithhealth
AstraZeneca
@AstraZeneca
Earlier this week, David Fredrickson shared his reflections on collective global efforts to end cancer as we know it.
Read his #wef23 article to learn why he believes we’re on the brink of great change. know.az/3kaBWx4
#itstartswithhealth
AstraZeneca
@AstraZeneca
At #wef23, our Chair Leif Johansson spoke on the importance of building sustainable and resilient health systems.
We must take urgent action to ensure a bright future for all.
@MarkJCarney @CokeHamilton @aagalloni @PaoloGentiloni
#itstartswithhealth -
AstraZeneca
@AstraZeneca
By creating spaces to facilitate collaboration we’re driving innovation to progress #drugdevelopment. Our #bioventurehub is home to a partnership with @uniofgothenburg @chalmersuniv and @CAMECA_News that is helping to show how drugs behave inside cells.
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Acting early is key to building sustainable healthcare solutions. Smarter investment in prevention, early detection and treatment of non-communicable diseases can improve patient outcomes and benefit society, the economy and the planet.
#itstartswithhealth
Foreign Policy
@ForeignPolicy
Non-communicable diseases kill 41M people annually, causing a premature death every 2 seconds. How can cooperation & investment in early detection reduce preventable deaths? Read the new FP Analytics issue brief, produced with support from @AstraZeneca: fpanalytics.foreignpolicy.com/2023/01/05/the-investment-c…
-
AstraZeneca
@AstraZeneca
Patients experiencing #asthma symptoms often use SABA inhalers. Yet taking a SABA does not address the underlying inflammation and may put patients at risk of future attacks. We're committed to helping to improve outcomes for patients. know.az/3ZrQAQR
-
AstraZeneca
@AstraZeneca
We are looking for novel solutions to challenges in health and life sciences research with our #cosolve challenges. Submit a proposal by 3rd March. Apply here: [know.az/3ZyLzGn]
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Today we announced an agreement to acquire @cincorpharma to strengthen our cardiorenal pipeline, where there is a high unmet need.
Additional important information can be found here: know.az/3Gug8nC
#investors #astrazenecabusinessnews -
AstraZeneca
@AstraZeneca
We’re harnessing the power of innovative science to transform the future of healthcare, working with our partners to integrate new technologies into the patient journey and elevate the standard of care available to eligible people all around the globe:
know.az/3idzmG9 -
AstraZeneca
@AstraZeneca
Our latest research in @agnew_chem and @NatureCatalysis underscores our commitment to making sustainable changes in the laboratory. Read more about the ways biocatalysts can be used to perform important chemical reactions in drug discovery. know.az/3VDWrQ1
-
AstraZeneca
@AstraZeneca
How is the nature of #clinicalinnovation evolving in the age of precision medicine? Our experts share their insights in the latest @PharmaReview know.az/3vfqfHY
-
AstraZeneca
@AstraZeneca
Prostate cancer is a global health issue with over 375,000 patients dying from the disease in 2020. By advocating for earlier diagnosis, patients can receive rapid care and a better chance of long-term survival.
-
AstraZeneca
@AstraZeneca
Ten days left until the submission window for our two #cosolve #sustainability Challenges closes. If you have an innovative solution to some of our real research challenges, we’d like to hear it. Find out more on our Open Innovation page know.az/3uICjRy
-
AstraZeneca
@AstraZeneca
Understanding the link between cardiovascular and renal diseases can be critical to improving patients’ overall health. Learn more about the cardiorenal connection: know.az/3PIgE5H
-
AstraZeneca
@AstraZeneca
During drug discovery, we screen millions of molecules producing a vast amount of complex data. At #neurips2022 we presented a novel computer model that can improve our ability to predict which molecules may have therapeutic potential.
Learn more: know.az/3W2hXPq -
AstraZeneca
@AstraZeneca
Sustainable transport solutions are critical for the health of people and planet. This month, AstraZeneca Netherlands achieved a fully electric vehicle fleet, three years ahead of schedule.
Find out more about Ambition Zero Carbon: know.az/3hAEhAu
#ev100 #evs -
AstraZeneca
@AstraZeneca
#cop15 in 🇨🇦 is underway, with the critical mission to protect and restore nature.
Through AZ Forest, we’re partnering with governments and communities to invest in biodiversity and foster environments where all life can thrive.
#whatsciencecando
⬇️ -
AstraZeneca
@AstraZeneca
Digital inclusivity is critical to bridging the disparities that remain in healthcare. A more equitable healthcare system requires collaboration between experts. Discover more from our leaders about our approach to innovation for health equity at @devex know.az/3BzGCCt
-
AstraZeneca
@AstraZeneca
With over 150 types of #bloodcancers spanning leukaemias, lymphomas and myelomas, there remains a profound need for new and effective solutions for those impacted, and we remain focused on helping fulfil that need at #ash22 and beyond.
-
AstraZeneca
@AstraZeneca
We’re shining a light on our #younghealthprogramme, and the proven impact it has made to reduce the risks of non-communicable diseases among young people. know.az/3BwAYBe
-
AstraZeneca
@AstraZeneca
Our research into the programmed cell death pathway has the potential to advance novel treatments in #bloodcancer. Find out how modulating this pathway can make a difference in some of the hardest-to-treat haematological malignancies. #ash22
-
AstraZeneca
@AstraZeneca
We’ve kept our top ranking on the @CDP's Climate Change and Water Security A Lists, recognised for the 7th year in a row for our environmental leadership and commitment to transparency #cdpalist
-
AstraZeneca
@AstraZeneca
We believe everyone should have access to sustainable healthcare, no matter where they live. Through our partnership with @Amref_Worldwide, we are supporting mobile health clinics in Kenya to offer health services to far-to-reach communities #uhcday2022
-
AstraZeneca
@AstraZeneca
We are delighted to retain our listing in the Dow Jones Sustainability Index, reflecting our top 10% score in the 2022 S&P Global Corporate Sustainability Assessment. We scored 80 out of 100, up 3 points from 2021. #csa2022 #sustainability know.az/3VZpoq4
-
AstraZeneca
@AstraZeneca
Do you have an innovative solution to a research challenges? There are three weeks left until the submission window for our two #cosolve sustainability challenges closes – find out more know.az/3W5jDY0
-
AstraZeneca
@AstraZeneca
At #ash22, we are showcasing the strength of our diverse haematology pipeline and how we are building on research in #immunooncology. Learn more about the possibilities of T-cell engagers and their ability to direct the immune system to attack cancer: know.az/3Bn5i1c
-
AstraZeneca
@AstraZeneca
As nations gather for #cop15 to agree new goals to protect nature, we're taking action through AZ Forest to address the climate and biodiversity crises. In Ghana, our community-led reforestation project aims to plant and maintain over 3 million trees. know.az/3Pi7QDy
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
In a @TheLancetPlanet paper, we are calling for joint action to accelerate the delivery of sustainable healthcare. Through our ecopharmacovigilance (EPV) programme, we are helping to lead a systems-level approach to identify solutions. Find out more: know.az/3VGaSnb
-
AstraZeneca
@AstraZeneca
The time is now to advance the value assessment of #cancer therapies to improve #patient access. Learn more: know.az/3FCJQHU. #oncology #oncologyvalueassessment
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
The evolving value assessment of cancer therapies: Seven principles from the cancer community’ outlines actions for the value assessments of cancer medicines. Learn more: know.az/3VVF3GT. #oncologyvalueassessment
-
AstraZeneca
@AstraZeneca
This week, we’re convening with the oncology community at both @SABCSSanAntonio and @ASH_hematology to present new research which shows how we are aiming to redefine breast and haematologic cancer care. #sabcs22 #ash22
-
AstraZeneca
@AstraZeneca
We’re partnering with @DisabilityIN to improve inclusion for people with disabilities.
Our Vice President of Global Talent and Development, Marc Howells reflects on the importance of an accessible workplace and what it means to be an ally. #idpwd know.az/3B4J1EW -
AstraZeneca
@AstraZeneca
We’re proud to be the top pharma company and ranked 2nd overall in the @tortoise Responsibility 100 Index which tracks the performance of FTSE companies from equality to climate change. Find out how we’re ‘walking the talk’ on sustainability: know.az/3VJAyza
-
AstraZeneca
@AstraZeneca
Our agreement to acquire Neogene Therapeutics, aims to unlock new possibilities in #cancer treatment by pioneering the next generation of T-cell therapies for patients with difficult to treat cancers. know.az/3Viu9Ll
-
AstraZeneca
@AstraZeneca
Through our flagship Young Health Programme partnership with @UNICEF and @OneYoungWorld, we are supporting young people to create the change they want to see to help address the climate crisis, as part of our commitment to youth health. know.az/3AIHsfO
-
AstraZeneca
@AstraZeneca
Dr. Javed Butler knows for physicians, it can be hard to diagnose heart failure (HF). Its symptoms are so common that something like shortness of breath could be a sign of HF. He says it's important to notice any new symptoms in patients because early detection can save lives.
-
AstraZeneca
@AstraZeneca
By digging deeper into the science of idiopathic pulmonary fibrosis (IPF), we’re learning more about the various mechanisms behind this complex chronic disease. This includes causes of fibrosis and approaches that could promote lung regeneration. know.az/3gqWS1t
-
AstraZeneca
@AstraZeneca
We’re building a pipeline of women in tech and are a gold sponsor of @WinTechSeries where attendees can exchange ideas on leading in a #digital future. #wosr22 know.az/3EshNcw
-
AstraZeneca
@AstraZeneca
Learn how we're leveraging #celltherapy innovation to explore therapies for some of the world’s most common diseases and taking a patient-centric approach in our new piece with @Fishawack. know.az/3EQFYTg
-
AstraZeneca
@AstraZeneca
Pancreatic cancer symptoms are non-descript, so diagnosis is often delayed, and the prognosis can worsen.
If you or someone you know has possible pancreatic cancer symptoms, contact your doctor, and get checked. #pancreaticcancerawarenessmonth -
AstraZeneca
@AstraZeneca
We’re working to reduce our total energy consumption, double our energy productivity and use 100% renewable energy to meet all our heat and electricity needs by the end of 2025. know.az/3hW05Xj
#whatsciencecando #cop27 -
AstraZeneca
@AstraZeneca
As a founding member of the #energize programme, we’re pleased to see the first group of suppliers use their collective purchasing power to buy renewable energy at scale & help decarbonise the pharma supply chain know.az/3VcXYN7 #cop27 #climateaction
Schneider Electric Sustainability Business
@SESustainable
We are thrilled to announce the #energize pharmaceutical supply chain renewable energy program has formed its first PPA Buyers' Cohort of 9 companies, including 7 suppliers and 2 sponsors, intending to purchase 2 terawatt-hours (TWh) of electricity demand. perspectives.se.com/blog-stream/energize-program-announce…
-
AstraZeneca
@AstraZeneca
Our latest study in @Nature explores how inhibiting ferroptosis, a type of programmed cell death that occurs exclusively in the tumour microenvironment, may help to restrict tumour growth and could offer a new target for cancer treatment.#whatsciencecando know.az/3TMaCSb
-
AstraZeneca
@AstraZeneca
At #hfpolicysummit22, @HFPolicyNetwork convened a group of heart failure (HF) advocates and key decision-makers to push for much-needed HF policy change. We’ve had the honor of attending and sponsoring the summit and are committed to helping evolve heart HF policies.
-
AstraZeneca
@AstraZeneca
Cases of #diabetes are continuing to rise rapidly. By studying the genetics of over 800k people across three global biobanks, we have identified a gene whose loss reduces the risk of both types of diabetes. Find out more: know.az/3TN2a4S #whatsciencecando
-
AstraZeneca
@AstraZeneca
It is important to continue raising awareness of the risks that diseases such as respiratory syncytial virus (RSV) can pose to premature infants, and how we can help protect infants against RSV: know.az/3hORxBr? #worldprematurityday2022
-
AstraZeneca
@AstraZeneca
Today is the final session of #hfpolicysummit22, which we're a proud sponsor of, held by @HFPolicyNetwork. Learn more about how participants are pushing for living well with heart failure and how HCPs can move towards more person-centred, integrated care. know.az/3ECSN3F
-
AstraZeneca
@AstraZeneca
Through collective action we can help patients with #copd, a disease in urgent need of attention. For #worldcopdday, we built upon #speakupforcopd to partner with a coalition of advocates, clinicians and industry to sign a declaration for policy change: know.az/3EyzYOY
-
AstraZeneca
@AstraZeneca
Our continued work to improve #accesstomedicine and health system resilience is reflected in our top three position in the latest @ATMIndex know.az/3UUoJpi
-
AstraZeneca
@AstraZeneca
Everyone’s experience of ovarian cancer is unique.
The ovarian cancer patient pathway, Olivia, is an interactive tool that can provide information relevant to a patient’s experience at the time they need it. Find out more: know.az/3tuPe9i -
AstraZeneca
@AstraZeneca
More than half a billion people worldwide live with diabetes, but millions are unaware they have it. Increased access to diabetes education can help with earlier diagnosis and improved quality of life. #educationtoprotect #worlddiabetesday
-
AstraZeneca
@AstraZeneca
Patients living with #lupus often rely on prolonged use of oral corticosteroids to treat disease symptoms. Our research presented at #acr22 could help improve outcomes for lupus patients. know.az/3O5F5cI
-
AstraZeneca
@AstraZeneca
Cell therapy is a new space with unique logistic and manufacturing challenges, but we continue to invest in processes and approaches to address these challenges. know.az/3to66hM
-
AstraZeneca
@AstraZeneca
At #cop27, we’re engaging with public and private sector partners to take bold action and accelerate the delivery of net zero healthcare – for people, society and the planet. know.az/3fSEJtf
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Our strong Q3 2022 results announced today reflect the benefit of our continued investment in R&D. We remain focused on delivering innovative medicines to patients around the world and achieving industry-leading growth through 2030. $AZN
-
AstraZeneca
@AstraZeneca
As a sponsor of the Heart Failure Policy Summit 2022 held by @HFPolicyNetwork we’re helping to drive HF policy forward. Learn more about how participants are driving awareness and increasing pathways to care for heart failure patients. #hfpolicysummit22 know.az/3TnABPA
-
AstraZeneca
@AstraZeneca
We’re spotlighting the innovative properties of bispecific antibodies that have the potential to target drivers of #cancer and advance the next wave of #immunotherapy medicines. Learn more about our progress in drug discovery:know.az/3Eg8dKX #sitc22
-
AstraZeneca
@AstraZeneca
For us, building a culture of #lifelonglearning is essential. Our #inclusive approach to mentoring empowers people to share and learn from one another so we can all perform at our very best. know.az/3FZWkKs
-
AstraZeneca
@AstraZeneca
Hyperkalaemia or high levels of potassium in the blood can be a severe and potentially life-threatening complication of chronic kidney disease and heart failure. A holistic approach to cardiorenal complications could help improve patient outcomes. know.az/3FTeqxu
-
AstraZeneca
@AstraZeneca
The time to act is now. Our CEO Pascal Soriot has joined 100 others to sign the @wef Alliance of CEO Climate Leaders open letter calling for urgent action to deliver #netzero. Through collaboration, we can scale up public-private efforts to address the climate crisis. #cop27
World Economic Forum
@wef
Ahead of @COP27, the Alliance of CEO Climate Leaders has published an open letter outlining actions that governments and businesses can take to limit global warming to 1.5°C. Read the full #cop27 letter now.
www.weforum.org/agenda/2022/11/cop27-alliance-of-ceo-clim… -
AstraZeneca
@AstraZeneca
Utilizing the advances in #digitalhealth technology drives our ambition to transform clinical trials, accelerate research and reimagine our patients’ experiences. #patientcentricity know.az/3FNtoVG
-
AstraZeneca
@AstraZeneca
#climatechange is the biggest global health threat of our time. #cop27 represents a critical opportunity to unite around actionable solutions to improve the health of people, society and the planet. know.az/3sVrH0N
-
AstraZeneca
@AstraZeneca
Chronic kidney disease and heart failure are interconnected conditions and even share some common symptoms. Knowing the signs of each and how to screen can help physicians intervene early. #kidneywk #aha22 know.az/3U7FCga
-
AstraZeneca reposted
Heart Failure Policy Network
@HFPolicyNetwork
We are delighted to announce the full programme for the #hfpolicysummit22 is now live! This year’s Summit will address how we can engage with policymakers and leaders to improve care for the millions of people living with heart failure across Europe.
-
AstraZeneca
@AstraZeneca
Research continues to show the link between cardiovascular and renal health. We're helping health care providers approach them as interrelated conditions and recognize that what’s good for the heart can be good for the kidneys and vice versa. #kidneywk #aha22
-
AstraZeneca
@AstraZeneca
Ahead of #cop27, today we announce sector-first commitments with global health leaders through the @TheSMI to accelerate the delivery of net zero health systems - for healthy people and planet. know.az/3sSbCsX #patientearth #cop27
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Congratulations to the winners of our R&D Postdoctoral Challenge. Six exceptional candidates were awarded fully funded #postdoc research positions to accelerate scientific discovery and turn their ideas into reality. know.az/3UimzPZ #whatsciencecando
-
AstraZeneca reposted
Lung Ambition Alliance
@LungAmbition
This Lung Cancer Awareness Month, we’re encouraging people everywhere to #taketheplunge – for their own lung health or the health of a loved one. Learn more: www.lungambitionalliance.com/News/Take-the-pLUNGe.html #lungcancer #lcam
-
AstraZeneca
@AstraZeneca
Each #breastcancer patient is unique. By evolving how we think, we aim to transform existing clinical practice, reduce recurrence and provide durable responses that help improve outcomes for all patients. #breastcancerawarenessmonth
-
AstraZeneca
@AstraZeneca
Primary care physicians (PCPs) can be essential to increasing earlier diagnosis of chronic kidney disease (CKD). Dr. Edgar V. Lerma shared two tests PCPs can use to understand their patients’ kidney health and diagnose CKD as early as possible. #ckd
-
AstraZeneca
@AstraZeneca
Approximately nine out of 10 people with chronic kidney disease (CKD) don’t know they have it. Dr. Edgar V. Lerma shared his thoughts on how primary care physicians (PCPs) may hold the key to changing this statistic through earlier detection and prevention of CKD. #ckd
-
AstraZeneca
@AstraZeneca
Collaboration is vital to achieving #netzero and we look forward to being at #cop27 to engage on this. Our aim is that by the end of 2025, 95% of our key suppliers will have science-based targets. know.az/3zmcNo3 #whatsciencecando
-
AstraZeneca
@AstraZeneca
Transthyretin amyloidosis (ATTR) is a progressive disease where proteins misfold and build up in the body, affecting different organs. Striving for more scientific advancements and raising general awareness could help increase options for ATTR patients. know.az/3NnGMSf
-
AstraZeneca
@AstraZeneca
We are thrilled to launch Olivia together with @ESGO_society and @ENGAGe_ESGO, delivering a dedicated, comprehensive resource for anyone impacted by ovarian cancer. Find out more know.az/3NiJfxd
#oliviaoc #ovariancancer #esgo2022 -
AstraZeneca
@AstraZeneca
Young people, such as children, adolescents, and young adults can develop chronic kidney disease too. These patients' mortality rate with end-stage disease is 30 times higher than their healthy peers. Dr.Manish Sood says one way to improve patient outcomes is earlier diagnosis.
-
AstraZeneca
@AstraZeneca
According to Dr. Manish Sood, earlier testing and diagnosis could be key to improved outcomes in chronic kidney disease (CKD) patients. Unfortunately, nearly 90% of patients with CKD don’t know they have it.
-
AstraZeneca
@AstraZeneca
We're thrilled to be partnering and raising awareness about amyloidosis with @AmyloidosisA. This underrecognised and complex disease needs much more attention. We're committed to helping to advance the science behind it on #worldamyloidosisday and beyond.
-
AstraZeneca
@AstraZeneca
Richard shares his story of learning to live with heart failure caused by cardiomyopathy. We are following the science to find new treatment options that address the underlying causes of cardiomyopathy, so people can live healthier lives. #heartfailure know.az/3N5fTSY
-
AstraZeneca
@AstraZeneca
Chronic kidney disease is a growing public health problem, presenting a significant burden for patients and health systems alike. Learn more about how we can work together to prevent growth of this neglected public health crisis. know.az/3PYi5wb
-
AstraZeneca
@AstraZeneca
Do you have a project with the potential to transform care for #lungcancer patients? The deadline for the Initiatives in Lung Cancer Care (ILC2) grant program has been extended to 31 October. Apply via @LungAmbition now.
Lung Ambition Alliance
@LungAmbition
Deadline extended! The Initiatives in Lung Cancer Care (ILC2) grant program is accepting applications thru October 31. We’re looking for projects aimed at improving the quality of care for patients with #lungcancer worldwide. Apply here: www.lungambitionalliance.com/our-initiatives/initiatives-…
-
AstraZeneca
@AstraZeneca
We believe that science and collaboration hold the answer to many of the sustainability challenges we face today.
This is #whatsciencecando to ensure a healthy future for us all 🧵👇Post not available here, view on X
AstraZeneca
@AstraZeneca
Science can drive equitable access and help to create more resilient health systems.
We believe that everyone should have access to solutions across the patient care pathway, so we invest in programmes such as Healthy Heart Africa to support local health systems.
AstraZeneca
@AstraZeneca
Through science, we can deliver transformative, net zero healthcare that benefits people, society, and the planet.
This is #whatsciencecando know.az/3TrhILU -
AstraZeneca
@AstraZeneca
Liver cancer is often diagnosed at advanced stages when prognosis is poor. Early detection and treatment are critical to addressing areas of high unmet need and improving outcomes for patients. #octoberis4livers
-
AstraZeneca
@AstraZeneca
A new interactive map highlighting #lungcancer screening programmes around the world provides a valuable resource to aid policy discussions on early screening and diagnosis. Explore the map by @LungPolicy, an initiative of @LungAmbition
Lung Cancer Policy Network
@LungPolicy
The new interactive map of #lungcancer screening showcases global examples of #ldct screening implementation, and provides an overview of the current status of early detection of lung cancer in various regions. #lcsm
Find it on our website: -
AstraZeneca
@AstraZeneca
We were one of the first seven companies worldwide to have our scope 1-3 emissions targets verified under @ScienceTargets Corporate Net-Zero Standard. We call on more companies to join us in setting net-zero targets now. #netzeroactionday #cop27 know.az/3VGeHJJ
-
AstraZeneca
@AstraZeneca
At #idweek2022 we’re showcasing new research and developing key partnerships as we set out our ambition to deliver long-lasting immunity for millions of people globally, ensuring no one is left behind. know.az/3VCqt7L
-
AstraZeneca
@AstraZeneca
This #globalethicsday, we’re shining a spotlight on our commitment to upholding ethical excellence and empower people through inclusion.
Together, we can unlock the power of #whatsciencecando.
know.az/3TgTsfK -
AstraZeneca
@AstraZeneca
Our R&D Postdoctoral Challenge has reached its final stage. Today, six shortlisted applicants from three different continents will be pitching their innovative research proposals to a world-leading panel in Gothenburg. Good luck to all the #postdocs.
-
AstraZeneca
@AstraZeneca
As many countries prepare for another winter of COVID-19, together with experts, we outline the need for more targeted policies and interventions to protect immunocompromised patients from the continued impact of the pandemic in our Call to Action. know.az/3ES9Jng
-
AstraZeneca
@AstraZeneca
#breastcancer is the world’s most prevalent cancer, affecting people of all ages and backgrounds.1 To make a difference to breast cancer care for all patients, we must rethink breast cancer diagnosis and treatment. #breastcancerawarenessmonth
-
AstraZeneca
@AstraZeneca
Our latest research in @NatureComms demonstrates that TLCD1/2 proteins play a role in regulating mitochondrial phospholipid metabolism and liver disease. Further investigation may uncover the potential implications of treating liver disease. know.az/3S2t8Vx
-
AstraZeneca
@AstraZeneca
Do you have a project with the potential to transform care for #lungcancer patients in your country or community? Apply for a grant now via @LungAmbition ILC2 program
Lung Ambition Alliance
@LungAmbition
Applications for the Initiatives in Lung Cancer Care (ILC2) program are now being accepted! This grant program aims to support innovative projects that drive improvements across all areas of #lungcancer patient care. Apply before October 19: www.lungambitionalliance.com/our-initiatives/initiatives-…
-
AstraZeneca
@AstraZeneca
Do you have a novel solution to our Open Innovation CoSolve sustainability challenge? Launched at @ELRIG_UK Drug Discovery 2022, we’re calling on all innovators across academia and industry, and in any discipline to submit their ideas before 31 December. know.az/3Mt2hAE
-
AstraZeneca
@AstraZeneca
Our #healthyheartafrica programme has expanded to support access to healthcare in Zanzibar, in collaboration with our partner @HIPZ_UK Learn more about the programme: know.az/3g3itfT
-
AstraZeneca
@AstraZeneca
We’ve discovered that peroxynitrite in the tumour microenvironment can help tumour cells evade detection, showing the need for therapies to target suppressive mechanisms within the tumour environment. New publication in @Cancer_Cell know.az/3SV3VNK #whatsciencecando
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Young women thrive when they have equitable access to healthcare and education. On #internationaldayofthegirl, we recognise the need for continued opportunities for women. #girlsbelonghere2022 #younghealthprogramme know.az/3T8r9Qq
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Synthetic data has the potential to change how biopharmaceutical research and clinical trials are conducted. #whatsciencecando know.az/3MdxpE1
-
AstraZeneca
@AstraZeneca
Throughout history infectious diseases have been a leading cause of death and disability. #vaccines have helped to prevent deaths, eradicate smallpox, and eliminate the circulation of certain infectious diseases across the world. #whatsciencecando know.az/3e7lUBH
-
AstraZeneca
@AstraZeneca
To address climate change and support ecological and community resilience, through AZ Forest Indonesia, we’re working with @onetreeplanted and @Trees4Trees to plant and maintain 10 million trees in the Citarum River Basin, helping to support 40,000 farmers. #cofo26
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
On Thurs 6 Oct, Juliette White, VP Sustainability will join cross-sector industry experts at the @Reuters Events Pharma to share how we’re embedding #sustainability in everything we do to create meaningful, system-wide change. Register here 👇
Reuters Events Pharma
@RE_Pharma
Is your company doing enough to drive environmental #sustainability across biopharma? Global ESG leaders from @AstraZeneca @Merck @Novartis @Deloitte discuss practical approaches to create change - join us: events.reutersevents.com/pharma/sustainability #netzero #pharma
-
AstraZeneca
@AstraZeneca
Through Ambition Zero Carbon we’re taking bold action to reduce GHG emissions across our global operations, including investing in clean heat and power to transition to 100% renewable power. Learn more from the @corporateknight case study #ckcasestudy #whatsciencecando
Corporate Knights
@corporateknight
Global biopharmaceutical company @AstraZeneca is partnering to build a #renewableenergy plant to provide #cleanheat and power across the company’s U.K. operations.
Learn more about AstraZeneca’s “Ambition Zero Carbon” program 👇
corporateknights.com/earth-index/ -
AstraZeneca
@AstraZeneca
On average, COPD causes over 3 million deaths per year, a mortality rate comparable to some cancers, but doesn’t always receive the same attention.
Hear Dr Richard Russell discuss visibility and prioritising people with COPD. #speakupforcopd know.az/3EbWk91 -
AstraZeneca
@AstraZeneca
Science can… Prevent, modify and one day, even cure different diseases.
This is the adventure of #whatsciencecando know.az/3y48flz -
AstraZeneca
@AstraZeneca
An estimated 100,000 people have been diagnosed with chronic lymphocytic leukaemia (CLL) in recent years. Learn more about the common symptoms of the most prevalent type of adult leukaemia. #bloodcancerawarenessmonth
-
AstraZeneca
@AstraZeneca
We’ve asked a few of our leading scientists about their innovations in epithelial science. Here’s what they had to say about the unmet needs and the role that epithelial science plays in severe #asthma. know.az/3USYIaQ
-
AstraZeneca
@AstraZeneca
Anyone with a prostate could develop prostate cancer so to help improve outcomes we must raise awareness of symptoms to drive early diagnosis. As cancer progresses the outlook may worsen, so taking action at the first sign of potential prostate cancer symptoms could be critical.
-
AstraZeneca
@AstraZeneca
We’re using our knowledge of science and ability to innovate to deliver sustainable healthcare. Here’s some examples of our work. ⬇️ #whatsciencecando
-
AstraZeneca
@AstraZeneca
About 64 million patients are affected by heart failure globally. One way to protect patients is by encouraging them to assess their risk. Spotlight On Heart Failure is a great place to start this #worldheartday. #useheart know.az/3LUXkk0
-
AstraZeneca
@AstraZeneca
We have a long legacy in the science of disease prevention. At OPTIONS and @rsv2022, we’re showcasing our commitment to continuing to play a leading role in tackling infectious diseases like #rsv and #flu. know.az/3LPaHls
-
AstraZeneca
@AstraZeneca
Dr MeiLan Han discusses how #covid19 disproportionately impacts those living with chronic respiratory illnesses, such as #copd, and how the pandemic is challenging health system sustainability. Let’s #speakupforcopd and make it a public health priority. know.az/3dOUz78
-
AstraZeneca
@AstraZeneca
We believe in fostering a culture of doing the right thing across our value chain.
That’s why we created our Supplier Diversity Programme which supports the growth of small and diverse businesses. #whatsciencecando know.az/3BGJXPy -
AstraZeneca
@AstraZeneca
We equip our researchers with #technology to turn science into medicine faster and with a higher probability of success. #whatsciencecando know.az/3rar2I1
-
AstraZeneca
@AstraZeneca
#realworldevidence (RWE) and clinical trial data are needed to give researchers a more complete picture of a medicine’s effectiveness, but RWE for cancer medicines is limited. #worldcancerresearchday
-
AstraZeneca
@AstraZeneca
We’re on a journey and while we have made significant progress, we know there is more we can do to accelerate change for our employees, patients and the communities we serve. #inclusion #diversity #whatsciencecando know.az/3LGzbO0
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Together, let’s #flipthescript to build a sustainable world for people, society, and the planet. We’re showing #whatsciencecando to transform the future of healthcare, for all of us. #act4sdgs #unga77
-
AstraZeneca
@AstraZeneca
To further our commitment to gender equality, in 2022, the #younghealthprogramme is providing $150,000 to women-led #stepup projects, to support the efforts of organisations like @maia_impact. #girlsbelonghere2022 know.az/3fiza6N
-
AstraZeneca
@AstraZeneca
#vaccines helped prevent approximately 25 million deaths from infectious diseases in 2021, and assisted in lowering the risk of severe illness and hospitalisation. #whatsciencecando know.az/3SuKbjl
-
AstraZeneca
@AstraZeneca
Thank you @AACR for the Outstanding Achievement Award for Service to Cancer Science and Medicine. Our relationship has been a long and fruitful one, built on an unwavering persistence to innovation and scientific advancement. know.az/3dJjk4m
-
AstraZeneca
@AstraZeneca
We’re taking bold action to accelerate the decarbonisation of healthcare. Here are four key lessons we’ve learned to accelerate the transition to net zero. #climateweeknyc #sdim22 #whatsciencecando know.az/3UyQaG2
-
AstraZeneca
@AstraZeneca
From the lab to the patient, we embed sustainability into everything we do.
This is #whatsciencecando to deliver healthcare that benefits:
✅People
✅Society
✅PlanetThis media couldn't be displayed. See it on the original post. -
AstraZeneca reposted
ESMO - Eur. Oncology
@myESMO
We are delighted to announce @antoniomarraMD as 1st recipient of the ESMO José Baselga Clinician Scientist Fellowship, aiming to help young oncologists develop as clinician scientists. To be awarded at the #esmo22 YO Fellowship Session (11/9) www.esmo.org/meetings/esmo-congress-2022/programme/young-…
@IEOufficiale -
AstraZeneca
@AstraZeneca
Overall survival is a key endpoint for cancer therapy efficacy, but the data can take a long time to mature. Alternative endpoints can measure other outcomes that patients value – like how long they may live without their tumour returning or growing after treatment.
-
AstraZeneca
@AstraZeneca
This #wlad, we’re joining @knowyournodes to raise awareness of lymphoma, including mantle cell lymphoma (#mcl). Education is a key tool for detection – find out more about the impact of this rare, yet aggressive type of non-Hodgkin lymphoma.
-
AstraZeneca
@AstraZeneca
Science can…make us pioneers.
This is the adventure of #whatsciencecando. know.az/3LdtYwE -
AstraZeneca
@AstraZeneca
Prostate cancer that does not respond to hormone therapy is described as castration-resistant, and is more likely to spread, worsening the outlook for the patient. Symptom awareness can enable rapid diagnosis and help ensure the best possible outcomes. know.az/3RRBv6I
-
AstraZeneca
@AstraZeneca
We are committed to helping redefine cancer care by advancing innovative research, so that Suzanne and thousands of people diagnosed with ovarian cancer have the potential to achieve better outcomes and live their fullest lives possible. Learn about Suzanne’s experience below.
-
AstraZeneca
@AstraZeneca
We are deeply saddened by the passing of Her Majesty Queen Elizabeth II and extend our condolences to her family and all those in the United Kingdom and around the world whose lives she touched.
-
AstraZeneca
@AstraZeneca
Improving access, timeliness, and coordination of multidisciplinary team (MDT) care can reduce premature deaths from #lungcancer. A new report by @LungAmbition identifies 3 priority areas where the biggest impact for patients can be realised. Learn more: know.az/3RyAy2S
-
AstraZeneca
@AstraZeneca
Our research being presented at #erscongress brings us one step closer to our goal of transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases.
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Malonate, a natural chemical in our bodies, helps to stop further damage following a heart attack. Our collaboration supporting @cambridge_uni and @mrc_mbu revealed how malonate enters damaged heart muscle, which could help to target future therapies. know.az/3RDC7wn
-
AstraZeneca
@AstraZeneca
This #wld22, learn more about chronic lymphocytic leukaemia (#cll), the most common form of adult leukaemia, and its impact on those living with this form of blood cancer. #bloodcancerawarenessmonth
-
AstraZeneca
@AstraZeneca
Prostate cancer is the second most common cancer in men globally, and if found early, can have better outcomes. This Prostate Cancer Awareness Month, we want to ensure people with a prostate know the symptoms - if you experience any of these, speak to a healthcare provider. #pcam
-
AstraZeneca
@AstraZeneca
From the beginning science has been at the front and centre of everything we do, taking us to places we never thought possible.
This is the adventure of what science can do…
#whatsciencecando know.az/3Q0jKkdThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
While many have resumed “normal” life, those living with chronic lymphocytic leukaemia (#cll) continue to face challenges and risks due to the COVID-19 pandemic. In honor of #wclld22 tomorrow, join us in raising visibility for this immunocompromised community.
-
AstraZeneca
@AstraZeneca
We are following the science to uncover eosinophilic inflammation and to advance our understanding of the key role it plays in a range of inflammatory diseases, allowing us to help improve diagnosis and care for millions of people worldwide. know.az/3R288hZ
-
AstraZeneca
@AstraZeneca
We’re excited to be back at the #oyw2022 Summit for 2022. Learn more about @OneYoungWorld and the 36 scholars that are joining us. #girlsbelonghere2022 know.az/3Q6pYyS
-
AstraZeneca
@AstraZeneca
Our commitment to heart failure (HF) doesn’t stop when #esccongress ends — we’ve listened to patients ask for resources and user-friendly guidelines on heart failure. We’re working with @GlobalHeartHub to develop the tools patients and their families need to manage HF diagnosis'.
-
AstraZeneca
@AstraZeneca
Inflammation plays a central role in the development of heart failure with preserved ejection fraction, where sustained inflammation may lead to tissue stress and injury, fibrosis and hypertrophy, and dysfunction of the heart muscle. #esccongress know.az/3wuInhV
-
AstraZeneca
@AstraZeneca
Latest work from our Centre for Genomics Research published in @ScienceAdvances reveals our novel tool OncMTR can pinpoint non-inherited, missense mutations that may cause cancer. This has implications for precision medicine approaches: know.az/3CBHok2
#whatsciencecandoThis media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Heart failure (HF) is a complex syndrome that is often complicated by multiple interrelated diseases. A greater understanding of the drivers of HF will help address the unique needs of the 64 million people living with the disease. #esccongress know.az/3pQIBvT
-
AstraZeneca
@AstraZeneca
Immunocompromised patients continue to face ongoing risks from COVID-19. In this @politico article, sponsored by AstraZeneca, Iskra Reic, EVP, Vaccines and Immune Therapies talks about policy action to protect this community: know.az/3CzEKey
-
AstraZeneca
@AstraZeneca
💦 #worldwaterweek2022: Join us Mon 29 Aug at 9:00 and 3:30 EDST, to learn about our approach to water stewardship & how we are improving circularity and water quality, and reducing reliance on this vital natural resource. know.az/3RdyrkU
@siwi_www @WWFWaterRisk
World Water Week
@siwi_www
🌐 World Water Week💦Find your way into water↪️Reconnect with colleagues↪️ Propose collaborations↪️Pitch yourself↪️Ask questions↪️ Dig deeper💦
🤔 How do I join?
⏰ You can still registered today▶️ worldwaterweek.org/2026/tickets
#wwweek
#worldwaterweek
#wwweek2022
#worldwaterweek2022 -
AstraZeneca
@AstraZeneca
Breast cancer is highly diverse and fueled by many factors. Being aware of this can be crucial in striving for earlier diagnosis and better outcomes for patients. Identifying ways to help prevent recurrence may allow patients valuable time to live their lives.
-
AstraZeneca
@AstraZeneca
Heart failure (HF) patients often experience interrelated diseases such as diabetes and chronic kidney disease. Research continues to investigate the need to consider cardiovascular, renal, and metabolic conditions as causes and risk factors for HF. know.az/3Th1K7R
-
AstraZeneca
@AstraZeneca
Delighted that the @EnvSciTech manuscript we co-authored on reducing the impact of medicines on the environment has won the @AmerChemSociety editor’s choice award. Find out more about the GREENER approach to pharmaceutical discovery and development. know.az/3AlWUh1
PREMIER Project
@PREMIERProject6
💊🍃 We are honoured that our manuscript on GREENER Pharmaceuticals published today in @EnvSciTech Letters has been selected as an ACS Editors’ choice!
👀 pubs.acs.org/doi/full/10.1021/acs.estlett.2c00446
@ACSPublications
@IHIEurope -
AstraZeneca
@AstraZeneca
A heart failure (HF) diagnosis can mean many things to different people. Discover a series of inspiring videos to learn how people felt when they were first diagnosed, and what they do now to live well with HF. #esccongress know.az/3dOt3Gq
-
AstraZeneca
@AstraZeneca
The #internationalrespiratorycoalition has ambitious goals to help transform post-pandemic care and aims to help reduce deaths from #respiratory diseases by a third by 2030. know.az/3QIRcfN
-
AstraZeneca
@AstraZeneca
Monoclonal antibodies are large molecules designed to mimic or improve the body’s natural immune response. Due to the complex nature of developing monoclonal antibodies, the speed and scale at which they are produced can be challenging. know.az/3zXj7lh
-
AstraZeneca
@AstraZeneca
There is an urgent need to prioritise #copd care for the 384 million people affected by this condition. Professor John Hurst lends his voice to #speakupforcopd because it’s time to recognise the devastating impact of COPD on individuals and society. know.az/3vV0Nbi
-
AstraZeneca
@AstraZeneca
Our latest research in @angew_chem details advances in molecular imaging technology that enables the analysis of large molecules and intact drug-target complexes which were previously deemed too large to detect. know.az/3PcEzs1
-
AstraZeneca
@AstraZeneca
This #internationalyouthday2022, we are proud to support the 27th Youth Assembly to empower a global network of young leaders and changemakers towards a healthier future. know.az/3d2iXkE
-
AstraZeneca
@AstraZeneca
#copd is the third leading cause of death worldwide but is often under-prioritised, underfunded, and undertreated. People living with this disease deserve better care. Lend your voice to #speakupforcopd and call for change.
-
AstraZeneca
@AstraZeneca
Patients with certain genetic mutations are at a higher risk of their cancer coming back after surgery. Biomarker testing at diagnosis allows doctors to make informed decisions about a patient’s care plan.
-
AstraZeneca
@AstraZeneca
In #haematology, we listen to those living with blood cancer at every stage of their journey. Hear more from Niko Andre, our Global Franchise Head of Haematology and Immuno-Oncology.
-
AstraZeneca
@AstraZeneca
We have expanded our #healthyheartafrica programme to Nigeria, working with our partners @NphcdaNG and @PSIimpact to tackle the burden of hypertension and cardiovascular disease. Learn more about how we drive access to sustainable healthcare in Africa: know.az/3vPilpo
-
AstraZeneca
@AstraZeneca
Many patients with non-small cell lung cancer will develop resistance to their initial treatment. Research into potential therapy combinations could reveal ways to overcome this resistance and prolong a patient’s response to treatment. #wclc22
-
AstraZeneca
@AstraZeneca
A booster is an additional #vaccine dose given after the initial vaccination course is completed to maximise protection against infection and prevent severe illness, hospitalisation and other serious outcomes. #whatsciencecando know.az/3d81ZBK
-
AstraZeneca
@AstraZeneca
The #worldmentalhealthreport has revealed that a collective effort towards addressing the #mentalhealth of adolescents and equipping them with the right support, can be effective in closing the widening treatment gap. @RTI_Intl
RTI International
@RTI_Intl
Investment in adolescent #mentalhealth can help improve the health, education, and economic outcomes of the next generation. Our new investment case finds that for every $1 invested, we expect $24 in benefits over 80 years.
Read more: www.rti.org/insights/investing-in-adolescent-mental-health -
AstraZeneca
@AstraZeneca
Earlier diagnosis of chronic kidney disease (CKD) can be critical in improving outcomes and quality of life. Join us in taking action against #ckd and sign the pledge: know.az/3oNNCF6
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We’re making positive progress this year with our strong H1 and Q2 2022 results recently announced. We look forward to continuing our progress and providing patients all over the world access to life-saving medicines. $AZN
-
AstraZeneca
@AstraZeneca
Closing the cancer care gap is a top priority but what collective effort is needed to ensure true equity when it comes to access? Ahead of World Lung Cancer Day, this @devex piece explores how we break through the barriers to redefine patient access. know.az/3SdD2oy
-
AstraZeneca
@AstraZeneca
We’re advancing our understanding of the underlying drivers and biological mechanisms of #severeasthma. We are determined to transform this pioneering research into new and innovative solutions for patients who remain underserved today. know.az/3J31d4G
-
AstraZeneca
@AstraZeneca
Today we officially launched our #healthyheartafrica programme in Rwanda, the eighth country of operation in Africa since 2014, in collaboration with our partners @RwandaHealth, @RBCRwanda and @PATHtweets. Learn more about the programme: know.az/3z4uh7m
-
AstraZeneca
@AstraZeneca
Richard Marshall, Senior Vice President and Global Head of Late Respiratory and Immunology, discusses the potential of epithelial science to transform outcomes for patients living with #severeasthma, and the urgency to tackle this unmet need worldwide. know.az/3PP4uHH
-
AstraZeneca
@AstraZeneca
We foster an environment that champions diversity and inclusion in all areas. Rebekah Martin, SVP of Reward and Inclusion, spoke with @HRGrapevine regarding championing #neurodiversity in the workplace: know.az/3PPJxf8
-
AstraZeneca
@AstraZeneca
Associate Director, CMC Regulatory Affairs, Dipkumar Patel shares how his experiences inspired him to pursue a career in Oncology and #regulatoryaffairs - putting patients at the heart of everything he does. know.az/3aQn8Q7
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We’ve partnered with @Microsoft to develop the HealthyMind app, giving quick and easy access to mental health support for our employees worldwide. #employeewellness #mentalhealthmatters know.az/3zhqghi
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We welcome the commitment for equitable access in pandemics from across the industry. We've made equitable access to vaccines a key priority in this pandemic and will continue to collaborate with partners worldwide on future pandemic preparedness. know.az/3aMW4kC
-
AstraZeneca
@AstraZeneca
The production of monoclonal antibodies involves several complex operations, raw materials, tight procedures, and quality controls to ensure the safety and quality of the final product. know.az/3Pxg75X
-
AstraZeneca
@AstraZeneca
Machine learning allows us to identify new targets for novel medicines. Our scientists are applying these methods and accelerating cancer drug discovery by combining CRISPR and AI. #icml2022 know.az/3aGOJTG
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Machine learning turns data into knowledge that we can use to design better clinical trials. In this video, @DinoOglic explains how his team uses machine learning to optimise audio recordings to improve patient experiences. #icml2022 know.az/3IDBCzg
-
AstraZeneca
@AstraZeneca
Our Centre for Genomics Research is using genome sequencing to reveal the biology underlying chronic diseases. Discover our latest publications on clonal haematopoiesis, idiopathic pulmonary fibrosis and Gene-SCOUT: know.az/3chUKq9 #whatsciencecando
-
AstraZeneca
@AstraZeneca
Meet the inspiring young health leaders who have been selected to receive a scholarship to attend the @OneYoungWorld Summit, empowering them to build their knowledge, skills and networks. #worldyouthskillsday know.az/3ciojbp
-
AstraZeneca
@AstraZeneca
Artificial intelligence and machine learning are crucial to our research and development strategy. At #icml2022, we will share how we are able to discover, test and accelerate the potential medicines of tomorrow. know.az/3O9Mh5K
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Be empowered to push the boundaries of science with an exciting pipeline and opportunities to grow and develop across the business. #discoverysciences know.az/3uJNeep
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
The application of novel technologies to precision medicine is leading to significant scientific and healthcare breakthroughs. Discover the technologies that we’re applying to enhance and accelerate our drug discovery in chronic diseases.#whatsciencecando know.az/3arCWIW
-
AstraZeneca
@AstraZeneca
Discover more about how we are helping young people around the world to achieve positive change in their communities, and develop the skills they need for the future world of work:. #worldyouthskillsday know.az/3z5u05z
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Transforming our understanding of respiratory disease is vital. Our joint blog with @asthmalunguk
discussing how patient cohorts will be critical to achieving this. #whatsciencecando know.az/3OLTWse -
AstraZeneca
@AstraZeneca
When found early, breast cancer tumours are often confined to one area, making the cancer easier to manage. As cancer grows and spreads, the survival rate falls making early diagnosis critical to help improve outcomes.
-
AstraZeneca
@AstraZeneca
We are exploring the potential of #immunooncology therapies such as T-cell engagers to generate an immune response against #cancer. Learn more about the exciting possibilities fuelling our next-generation pipeline.
-
AstraZeneca
@AstraZeneca
People with BRCA mutations tend to develop breast cancer at a younger age than people without them – the average age at diagnosis is ~42. If you have a family history of breast cancer, discuss biomarker testing with your doctor, or during a routine breast screening.
-
AstraZeneca
@AstraZeneca
We know that #innovation doesn’t happen in isolation. Our A.Catalyst Network hub in India partners with leading #healthtech start-ups to bridge gaps in existing healthcare infrastructure, support underserved communities and transform patient outcomes know.az/3R8GNuF
-
AstraZeneca
@AstraZeneca
Triple negative #breastcancer is an aggressive cancer with risk factors such as a family history of breast cancer which may be caused by genetic factors (e.g. BRCA mutations) and being overweight. If you are concerned, speak to your doctor.
-
AstraZeneca
@AstraZeneca
Learn about how we leveraged @WWFWaterRisk's tool to inform our water stewardship activities and to inform how we assess and respond to physical climate-related risks at our sites: know.az/3y6KRD9
Rylan Dobson 💧
@rylan_dobson
🚨NEW CASE STUDY🚨Learn about how @AstraZeneca leveraged the @WWFWaterRisk's new #tcfd aligned #scenarios tool along with other data to enable it to engage sites to create #contextualised #waterstewardship response plans cdn.kettufy.io/prod-fra-1.kettufy.io/documents/waterriskf…
-
AstraZeneca
@AstraZeneca
Last week, we joined global discussions on the delivery of sustainable, equitable healthcare at #chogm2022. Through the @TheSMI Health Systems Taskforce, we are taking action to accelerate the delivery of net zero healthcare – for people and the planet. know.az/3a2Yuvd
-
AstraZeneca
@AstraZeneca
To help bring healthcare closer to patients, we’ve joined with @MOH_Kenya and @Amref_Worldwide to launch mobile #covid19 vaccination clinics in hard-to-reach communities across Kenya. #thelastmile
-
AstraZeneca
@AstraZeneca
Our latest study in @NatMachIntell details a new machine learning training strategy called Curriculum Learning that virtually generates new molecules faster and results in more molecules fulfilling a set of criteria compared to more traditional methods. know.az/3OIlY7q
-
AstraZeneca
@AstraZeneca
As a Global #inclusion and #diversity (I&D) Council member, Russel Smith plays an important role in helping to advance our I&D mission. As we celebrate #pride month, Russel reflects on his role as a Council member and ally. know.az/3u7IUoN
-
AstraZeneca
@AstraZeneca
Next week, the 2022 International Respiratory Coalition (IRC) Summit will take place in Paris. Join us and our partners on 28 June, as we discuss how the Coalition aims to support the transformation of #respiratory care at national level. Register here: know.az/3u2uTst
-
AstraZeneca
@AstraZeneca
To continue advancing science, we are harnessing technologies like circulating tumour DNA (ctDNA). In this new @GeneticsUnzip podcast episode, @susanmgalbraith discusses how we are leveraging ctDNA to better detect, select and monitor cancer: know.az/3tXfwRZ
-
AstraZeneca
@AstraZeneca
AZPride Australia and New Zealand recently held an industry networking event with more than 40 attendees coming together to raise awareness of IDAHOBIT and to re-start an APAC chapter of the Proud Science Alliance (PSA). #pridemonth2022
-
AstraZeneca
@AstraZeneca
We are entering a new era of drug discovery using precision medicine to target the right treatment to the right patient at the right time. Explore our approach and aspirations to change future outcomes for patients with chronic diseases. #whatsciencecando know.az/3b7OroN
-
AstraZeneca
@AstraZeneca
COPD is the 3rd leading cause of death worldwide, yet it is often underprioritised, leading to increased hospitalisations and mortality. New COPD quality standards, developed by experts and funded by AstraZeneca, call for change within healthcare systems: know.az/3MQeX32
-
AstraZeneca
@AstraZeneca
With our ground-breaking pipeline, the outlook is bright. Be proud to be part of a place that has achieved so much, yet is still moving forward. #celltherapy #whatsciencecando know.az/3QgqwDu
-
AstraZeneca
@AstraZeneca
Join a team with science at its heart, this is the place where breakthroughs born in the lab can become transformative medicines — for the world’s most complex diseases. #celltherapy #whatsciencecando know.az/39j3efL
-
AstraZeneca
@AstraZeneca
At the first hybrid #eha2022, we are expanding our commitment to those with malignant and rare blood diseases, and seeking to address the challenges faced by patients with chronic lymphocytic leukaemia.
-
AstraZeneca
@AstraZeneca
Stopping the spread of viruses and maximising protection against new variants remains key to tackling the global pandemic and ensuring that all members of the community can be protected. #whatsciencecando know.az/3tj5cUf
-
AstraZeneca
@AstraZeneca
Breast cancer research is experiencing a transformation as breakthrough advances are being made across multiple treatment settings, tumour types and stages of the disease. Learn how we’re working to redefine the future of breast cancer research. know.az/3xe1BJi #asco22
-
AstraZeneca
@AstraZeneca
It was a pleasure welcoming Dr Karen DeSalvo, Chief Health Officer @Google to Cambridge for the 2022 Evidence Summit and learning about Google Health’s strategy. Innovation is crucial to improving patient outcomes and when companies collaborate great things can happen.
-
AstraZeneca
@AstraZeneca
We are pushing the boundaries of science in immuno-oncology. This includes unlocking the full potential of bispecific antibodies to develop more targeted and powerful options for patients. Learn more about our advances in IO. #asco22 know.az/3MhxHID
-
AstraZeneca
@AstraZeneca
Cancer survivor Franco shares how an early diagnosis saved his life. On #ncsd2022 we want to celebrate survivors and encourage people to access the screening services available to them. Cancer doesn’t wait, neither should you. #newnormalsamecancer
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We’re following the science reduce our greenhouse gas (GHG) emissions and investing in nature and biodiversity to help protect and restore our common home. #worldenvironmentday #onlyoneearth know.az/3GDoWXW
-
AstraZeneca
@AstraZeneca
At #asco22, our teams are presenting new data in oncology, participating in scientific exchange — and some are catching their first American baseball game!
-
AstraZeneca
@AstraZeneca
We’re joining organisations across the globe to commemorate #stockholm50 and demonstrate our commitment to human and planetary health through bold, urgent action on the ground. #onlyoneearth know.az/3t5GJ4A
-
AstraZeneca reposted
AstraZenecaUK
@ASTRAZENECAUK
We’re joining the whole UK in celebrating Her Majesty the Queen’s #platinumjubilee. Throughout her reign, HMTQ has been an advocate for #science, which has had a lasting impact on the lives of patients. Congratulations @RoyalFamily on this momentous occasion!
-
AstraZeneca reposted
Devex
@devex
Through @TheSMI, health care sector leaders are now joining forces to accelerate delivery of net-zero health systems. Read more: www.devex.com/news/opinion-taking-collective-action-to-de… #sponsored @SustHCoalition @novonordisk @roche @sanofi @karolinskainst @UNICEF @AstraZeneca @unipv @GSK @Merck
-
AstraZeneca
@AstraZeneca
We are joining the #lupus community at #eular2022 to discuss how our science is accelerating understanding of the complex pathways that drive autoimmune diseases such as systemic lupus erythematosus. know.az/3x6F69a
-
AstraZeneca
@AstraZeneca
There is #onlyoneearth and we must all play our part to protect it. As part of @TheSMI Health Systems Taskforce, we’re calling for collective action across all aspects of healthcare delivery to accelerate decarbonisation of the sector. #worldenvironmentday know.az/3aCQnW3
-
AstraZeneca
@AstraZeneca
Congratulations to Pascal Soriot, AstraZeneca CEO, who has been awarded a knighthood for services to UK life sciences and leadership in the global response to the COVID-19 pandemic.
-
AstraZeneca
@AstraZeneca
Happy #pride! In Poland our #lgbtqia+ employee resource group promotes the message that inclusion starts with education. Poland provides a dedicated inclusion & diversity library with books on cultural diversity, mental health, and more. #pridemonth2022
-
AstraZeneca
@AstraZeneca
Our partnership with @SlushHQ will continue throughout 2022, supporting healthcare-focused innovators and entrepreneurs worldwide to transform the lives of patients. know.az/3PLjV3M
-
AstraZeneca
@AstraZeneca
New research in @NatureComms shows how VHH intrabodies improve function of the impaired heart by disrupting the inhibitor protein PLN. Combined with a vehicle for drug delivery, this could form the basis for new #heartfailure treatments in the future. know.az/3x1FKU3
-
AstraZeneca
@AstraZeneca
As part of the #edisonalliance, we are excited to join the 1 Billion Lives Challenge to improve access to innovative digital solutions in health by 2025, with a focus on underserved communities.
@WEF know.az/3t1VVQo
World Economic Forum
@Davos
.@AstraZeneca joins the 1 Billion Lives Challenge by committing to screen 5 million people globally by 2025 using AI-based technology.
#edisonalliance
www.weforum.org/partners/live-updates/wef-partners-drivin… -
AstraZeneca
@AstraZeneca
We’re committed to advancing the science behind immune-driven diseases by unlocking the complex processes at the pathway level that drive disease activity in areas of high unmet need, such as lupus nephritis: know.az/3wUKo7I
-
AstraZeneca
@AstraZeneca
In recent years, there has been a great deal of progress made in understanding blood cancer. Join us in honouring #worldbloodcancerday and learn more about the disease here: know.az/3Gra8eV
-
AstraZeneca
@AstraZeneca
A Lung Cancer Collaboration report states early diagnosis of lung cancer offers the best chance of a favorable prognosis. Urgent investment in screening and treatment is needed to improve lung cancer survivability. know.az/3wTj75y #wha22
-
AstraZeneca reposted
AstraZenecaUK
@ASTRAZENECAUK
Today, the UK and Sweden signed an MOU that will enhance cooperation & provide a supportive environment for collaboration between our life sciences sectors. As an Anglo-Swedish enterprise, we are proud to be involved in the development of this agreement. know.az/3PNYW0r
-
AstraZeneca
@AstraZeneca
In the lead up to #stockholm50, we’re looking at how Green Chemistry is helping us to reduce our environmental footprint through reducing waste, conserving energy, and eliminating hazardous substances. Find out more: #whatsciencecando #onlyoneearth know.az/3GnsIEW
-
AstraZeneca
@AstraZeneca
Today we were delighted to host King Carl XVI Gustav and Queen Silvia at The Discovery Centre (DISC) in Cambridge, UK. As part of a wider visit to the UK Their Majesties toured our R&D facility where we demonstrated how we carry out cutting-edge research.
-
AstraZeneca
@AstraZeneca
Tackling climate change, biodiversity loss and pollution requires bold and immediate action. In the lead up to #stockholm50, read about the initiatives we are championing to create a resilient, sustainable and healthy future for people and the planet. #onlyoneearth
-
AstraZeneca
@AstraZeneca
Today at @Davos our Chair, Leif Johansson, discussed how public-private partnerships can help build resilient, sustainable health systems. With #phssr leaders, we’re working to ensure #healthsystems globally withstand future stresses and shocks: know.az/3Gisuig
AstraZeneca
@AstraZeneca
Thank you to @JMDBarroso and our partners @wef, @LSEHealthPolicy, @Philips, @KPMGHealthcare @WHOFoundation and @ResilienceAPAC for a great discussion.
-
AstraZeneca
@AstraZeneca
At @Davos this year, we’re exploring how to approach health equity from all angles. The pharmaceutical industry has an important role to play in addressing diversity, equity and inclusion imperatives, towards better health outcomes for all. #wef22
-
AstraZeneca
@AstraZeneca
The global response to COVID-19 will be an important discussion at this year’s @Davos annual meeting. We continue to work towards our goal of vaccine equity, as well as protecting vulnerable populations from COVID-19. #wef22
-
AstraZeneca
@AstraZeneca
At #wef22 our Chair, Leif Johansson, announced we’re joining the #edisonalliance which aims to improve 1bn lives globally through digital inclusion, focusing on health, education and finance. know.az/3a8ctPR
-
AstraZeneca
@AstraZeneca
We are committed to ensuring we remain a key strategic partner in Poland, with both short and long-term investments that help to contribute towards Poland’s life sciences footprint and improve healthcare delivery for the benefit of patients.
Chancellery of the Prime Minister of Poland
@PremierRP_en
PM @MorawieckiM met with Chairman of @AstraZeneca, Leif Johansson, during the World Economic Forum in Davos. #wef22
-
AstraZeneca
@AstraZeneca
Up to 40% of patients with heart failure (HF) also have chronic kidney disease (CKD) and the worsening of one disease can worsen the other. Understanding this link is critical to improving patient outcomes. #era22 #heartfailure2022
-
AstraZeneca
@AstraZeneca
The World Economic Forum @Davos 2022 starts in Davos today, with the theme of Working Together, Restoring Trust. We look forward to joining this year’s sessions and driving global cooperation to address the world’s biggest public health challenges. #wef22
-
AstraZeneca
@AstraZeneca
We embrace the diversity of our people and our patients. It is what propels us forward, harnessing our differences to unlock challenges and bring new solutions. #wdcddd know.az/3wCmkoU
-
AstraZeneca
@AstraZeneca
On International #clinicaltrialsday, we would like to thank the researchers, patients and caregivers who make our trials, and trials around the world, possible. Your involvement is critical to progressing science and providing equitable care to patients worldwide.
-
AstraZeneca
@AstraZeneca
We’re proud to support the @WEF Resilience Consortium, and the strengthening of health systems through initiatives like #phssr. To create a better tomorrow, we need organizations and societies that respond effectively to major disruptions.
World Economic Forum
@wef
How do we create institutions that respond effectively to major disruptions?
In collaboration with @McKinsey, the @wef is launching the Resilience Consortium to help governments, companies, and NGOs build their resilience. wef.ch/3wtJG14
#wef22 -
AstraZeneca
@AstraZeneca
We recently participated in multiple events as part of President Biden’s #cancermoonshot, an initiative with a bold ambition – to reduce the death rate from cancer by at least 50 percent over the next 25 years. Read more: know.az/3Npk5fj
-
AstraZeneca
@AstraZeneca
If you’re an outstanding final year MD/PhD student or Postdoctoral Researcher with an innovative idea that could help advance drug discovery, enter the R&D Postdoctoral Challenge. know.az/3Mwkuwq
-
AstraZeneca
@AstraZeneca
We're pushing the boundaries of science to help move towards a world where disease modification in #copd can become a reality, so patients can start to live a life without the limits of living with this debilitating and life-threating condition. know.az/3sK30F8 #ats2022
-
AstraZeneca
@AstraZeneca
Chronic diseases are associated with tissue damage, and together with @ARMI_Labs, our collaboration seeks to better understand the role of macrophages in mediating regeneration. Read more: know.az/3wtd9rQ
-
AstraZeneca
@AstraZeneca
As research continues to show connections between cardiovascular and renal diseases, we’ll continue to follow the science and leverage evidence to encourage a holistic approach to the management of cardiorenal diseases. #era22 #heartfailure2022
-
AstraZeneca
@AstraZeneca
We are following the science to uncover eosinophilic inflammation and its impact across diseases. This will allow us to help improve diagnosis and treatment needs for millions of people worldwide. Explore the role of eosinophilic inflammation: know.az/3sHwZxc. #ats2022
-
AstraZeneca
@AstraZeneca
By advancing our understanding of the key role of the airway epithelium and epithelial cytokines in triggering asthma inflammation, we aim to provide new focus to help address the remaining unmet needs in asthma for millions of people worldwide. know.az/3ws6ZIF #ats2022
-
AstraZeneca
@AstraZeneca
Hypertension can often be prevented or reduced by healthy lifestyle behaviours. This #worldhypertensionday, learn how our Young Health Programme is empowering young people to make more informed health choices for longer and healthier lives. know.az/3FXrDDE
-
AstraZeneca
@AstraZeneca
Many patients experiencing #asthma symptoms use a SABA inhaler as a rescue medicine. Yet taking a SABA alone, does not address inflammation and can leave patients at risk of attacks. A new approach to asthma management is needed: know.az/37RSt3d #ats2022
-
AstraZeneca
@AstraZeneca
Our Healthy Heart Africa programme aims to reach 10 million people with elevated blood pressure in Africa by 2025, through education on risks, training, screening, and treatment services. #worldhypertensionday know.az/3LaVlG2
-
AstraZeneca
@AstraZeneca
For the third year in a row, we are proud to be included on the @DiversityInc Top 50 Companies for Diversity list in the US, furthering our commitment to creating an inclusive culture and making the most of the diversity of all employees. know.az/3MidjaR #ditop50
-
AstraZeneca
@AstraZeneca
As we work to improve outcomes for people with chronic respiratory diseases, we’re also embedding sustainability across our portfolio of medicines, advancing next-generation respiratory inhalers with near-zero Global Warming Potential propellants. #ats2022
-
AstraZeneca
@AstraZeneca
We are honoured to have been recognised by @WEConnection as one of the Top Global Champions for Supplier Diversity & Inclusion (SD&I) for our commitment to being intentional about buying from diverse suppliers.
WEConnect International
@WEConnection
We are thrilled to recognize these powerful global champions for being leaders in taking action & being intentional about buying from diverse suppliers with the goal of driving greater socio-economic equity in communities worldwide: weconnectinternational.org/2022-top-global-champions-for-…
-
AstraZeneca
@AstraZeneca
Heart failure (HF) patients often experience interrelated diseases such as diabetes and chronic kidney disease. Research continues to investigate the need to consider cardiovascular, renal, and metabolic conditions as causes and risk factors for HF. spotlightonheartfailure.com
-
AstraZeneca
@AstraZeneca
New research published in the American Journal of Respiratory and Critical Care Medicine reveals that variations in the KIF15 gene increases susceptibility to idiopathic pulmonary fibrosis. Find out how genomics are being used to explore #whatsciencecando. know.az/3l7xE78
-
AstraZeneca
@AstraZeneca
The COVID-19 pandemic has had a devastating impact on cancer care services across the world. Franco’s decision not to wait any longer to get checked significantly improved his outcome. Don’t wait. Contact your doctor. Get checked. #newnormalsamecancer
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Our latest collaborative study in @NatureCellBio found human progenitor cells can regenerate lost heart tissue and prevent fibrotic scarring caused by a heart attack. This innovative research could form the basis for future #heartfailure treatments. know.az/39VKNxJ
-
AstraZeneca
@AstraZeneca
Are you involved in a project focused on developing the knowledge of young healthcare leaders towards non-communicable diseases? We want to lend a hand. Learn how to apply for a #younghealthprogramme Step Up! Grant today: know.az/3kPKQ00
-
AstraZeneca
@AstraZeneca
As an active member of the @PSCInitiative, we are collaborating with industry peers to build responsible supply chains and drive excellence in safety, environmental and social outcomes. Find out more about our approach to Ethics and transparency: www.astrazeneca.com/sustainability/ethics-and-transparenc…
-
AstraZeneca
@AstraZeneca
Our chronic kidney disease (CKD) ambassadors shared the importance of earlier detection of CKD. Learn more and sign the CKD pledge to improve kidney health and build sustainable health systems. know.az/3LYrguL
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We have dedicated years of research on ways to alleviate the burden of respiratory syncytial virus, or #rsv, a common and contagious virus. We are looking forward to attending @ESPIDsociety this week and taking part in important discussions around RSV. #espid2022
-
AstraZeneca
@AstraZeneca
Yesterday @MenePangalos was elected to join eminent scientists, engineers and technologists as a Fellow of the @royalsociety. Sir Mene’s career demonstrates the power of scientific endeavour and its potential to benefit humanity. #whatsciencecando know.az/3yqX874
-
AstraZeneca
@AstraZeneca
Significant advances have been made in the treatment and prevention of heart failure (HF), but proactive management of the condition is important as the outlook for people living with HF varies from case to case.
-
AstraZeneca
@AstraZeneca
We’re on a mission to build a better future for the lupus community by advocating for improvements in diagnosis and access to care. This #worldlupusday, we’re working to #makelupusvisible in support of those living with this often-debilitating disease. know.az/3FvWoiI
-
AstraZeneca reposted
Lupus Europe
@LupusEurope
We support the 5 MILLION people living with lupus, a condition that can affect any organ in the body including the heart, kidneys, lungs, skin and more. Lupus occurs in people of all ages, races, ethnicities and genders.
Let's #makelupusvisible together! #worldlupusday -
AstraZeneca
@AstraZeneca
Huge congratulations to @MenePangalos for being elected a Fellow of the @royalsociety. This prestigious recognition reflects his outstanding contribution to advancing discovery within medical sciences. #whatsciencecando know.az/3wBm7lV
-
AstraZeneca
@AstraZeneca
As more countries ease or lift #covid19 restrictions, patient groups are calling on governments and health system leaders to introduce measures that address the unmet needs of the immunocompromised. Read our joint statement to learn more: know.az/3wej5Ur
-
AstraZeneca
@AstraZeneca
Ovarian cancer can impact anyone born with ovaries, regardless of background or gender identity. On #wocd2022, we stand with the ovarian cancer community so that when it comes to rapid diagnosis and care there is #nopersonleftbehind. Learn more: know.az/3KKVvnm
-
AstraZeneca
@AstraZeneca
#biomarker testing in #lungcancer is critical to identifying patients most likely to benefit from targeted therapies, yet uptake of such critical testing remains low. A new report from @LungAmbition identifies 3 areas to improve access: know.az/3w4qTrB #lungambition
-
AstraZeneca
@AstraZeneca
We’re partnering with the respiratory community to call for policies that challenge oral corticosteroids use as the status quo in #asthma care. know.az/37Zywrp
-
AstraZeneca
@AstraZeneca
We are committed to creating an environment where science can thrive. Our postdocs gain access to the expertise, compounds, novel tools and mentoring support they need to turn ideas into reality. Our vibrant community is exploring #whatsciencecando. know.az/3KsMaAh
-
AstraZeneca
@AstraZeneca
Ongoing gaps in asthma care, such as SABA over-reliance, have been revealed in a new Annual Asthma Patient Survey, conducted by IPSOS and funded by AstraZeneca with @GAAPP counsel on content. Here's why change is needed: know.az/38IEyww #worldasthmaday
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
As we begin to return to a ‘normal’ way of life, people with chronic lymphocytic leukaemia who are immunocompromised must take extra precautions to ensure their health and safety. Dr. Nitin Jain, who specializes in #cll at @MDAndersonNews, explains the challenges patients face.
-
AstraZeneca
@AstraZeneca
2022 is off to a positive start at AstraZeneca with strong Q1 results announced today. We look forward to another year of progress and providing patients all over the world access to our life-saving medicines. $AZN
-
AstraZeneca
@AstraZeneca
Tomorrow 29 April we will announce our 2022 Q1 financial results. A conference call and webcast for investors and analysts is planned, followed by Q&A. Register here: know.az/3EXJKIM $AZN
-
AstraZeneca
@AstraZeneca
.@MenePangalos discussed the potential of Precision Medicine for chronic diseases during #wuxihealthcareforum. Novel genetic and biomarker insights will help us better understand and treat billions of patients worldwide. Video available here: know.az/3ENjKA2
-
AstraZeneca
@AstraZeneca
Cancer care has been profoundly impacted by the pandemic. In the UK, an estimated 12,000 people could be living with undiagnosed breast cancer due to the impact of the pandemic on national screening services.
Don’t wait. Contact your doctor. Get checked #newnormalsamecancer -
AstraZeneca
@AstraZeneca
Throughout the COVID-19 pandemic, it has been challenging to assess the potential risks and benefits of every situation for an immunocompromised person living with chronic lymphocytic leukaemia (CLL). Dr. Joanna Rhodes, a #cll expert from @NorthwellHealth, shares her view.
-
AstraZeneca reposted
The Sustainable Markets Initiative
@TheSMI
Over 450 organisations now support the Terra Carta; a recovery plan that puts Nature, People and Planet at the heart of global value creation. Get involved here: terracarta.report/get-involved #earthday #terracarta
-
AstraZeneca
@AstraZeneca
If a person becomes infected with COVID-19, their symptoms and severity of illness depend on many factors. Prevention remains the ultimate goal in protecting those at highest risk of becoming severely ill or dying. know.az/3JY7Kws
-
AstraZeneca
@AstraZeneca
In collaboration with @stefano_romeo76, we identified and validated PSD3, a novel therapeutic target for non-alcoholic steatohepatitis (NASH) — a chronic liver disease. Learn more about the early R&D process for identifying and validating novel targets: know.az/3OqAxgN!
-
AstraZeneca
@AstraZeneca
We are focused on our collective responsibility to create a more sustainable world for people, society, and the planet — working together and without delay. Find out what actions we are taking to #investinourplanet know.az/3K36mbS #earthday2022
-
AstraZeneca
@AstraZeneca
We're proud to be one of the first companies aligned to @sciencetargets #netzerostandard
Using a science-led approach, we’re delivering deep decarbonisation across our value chain through our flagship Ambition Zero Carbon programme: know.az/3JWSZdi #netzeroactionday
Science Based Targets initiative
@sciencetargets
🌎 Today, during Earth Week, the SBTi is leading a #netzeroactionday! 🌍
On this day, we're celebrating companies with approved science-based #netzero targets and calling on more businesses across the world to set science-based #netzerotargets.
sciencebasedtargets.org/blog/netzeroactionday-its-now-or-… -
AstraZeneca
@AstraZeneca
With public health measures against COVID-19 relaxing in many countries, and an increased prevalence of the highly transmissible Omicron BA.2 subvariant, we believe there has never been a more important time to protect vulnerable populations from COVID-19. know.az/3vvKXmD
-
AstraZeneca
@AstraZeneca
Pushing the boundaries of science has never been more urgent. Enter the R&D Postdoctoral Challenge — innovative ideas will be critiqued by a world-leading judging panel with potential to secure a fully funded postdoctoral position. #postdoc know.az/37ljv2c
-
AstraZeneca
@AstraZeneca
Scientists work to establish the type of cells and antibodies a #vaccine triggers to prevent illness and their levels over time. This can inform how well and how long a vaccine can offer protection and the benefits #boosters may provide. #whatsciencecando know.az/37bk8fr
-
AstraZeneca
@AstraZeneca
Clinical trial data reflect a controlled trial environment, while #realworldevidence refers to data collected in everyday clinical practice. Utilising both trial data and RWE can help physicians improve patient care and prognosis. #lcsm
-
AstraZeneca
@AstraZeneca
Matthew Ellis, who joined AstraZeneca after a long career in academia, shares his enthusiasm about the research we presented at @AACR. Learn how we’re following the science to develop the next wave of cancer medicines: know.az/37gSzkA #aacr22
-
AstraZeneca
@AstraZeneca
BioVentureHub is our #acatalystnetwork R&D innovation hub in Sweden, providing opportunities for emerging companies and academic groups to partner with AstraZeneca scientists to deliver innovative, patient-centric, healthcare solutions.
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Our 6 months at @Expo2020Dubai has come to a close, where we convened leading minds to solve some of societies’ greatest challenges. Learn how collaborations sparked at #expo2020 will drive the solutions of tomorrow: #collab4healthierworld know.az/3xtzg2f
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Join our upcoming Immunology R&D Spotlight event to learn how we are advancing research for immune diseases. Meet our experts and learn about their career pathways and current areas of innovative scientific focus. know.az/3jxbqL0
-
AstraZeneca
@AstraZeneca
To tackle the #covid19 pandemic, we are fostering collaboration across all sectors, exploring new agile ways of working together. We know how important it is to pair cutting-edge science with a truly unified response. know.az/379zLUi
-
AstraZeneca
@AstraZeneca
Supporting healthy people and a healthy planet, we’re pleased to announce @VidyutMohan of @BiomassTakachar as a winner of @OneYoungWorld Lead2030 Challenge. Takachar’s innovative technology reduces the harmful effects of air pollution. #oyw2022 #younghealthprogramme
-
AstraZeneca
@AstraZeneca
Last month we launched the #occ, a coalition between AstraZeneca, @ESGO_Society and ENGAGe. The OCC aims to be the catalyst for a new era of innovation, by bringing together stakeholders to help ignite a behavioural change and deliver progress and science. know.az/37ea6d0
-
AstraZeneca
@AstraZeneca
Using immuno-oncology (IO) agents we are providing the immune system tools to trigger natural defenses against cancer. Read about our latest innovations in IO including the emerging promise of bispecific antibodies: know.az/3NV7otD #aacr22
-
AstraZeneca
@AstraZeneca
We are once again listed as an @FT Europe Climate Leader. Our bold action on climate puts us among the leading companies across Europe that have shown the highest reduction in emissions intensity in 2015-2020. Learn more about Ambition Zero Carbon: know.az/35Smj6K
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
With World Health Day focused on ‘Our health, our planet’, we’re proud to announce Enkhuun Byambadorj of @BreatheMongolia as a @OneYoungWorld Lead2030 Challenge winner. Enkhuun shares her mission to combat air pollution. #oyw2022 #younghealthprogramme know.az/3DTM5UP
-
AstraZeneca
@AstraZeneca
This World Health Day, we remain committed to broadening access to healthcare. By following a science-led #sustainability approach, we believe in creating a #healthiertomorrow for our planet and our health. know.az/3JbPHm8
-
AstraZeneca
@AstraZeneca
#vaccines can provide effective protection against serious illness for people who have been vaccinated and help to reduce the spread of infection in a population. #whatsciencecando know.az/3NW87em
-
AstraZeneca
@AstraZeneca
Global collaboration is key to scientific discovery. Our postdocs come from all corners of the world. The R&D Postdoctoral Challenge will bring together some of the brightest minds in the industry to accelerate progress. #postdoc #whatsciencecando know.az/3K9QwgF
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
For decades, SABA reliever inhalers have been readily available to people with asthma, but new evidence shows that using three or more SABA inhalers a year can increase the risk of asthma attacks. Learn more on why now is the time to #breakoverreliance know.az/3Dnr9Fe
-
AstraZeneca
@AstraZeneca
John Bowis, former UK Minister of Health, provides us with his insights from the Chronic Kidney Disease Summit at EXPO Dubai 2020 which brought together policymakers, healthcare workers, and health stewards from across the kidney community. know.az/3qDMdSV
-
AstraZeneca
@AstraZeneca
Earlier detection of chronic kidney disease (CKD) is critical for slowing the progression of the disease and reducing complications.
Our article in @NewsMedical outlines steps physicians can take to start diagnosing CKD earlier in their patients. know.az/3NqQcfA -
AstraZeneca
@AstraZeneca
Everyone should know their kidney health. There are common risk factors to consider, and it only takes one minute to help assess if you are at risk. Learn from our sponsored article with @Guardian why now is the time to check your kidneys. know.az/3DfZDK6
-
AstraZeneca
@AstraZeneca
Unlocking ground-breaking innovation calls for determination to make the right choices to win. Learn how we’re guided to continuously grow and strengthen our capabilities: know.az/3DmVIeA
-
AstraZeneca
@AstraZeneca
At @expo2020dubai we launched our R&D Postdoctoral Challenge. Outstanding candidates can secure a fully funded postdoc role to help accelerate drug discovery. Our launch event includes details on how to propose your innovative R&D ideas. #postdoc know.az/3tKcn8o
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
One year ago this week, we learned of the tragic, sudden passing of José Baselga, a visionary leader whose contributions transformed oncology treatment and research. We are sharing the story of #cancersfiercestopponent to celebrate José’s life and legacy. know.az/3JJE2My
-
AstraZeneca
@AstraZeneca
Triple negative breast cancer is an aggressive form of breast cancer in which the tumour doesn’t express oestrogen or progesterone receptors and makes low levels of HER2 proteins. It is associated with poor outcomes, making new approaches to care crucial to help patients.
-
AstraZeneca
@AstraZeneca
Latest research published in @NatureComms advances #crispr gene editing for precise DNA insertions. know.az/3NlLDTG
-
AstraZeneca
@AstraZeneca
We’re announcing two new #reforestation projects in Ghana and the US with @circbioalliance, @NGP_TechAssist and @NFWFnews, as part of our #azforest goal to plant over 50m trees globally by the end of 2025, supporting ecological and community resilience. know.az/3qybPRc
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Individuals with BRCA1 or BRCA2 gene mutations have an increased risk of developing certain cancers such as prostate, breast, gastric or colorectal cancers. BRCA testing can help identify those at increased risk and inform care plans for those who are diagnosed with cancer.
-
AstraZeneca
@AstraZeneca
Our postdocs gain valuable industry experience with the room to remain on the academic track. They have the autonomy to undertake their own research to advance scientific discovery. Help accelerate drug development through the R&D Postdoctoral Challenge. know.az/3qsykXQ
-
AstraZeneca
@AstraZeneca
As pressure on our water resources grows, so does the need for #waterstewardship. We are working collaboratively with @_A4WS and @WWF towards addressing shared water challenges. #worldwaterday Learn more: www.astrazeneca.com/sustainability/environmental-protecti…
Alliance for Water Stewardship (AWS) 💧
@_A4WS
Happy #worldwaterday! Today reminds us all how important our water resources are. Good #waterstewardship can help protect our #groundwater and #surfacewater for future generations. But what is Water Stewardship? Watch our video below & learn more at a4ws.org
-
AstraZeneca
@AstraZeneca
We’re a founding member of @NDinBusiness in the UK — an industry forum to support #neurodivergent individuals in the workplace. It’s part of our commitment to ensure that all our employees can make the biggest possible difference to patients and society.
-
AstraZeneca
@AstraZeneca
The risk of developing ovarian cancer is influenced by several factors. However, having one or more risk factors does not mean that you will definitely develop the disease. If you have concerns or want to learn more about the risk factors speak to your doctor. #sgomtg
-
AstraZeneca
@AstraZeneca
For us, #neurodiversitycelebrationweek is another reminder of the strength our differences bring. Read what Ashley, one of our neurodivergent colleagues, has to say: know.az/36cOZaE
-
AstraZeneca
@AstraZeneca
Doctors can use the presence of certain biomarkers to gain an understanding of people’s genetic differences and their cancers. This can help tailor care plans for each patient. To learn more about the potential role of biomarkers in cancer care plan speak to your doctor. #sgomtg
-
AstraZeneca
@AstraZeneca
Launched today, the R&D Postdoctoral Challenge is seeking innovative research proposals. Transformative breakthroughs could help advance scientific discovery. #postdoc #whatsciencecando know.az/3ie4phc
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Great discussions on nurturing early talent during @expo2020dubai. Scientific leaders including Nobel Laureate @e__charpentier and @MenePangalos shared their thoughts on the future of R&D and how to develop science leaders of tomorrow. know.az/3COPDaa
-
AstraZeneca
@AstraZeneca
Tomorrow we’re launching an ambitious challenge where outstanding candidates can secure fully funded postdoctoral research positions to transform future treatments. Register to join the live launch event. #postdoc know.az/3JtlDTK
-
AstraZeneca
@AstraZeneca
This week Nobel Laureate @e__charpentier will be leading a Nobel Prize Inspiration Initiative session alongside @MenePangalos during @expo2020dubai. Live event at 11am GST with insights and guidance for students interested in science careers. know.az/3KKahuR
-
AstraZeneca
@AstraZeneca
At @expo2020dubai, we launched Accelerating Change Together (ACT) for Cancer Care, an initiative aimed at transforming the way people with cancer are diagnosed and treated. Learn more: know.az/36kyitR
-
AstraZeneca
@AstraZeneca
We are advancing a partnership with @honeywell to develop next-generation pressurised metered-dose inhalers (pMDIs), with a near-zero Global Warming Potential propellant as part of our #ambitionzerocarbon commitment. #sustainability know.az/3MG7t3P
-
AstraZeneca
@AstraZeneca
How do we empower each other to be the best we can be to deliver life-changing medicines to patients? Learn how our coaching and feedforward approach is making a difference at AstraZeneca: know.az/37pkQ8r
-
AstraZeneca
@AstraZeneca
While respiratory syncytial virus leads to mild, cold-like illness for most infants, it is the leading cause of lower respiratory tract infections among young children worldwide.
Sanne’s son, Thjis, required hospitalisation when he contracted RSV at five weeks old. -
AstraZeneca
@AstraZeneca
Are you excited to progress scientific discovery? Register to learn the details of our new R&D Postdoctoral Challenge launching next week, offering outstanding candidates the opportunity to secure a fully funded postdoctoral position. #postdoc know.az/3I96ghP
-
AstraZeneca
@AstraZeneca
Our revolution to redefine cancer care continues today at @expo2020dubai as we host global experts in a discussion on how we can make cure a reality. know.az/35KLJDs #collab4healthierworld
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Our Oncology Summit at @expo2020dubai starts now. But you don’t have to be in Dubai to participate. Follow @cancermd — Dr. Sunil Verma, our Global Head of Oncology, Medical — for live updates from #expo2020 #collab4healthierworld
-
AstraZeneca
@AstraZeneca
This #worldkidneyday, prioritise your health and set aside one minute to take a quiz to learn about your risk of developing chronic kidney disease. know.az/3KvRN13
Quiz developed by @ISNKidneyCare with support from AstraZeneca. -
AstraZeneca
@AstraZeneca
On #worldkidneyday join us virtually for the first Chronic Kidney Disease (CKD) Summit at EXPO Dubai 2020. We'll identify solutions together to catalyse action & improve kidney health while strengthening the health care system as part of pandemic recovery. know.az/360vfqe
-
AstraZeneca
@AstraZeneca
Respiratory syncytial virus, or #rsv, can be unpredictable. While it typically causes mild symptoms, some infants can develop severe disease and potentially require hospitalisation during their first RSV season. know.az/3vO6NDw
-
AstraZeneca
@AstraZeneca
Ovarian cancer causes more deaths than any other gynaecological cancer. Today we launch the Ovarian Cancer Commitment (#occ), a coalition with @ESGO_Society and ENGAGe that aims to improve outcomes in ovarian cancer. know.az/3sUvjRq
-
AstraZeneca
@AstraZeneca
Do you share our passion for advancing scientific discovery? Then register to hear about our new R&D Postdoctoral Challenge, launching on 17 March. It’s your opportunity to explore #whatsciencecando for some of the world’s most complex diseases. #postdoc know.az/3tWkXA7
-
AstraZeneca
@AstraZeneca
.@susanmgalbraith and many other women across AstraZeneca #breakthebias every day in their work delivering life-changing medicines to patients.
Discover how we’re empowering #womeninscience:
know.az/3hOeqBH
#iwd2022 -
AstraZeneca
@AstraZeneca
Over the last two years, the scientific community has come together and made strides to tackle #covid19. But our work isn't done yet – we must address #vaccinequity globally to succeed in the fight against the pandemic. know.az/3tseDjj
-
AstraZeneca
@AstraZeneca
Nearly one year ago, we lost a pioneering doctor who made a lasting impact on cancer research. Today “José Baselga: Cancer’s Fiercest Opponent” premieres to honour his legacy. Watch on @TheAtlantic: know.az/3hMabXe #cancersfiercestopponent
-
AstraZeneca
@AstraZeneca
We are proud to contribute to the @FTSEWomenLeader and reinforce our commitment to gender equality and inclusion. Read the full report here: know.az/34ipaVW
-
AstraZeneca
@AstraZeneca
#rsv, a common respiratory virus among infants and young children spread through coughs or sneezes, is contracted by 90% of all children by the age of two. know.az/3HIv93U
-
AstraZeneca
@AstraZeneca
Ongoing disruptions to #colorectalcancer care due to the COVID-19 pandemic are increasing the number of late-stage diagnoses. Access to screening and early diagnosis is vital to improve survival rates. #newnormalsamecancer
-
AstraZeneca
@AstraZeneca
Our 2021 #sustainability Report outlines the progress we have made with partners on delivering our interconnected sustainability priorities for healthy people, a healthy society, and a healthy planet. know.az/3HvxMGc
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
We are deeply troubled by the events unfolding in #ukraine and the tragic loss of life. We condemn any unprovoked attack and have been working to assist the people affected by this tragedy — protecting employees, ensuring medicines reach patients, and assisting relief efforts.
-
AstraZeneca
@AstraZeneca
Our ambition is to one day cure cancer in every form. But how close are we to making this reality? Join us virtually at @expoDubai2020 for our oncology event on 11 March with experts from the cancer community. Register here know.az/3C1Zbyo #collab4healthierworld #expo2020
-
AstraZeneca
@AstraZeneca
Epithelial science is an evolving frontier in asthma research. Continuing to uncover the complexities and characterisation of the epithelium is critical in addressing the unmet needs in #severeasthma and revolutionising treatment options. #aaaai22
-
AstraZeneca
@AstraZeneca
The Healthcare System Resilience Summit at @expo2020dubai convened leaders and experts to drive stronger health systems.
These leaders have signed a global statement urging action to ensure health system integrity in a post-pandemic world: know.az/3vp663n
AstraZeneca
@AstraZeneca
@wef, @LSEhealthpolicy, @Philips, @HospitalsApollo, @KPMGHealthcare.
-
AstraZeneca
@AstraZeneca
We push the boundaries of science to transform the lives of people living with #severeasthma and enable them to live full and healthy lives on their terms. We’re sharing the latest research in epithelial science at #aaaai22 know.az/3hrOtHP
-
AstraZeneca
@AstraZeneca
A new opportunity is coming soon for outstanding final year MD and/or PhD students and Postdoctoral Researchers. Register to find out how you can help improve the lives of people with some of the world’s most complex diseases. #postdoc know.az/3Ma3SKZ
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
It is not widely known that a broad range of inflammatory diseases may share a common underlying cause, but we now know that for some patient groups, eosinophilic inflammation may be a key driver of their disease. Learn why this is important: know.az/3M0qWfe #aaaai22
-
AstraZeneca
@AstraZeneca
We were one of the first companies globally to have our #netzero targets verified by @sciencetargets. We’re now also calling on our key suppliers and partners to have science-based targets to help decarbonise the healthcare value chain: know.az/3vdpZdx
-
AstraZeneca
@AstraZeneca
We’re making good progress on our ambition to be zero carbon for Scopes 1 and 2 by the end of 2025 and we’re engaging across our supply chain to accelerate the delivery of #netzero healthcare. know.az/3I8ZGZO
-
AstraZeneca
@AstraZeneca
Our latest publication in the European Respiratory Journal explored a new proteomics panel to detect proteins associated with #asthma. It could help us to identify new asthma biomarkers and potentially lead to novel targets. know.az/3h4xOdq
-
AstraZeneca
@AstraZeneca
Gallbladder and bile duct cancers are rare but devastating. While the pandemic continues to stretch healthcare resources, some people are facing delays to surgery. Early diagnosis and treatment remain critical for all cancers to improve treatment outcomes. #newnormalsamecancer
-
AstraZeneca
@AstraZeneca
Many of the risk factors associated with prostate cancer are predetermined. Despite this, there are steps we can take to mitigate the risks, including regular screening. For those with known genetic mutations and/or family history, screening should begin at an earlier age. #gu22
-
AstraZeneca
@AstraZeneca
Early diagnosis remains one of the best ways of improving outcomes in #prostatecancer. Understanding the potential symptoms and risk factors can greatly increase the chance of diagnosing it early. #gu22 know.az/3gQk6KY
-
AstraZeneca
@AstraZeneca
Our scientists are working hard to usher in a new era of care for systemic lupus erythematosus (SLE). Understanding the disease pathology at the pathway level can give us an opportunity to bring balance back to the immune system. know.az/3rVOk5M
-
AstraZeneca
@AstraZeneca
Systemic lupus erythematosus (SLE) can impact any organ system and organ damage can accumulate even during periods of remission, when the disease is seemingly quiet. We’re challenging the status quo by unlocking innovative scientific advancements to support the #lupus community.
-
AstraZeneca
@AstraZeneca
In honour of #february11 the International Day of Women and Girls in Science, some of our #womeninstem shared what motivated them to pursue science careers. See how #stem has impacted them. know.az/3JgBe8O
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
2021 was a remarkable year in the history of AstraZeneca, as we welcomed our new colleagues from @AlexionPharma, delivered pipeline advances and achieved double digit growth in all major regions. know.az/3Jz5PyP $AZN
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Today we announce our 2021 financial results, as we reflect on a year of exceptional pipeline and commercial delivery, coupled with accelerated strategic and financial transformation through the acquisition of @AlexionPharma. know.az/3BaRmpy $AZN
-
AstraZeneca
@AstraZeneca
We are looking forward to this collaborative webinar on 15 February, organised by the @HealthPolicyPtp. Join us to hear leading experts and policymakers discuss how we can improve the diagnosis, treatment and care of #lungcancer in Europe.
The Health Policy Partnership
@HealthPolicyPtp
How can we ensure advances in #lungcancer diagnosis and treatment improve outcomes across Europe?
Join us for the webinar ‘Building a comprehensive approach to lung cancer in Europe’ to hear the answers from leading experts. Register now: hpolicy.co/LC-webinar -
AstraZeneca
@AstraZeneca
#vaccinefacts - Technology and science work hand in hand to discover and manufacture vaccines rapidly without compromising safety, quality or effectiveness. #whatsciencecando know.az/34lF4yS
-
AstraZeneca
@AstraZeneca
How can we improve and strengthen healthcare delivery? Leon Wang, EVP International, will explore how we can co-create future care pathways to improve health in emerging economies through innovative partnerships and technology. #prescriptionforprogress know.az/34o4I5X
-
AstraZeneca
@AstraZeneca
The #acatalystnetwork is seeking partners — from healthcare professionals, academia, policy makers to entrepreneurs — to develop patient-centric solutions. Join our mission, submit a partnership proposal today: know.az/3H6PccF
-
AstraZeneca
@AstraZeneca
Cancer doesn’t wait. But the pandemic has amplified equity gaps in cancer care, reducing access to vital services for those already experiencing barriers to care. To #closethecaregap, access to prevention and treatment must be available to all #worldcancerday #newnormalsamecancer
-
AstraZeneca
@AstraZeneca
We continue to push for better access to life-saving screenings and treatments that have the potential to redefine cancer care. We are making tangible progress - but we cannot do this alone. Now more than ever, we need to work together to #closethecaregap #worldcancerday
-
AstraZeneca
@AstraZeneca
Ahead of #worldcancerday, we are honouring #cancersfiercestopponent — José Baselga — and his groundbreaking contributions in #oncology with a clip from the documentary film, “José Baselga: Cancer’s Fiercest Opponent” premiering on @TheAtlantic in March.
-
AstraZeneca
@AstraZeneca
Together with @PlanUK, our #younghealthprogramme is focused on tackling the growing #mentalhealth and wellbeing challenges faced by young people across the UK. This #timetotalk Day, we encourage you to start a conversation about mental health with a young person in your life.
-
AstraZeneca
@AstraZeneca
#vaccinefacts – As more people in a community are vaccinated, the circulation of a virus is expected to decrease, reducing the chance of further infection. #whatsciencecando know.az/32UsENC
-
AstraZeneca
@AstraZeneca
The #acatalystnetwork has over 20 global hubs working with many stakeholders to tackle healthcare challenges through innovation. If you have an idea that can transform patient lives, submit your proposal: know.az/3KXtv1b
-
AstraZeneca
@AstraZeneca
We identified a gene in which a variation can protect against liver fat accumulation, inflammation and fibrosis. Downregulating the gene reduces fatty liver disease, which could lead to new therapies to treat NASH. know.az/3rfSvZH #precisionmedicine #nash
-
AstraZeneca
@AstraZeneca
Our @expo2020dubai Healthcare System Resilience Summit today at @expo2020se has brought together health ministers and global experts, urging adoption of the #phssr resilience framework and harnessing the power of collaboration for a healthier world. www.astrazeneca.com/media-centre/articles/2022/Convening-…
AstraZeneca
@AstraZeneca
-
AstraZeneca
@AstraZeneca
Health Week begins tomorrow @expo2020dubai. As partners of @expo2020se we’re working with governments, leaders and innovators to drive real progress on health system resilience, a part of our #collab4healthierworld programme know.az/3rW0M4h
-
AstraZeneca
@AstraZeneca
A new collaboration with @ScorpionTX will create therapies targeting transcription factors, a key class of proteins in #oncology that were once considered undruggable. Patients globally may benefit from the discovery and development of these transformative treatments.
-
AstraZeneca
@AstraZeneca
Our new global R&D facility - The Discovery Centre (DISC) - in #cambridge, UK exemplifies our belief in #whatsciencecando. It demonstrates our dynamic and innovative approach to R&D and our commitment to delivering breakthroughs that will benefit patients around the world.
-
AstraZeneca
@AstraZeneca
Congratulations to Aradhana Sarin, Executive Director & CFO, for being named one of @FiercePharma's Fiercest Women in Life Sciences 2021. Aradhana’s diverse experience has always aligned with her mission of positively impacting the health of others. www.fiercepharma.com/special-report/women-life-sciences-2…
-
AstraZeneca
@AstraZeneca
Inspiring students to pursue a passion for STEM from a young age, like @susanmgalbraith did, is integral to our commitment to STEM education. Explore our #stemed content this week during #scifest, a virtual expo hosted by @USAScienceFest: scifest.vfairs.com?linkId=136508911
-
AstraZeneca
@AstraZeneca
Female representation, particularly in senior leadership positions, is crucial for healthy societies. Join us to show #girlsbelonghere. #younghealthprogramme www.astrazeneca.com/media-centre/articles/2021/girls-belo…
-
AstraZeneca
@AstraZeneca
Creating education & employment opportunities for girls and women can improve their health outcomes. To show #girlsbelonghere, see how girls around the world are stepping into AstraZeneca leadership positions. #dayofthegirl #younghealthprogramme @PlanUK
This media couldn't be displayed. See it on the original post. -
AstraZeneca
@AstraZeneca
Our AZ Forest initiative to plant and maintain 50 million trees worldwide by 2025 is contributing to @WEF’s @1t_org and the #trilliontrees community to help accelerate the sustainable transition. 1tr.org
-
AstraZeneca
@AstraZeneca
Pascal Soriot, CEO, discusses the importance of urgency, innovation and partnership to tackle climate change in a new @WEF blog post. #sdis21 know.az/2XCR8rr
-
AstraZeneca
@AstraZeneca
Our new EVP of Oncology R&D @SusanMGalbraith recently discussed her inspiring career journey and reflected on her experience as a woman in leadership in a recent podcast with @PharmaVoice. Listen here: know.az/3eCdvTD
-
AstraZeneca
@AstraZeneca
To address the urgent crisis in India, we are pledging humanitarian aid that will provide oxygen concentrators, medicines, PPE and other supplies via @DirectRelief. We also remain focused on fair, equitable access to vaccination to help end the pandemic. know.az/3o52cXE
-
AstraZeneca
@AstraZeneca
Today, on #earthday2021 and ahead of #cop26, EVP Sustainability, Katarina Ageborg joined @JudithMGough, @Perssonasa and @FrancesWay at @UKinSweden to share how we’re delivering on our #netzero commitments know.az/2QOslgY
-
AstraZeneca
@AstraZeneca
We are deeply saddened by the news that José Baselga, EVP Oncology R&D, has passed away. An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca. We send our condolences to his family. know.az/3tMm6sd
-
AstraZeneca
@AstraZeneca
How have health systems adapted to #covid19? Hear from leading experts on health sustainability and resilience, as part of our partnership with @LSEnews @WEF. Join the discussion, register from #phssr Summit, March 15-19. know.az/38g7HMm
-
AstraZeneca
@AstraZeneca
Last year, six of our R&D sites were certified by @My_Green_Lab, who measure best practices for sustainable labs. This is part of how we’re proactively managing our environmental impact. Discover our progress in this area in our 2020 Sustainability Report. know.az/3s1OOV7
-
AstraZeneca
@AstraZeneca
For a vaccine to progress from inception to authorisation in less than 12 months demonstrates #whatsciencecando. The collective efforts and dedication from everyone involved has made this monumental achievement possible.
-
AstraZeneca
@AstraZeneca
In 2020, teams across AstraZeneca have risen to the challenges #covid19 has posed to global health. Today’s advancement is a significant step forward in the fight against this pandemic. #whatsciencecando
-
AstraZeneca
@AstraZeneca
$AZN to acquire @AlexionPharma, accelerating the Company’s strategic and financial development $ALXN know.az/3mewhl3
-
AstraZeneca
@AstraZeneca
#covid19 should never stop anyone from seeking help in an emergency. If you have symptoms of a heart attack or stroke, seek help immediately. More advice here: world-heart-federation.org/heart-health/covid-19/ #useyourheart
-
AstraZeneca
@AstraZeneca
Digital and technology solutions are enabling R&D to operate effectively during the #covid19 pandemic by keeping our clinical trials on track, ensuring a positive patient experience within our trials and enabling R&D colleagues to stay connected: www.astrazeneca.com/what-science-can-do/labtalk/uncategor…
-
AstraZeneca
@AstraZeneca
We have reached an agreement with the Inclusive Vaccines Alliance to supply up to 400 million doses of @UniofOxford’s potential #covid19 vaccine to Europe at no profit www.astrazeneca.com/media-centre/articles/2020/astrazenec…
-
AstraZeneca
@AstraZeneca
Beyond #pride taking place each June, our efforts to cultivate an inclusive workplace culture for everyone, including those in the LGBTQIA+ community, are always ongoing. We're focused on making tangible progress year-round to advance equality for all. www.astrazeneca.com/content/astraz/media-centre/articles/…
-
AstraZeneca
@AstraZeneca
In our ambition to discover and develop monoclonal antibodies that recognise, bind to and neutralise the SARS-CoV-2 virus, we have signed new agreements with academia and US government agencies and plan to progress a combination approach: www.astrazeneca.com/media-centre/articles/2020/advancing-…
-
AstraZeneca
@AstraZeneca
On #worldenvironmentday we show our commitment to a circular bioeconomy to support sustainable post-COVID-19 recovery. Professor Jason Snape, Global Head of Environmental Protection, shares his thoughts on a resilient and healthy future: www.astrazeneca.com/content/astraz/media-centre/articles/…
-
AstraZeneca
@AstraZeneca
To further provide broad and equitable access to @UniofOxford potential #covid19 vaccine, we've signed agreements with @CEPIvaccines, @gavi & @SerumInstIndia to supply low-and-middle income countries and beyond www.astrazeneca.com/media-centre/articles/2020/astrazenec…
-
AstraZeneca
@AstraZeneca
The majority of #lungcancer cases are non-small cell lung cancer (NSCLC). Globally, up to 40% are #egfr-mutated disease. New targeted treatment approaches aim to address these specific receptors in cancer treatment. #asco20
-
AstraZeneca
@AstraZeneca
In a new @NatMachIntell paper, our scientists describe novel #ai based models that enable chemists and computers to work interactively to speed up the exploration of chemical space and the design of potential new drug molecules: go.nature.com/36847Sj
-
AstraZeneca
@AstraZeneca
We are stronger together in the fight against #covid19. @WorldHeartFed’s #useyourheart initiative is part of our new partnership to provide ongoing support and resources for people with cardiovascular disease and associated risks. www.astrazeneca.com/content/astraz/media-centre/articles/…
-
AstraZeneca
@AstraZeneca
Together with partners across industry, academia and government, we are taking a multipronged approach to helping patients around the world facing #covid19.
-
AstraZeneca
@AstraZeneca
Together with public research bodies and academic institutions, we are part of ACCORD, a new UK government-led initiative aiming to expedite the development of medicines to treat patients hospitalised with #covid19: www.astrazeneca.com/media-centre/articles/2020/astrazenec…
-
AstraZeneca
@AstraZeneca
Clean and plentiful water is fundamental to human health, which is why we’ve begun a partnership with @WWFSverige to continue to develop our approach to water stewardship. www.astrazeneca.com/media-centre/articles/2020/water-stew… #earthday2020
-
AstraZeneca
@AstraZeneca
We believe in the power of collaboration and we’re honored to be a part of this new partnership with @NIH and @FNIH_Org to drive solutions in the fight against #covid19. #activ
-
AstraZeneca
@AstraZeneca
We're accelerating research on #covid19 therapies and partnering to boost testing to help patients in urgent need. We announced a new trial evaluating how one of our existing medicines may help alleviate the “cytokine storm” associated with this disease. www.astrazeneca.com/media-centre/articles/2020/investigat…
-
AstraZeneca
@AstraZeneca
Huge congratulations to @MenePangalos, EVP BioPharmaceuticals R&D, who has been awarded a knighthood by Her Majesty The Queen in the New Year 2020 Honours List. The award recognises Mene’s services to UK science:
www.astrazeneca.com/media-centre/press-releases/2019/astr… #newyearshonours -
AstraZeneca
@AstraZeneca
We believe #machinelearning and #deeplearning can help us make a big change in how we design new medicines. But collaboration –internally and externally – is essential to realising the potential of data science and #ai. Watch more: www.youtube.com/watch?v=jRd1psHY-XU
-
AstraZeneca
@AstraZeneca
Our IMED Biotech Unit EVP @MenePangalos delivered the opening lecture at @BritPharmSoc #pharmacology2018, discussing hot trends in #pharmacology and how our 5Rs approach to #drugdiscovery has transformed our pipeline. Find out more here www.bps.ac.uk/news-events/events/2018/december/pharmacolo…
-
AstraZeneca
@AstraZeneca
Our business mentors are supporting the @pitchatpalace Final tonight with @TheDukeofYork at Buckingham Palace, as part of our ongoing support for entrepreneurs. Good luck to the pitching teams!
-
AstraZeneca
@AstraZeneca
Congratulations to John B. Glen on winning the 2018 Lasker award for clinical medical research. John worked at ICI, a legacy company of AstraZeneca, and his work on developing anaesthetics has impacted worldwide, enabling millions of life-saving operations every year.
-
AstraZeneca
@AstraZeneca
As leaders in #diabetesresearch, we understand the importance #diabeteseducation plays in behaviour changes #t2d #wdd17
-
AstraZeneca
@AstraZeneca
Guest #labtalk post from @CellDynamics on the latest pluripotent #stemcell #technology we’re applying to our research www.labtalk.astrazeneca.com/hot-topics/guest-post-human-i…

















































































































































































































































































































































































































